About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Immunosuppressive Agents
- Company
- City of Hope Medical Center
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 150 recruiting
Efficacy results: Not yet reported
150 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 18, 2026
Find a Clinical Trial Near Me
See recruiting studies for Immunosuppressive Agents and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT00001352
Fungal Infection Susceptibility
National Institute of Allergy and Infectious Diseases (NIAID) 800 participants 1 siteOther conditions: Cryptococcal Infection, Cryptococcal Pneumonia, Pulmonary Cryptococcosis, Cryptococcal Meningitis, CryptococcosisView official trial listing → -
Recruiting NCT NCT01283295
Immune Monitoring and Assay Development in Organ Transplant Recipients
Emory University 5000 participants Est. completion 2028-12 2 sitesOther conditions: Organ Transplantation, Transplantation ImmunologyView official trial listing → -
Recruiting NCT NCT01555892
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
Not yet reported Baylor College of Medicine 136 participants Est. completion 2027-07-01 3 sitesOther conditions: Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease, LymphomaView official trial listing → -
Recruiting NCT NCT02310867
Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
Not yet reported Linda Cendales 50 participants Est. completion 2028-06 1 siteOther conditions: ImmunosuppressionView official trial listing → -
Recruiting NCT NCT02446431
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
Not yet reported Miller Children's & Women's Hospital Long Beach 20 participants Est. completion 2029-07 2 sitesOther conditions: Solid TumorView official trial listing → -
Recruiting NCT NCT03092180
Optimizing Treatment on Idiopathic Inflammatory Myopathies
University of Sao Paulo 60 participants Est. completion 2024-12-04 1 siteOther conditions: Idiopathic Inflammatory MyopathiesView official trial listing → -
Recruiting NCT NCT03173937
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 37 participants Est. completion 2032-03-01 1 siteOther conditions: Severe Aplastic Anemia, Hypo-Plastic MDS, Myelodysplastic Syndrome (MDS)View official trial listing → -
Recruiting NCT NCT03399175
Early Immunosuppressive Therapy on the Course of Vogt-Koyanagi-Harada Disease
Not yet reported University of Sao Paulo 40 participants Est. completion 2028-12 1 siteOther conditions: Vogt Koyanagi Harada DiseaseView official trial listing → -
Recruiting NCT NCT03520647
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 56 participants Est. completion 2028-06-01 1 siteOther conditions: Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)View official trial listing → -
Recruiting NCT NCT03591302
Delayed Blood Stem Transplantation in HLA Matched Kidney Transplant Recipients to Eliminate Immunosuppressive Drugs.
Not yet reported Stephan Busque 25 participants Est. completion 2028-10-01 1 siteOther conditions: Immune ToleranceView official trial listing → -
Recruiting NCT NCT03835312
Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM
Not yet reported Children's Hospital of Fudan University 50 participants Est. completion 2030-12-31 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1, Immunologic Deficiency SyndromesView official trial listing → -
Recruiting NCT NCT03852407
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning
Not yet reported University of Liege 114 participants Est. completion 2038-11-01 10 sitesOther conditions: Acute Myeloid Leukemia in Remission, Myelodysplastic Syndromes, Chronic Myeloid Leukemia in Remission, Myeloproliferative Syndrome, Myeloproliferative Disorder, Acute Lymphoid Leukemia in Remission, Multiple Myeloma, Chronic Lymphoid Leukemia, Non Hodgkin Lymphoma, Hodgkin LymphomaView official trial listing → -
Recruiting NCT NCT04098133
Epidemiology of Carbapenemase-producing Bacteria in a Swiss Tertiary Care Hospital
University Hospital, Basel, Switzerland 100 participants Est. completion 2029-06-30 1 siteOther conditions: Infections With CPBView official trial listing → -
Recruiting NCT NCT04106830
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Beijing Tiantan Hospital 1000 participants Est. completion 2028-12-31 1 siteOther conditions: NMO Spectrum Disorder, MRI, Multiple Sclerosis, MOGADView official trial listing → -
Recruiting NCT NCT04150744
RFA Plus Carrizumab vs Carrizumab Alone for HCC
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 120 participants Est. completion 2026-12-30 1 siteOther conditions: Tumor Immunity, Immunosuppression, Radiofrequency AblationView official trial listing → -
Recruiting NCT NCT04180085
Pilot Study: Interest of Belatacept as a Non-nephrotoxic Immunosuppressive Treatment in Cardiac Transplant Patients at Risk of Chronic Renal Failure (BELACOEUR)
Not yet reported Nantes University Hospital 25 participants Est. completion 2028-01-01 4 sitesOther conditions: Heart Transplant FailureView official trial listing → -
Recruiting NCT NCT04182984
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
Tang-Du Hospital 200 participants Est. completion 2026-06-30 1 siteOther conditions: Ocular Myasthenia GravisView official trial listing → -
Recruiting NCT NCT04207580
A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
University Hospital, Limoges 1180 participants Est. completion 2048-01 48 sitesOther conditions: Idiopathic Nephrotic SyndromeView official trial listing → -
Recruiting NCT NCT04474847
Abatacept for the Treatment of Giant Cell Arteritis
Not yet reported University of Pennsylvania 78 participants Est. completion 2029-12 10 sitesOther conditions: Giant Cell ArteritisView official trial listing → -
Recruiting NCT NCT04521790
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
Scientific Institute San Raffaele 1000 participants Est. completion 2035-12-31 1 siteOther conditions: Myocarditis, Ventricular Arrythmia, Inflammatory Cardiomyopathy, Genetic Predisposition, Autoimmunity, Arrhythmia, Cardiomyopathies, Immunosuppression, Catheter AblationView official trial listing → -
Recruiting NCT NCT04545762
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Not yet reported C. Babis Andreadis 36 participants Est. completion 2026-10-31 1 siteOther conditions: Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Diffuse Large B Cell Lymphoma, Small Lymphocytic Lymphoma, Transformed Lymphoma, Non-Hodgkin LymphomaView official trial listing → -
Recruiting NCT NCT04625907
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Not yet reported, Not yet reported University of Birmingham 1672 participants Est. completion 2030-06 128 sitesObstructive sleep apneaView official trial listing → -
Recruiting NCT NCT04702022
Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients
Not yet reported University of Liege 50 participants Est. completion 2027-01-01 1 siteOther conditions: Kidney Transplant Rejection, Kidney Transplant; ComplicationsView official trial listing → -
Recruiting NCT NCT04742621
Liver Transplantation for Unresectable Liver Limited Colorectal Metastases
Weill Medical College of Cornell University 20 participants Est. completion 2035-07-27 1 siteOther conditions: Unresectable Liver-limited Colorectal MetastasesView official trial listing → -
Recruiting NCT NCT04745728
Different Immunosuppressive Treatment in iMN
Not yet reported Peking Union Medical College Hospital 200 participants Est. completion 2029-12 1 siteOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Recruiting NCT NCT04877288
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Not yet reported Bristol-Myers Squibb 102 participants Est. completion 2034-06-30 38 sitesOther conditions: Renal Allograft RecipientsView official trial listing → -
Recruiting NCT NCT04888741
Methods of T Cell Depletion Trial (MoTD)
Not yet reported University of Birmingham 400 participants Est. completion 2027-08-23 17 sitesOther conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Chronic Myelogenous Leukemia, MyelofibrosisView official trial listing → -
Recruiting NCT NCT04924491
Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Prevent Rejection in Heart Transplant Children
Not yet reported, Not yet reported Rafael Correa-Rocha 11 participants Est. completion 2026-12-31 1 siteOther conditions: Heart TransplantationView official trial listing → -
Recruiting NCT NCT04936854
Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
Not yet reported Haukeland University Hospital 60 participants Est. completion 2028-12 1 siteOther conditions: Thyroid-Associated OphthalmopathyView official trial listing → -
Recruiting NCT NCT04972760
Baricitinib in Patients With Relapsing or naïve Dermatomyositis
Not yet reported Assistance Publique - Hôpitaux de Paris 62 participants Est. completion 2028-02-28 1 siteOther conditions: DermatomyositisView official trial listing → -
Recruiting NCT NCT05043870
Combined Immunosuppression for Pediatric Crohn's Disease
Not yet reported Children's Hospital of Fudan University 128 participants Est. completion 2026-12-31 1 siteOther conditions: Crohn Disease, Infliximab, Immunosuppression, Children, OnlyView official trial listing → -
Recruiting NCT NCT05284877
The Organ Transplant Recipient HPV and Skin Cancer Study
Merete Haedersdal 1500 participants Est. completion 2043-03 3 sitesOther conditions: Solid Organ Transplant Recipient, Skin Cancer, Skin Dysplasia, HPV Infection, Cervical Intraepithelial Neoplasia, Cervical Cancer, HPV-Related MalignancyView official trial listing → -
Recruiting NCT NCT05305066
Stand UP to Rheumatoid Arthritis (SUPRA)
Not yet reported Marie Hudson, MD 75 participants Est. completion 2030-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT05321758
Fecal Microbiota Transplantation as the First-line Treatment in Active Pediatric Crohn's Disease
Not yet reported Tongji Hospital 50 participants Est. completion 2027-06-30 1 siteOther conditions: Crohn DiseaseView official trial listing → -
Recruiting NCT NCT05385432
Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
Not yet reported University Hospital, Tours 244 participants Est. completion 2030-12-30 1 siteOther conditions: Renal Transplant Rejection, Induction TherapyView official trial listing → -
Recruiting NCT NCT05415267
Immunosuppression and COVID-19 Boosters
Not yet reported Kirby Institute 320 participants Est. completion 2026-12-31 5 sitesOther conditions: COVID-19View official trial listing → -
Recruiting NCT NCT05436418
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Not yet reported, Not yet reported National Cancer Institute (NCI) 260 participants Est. completion 2028-06-25 2 sitesOther conditions: Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell TransplantationView official trial listing → -
Recruiting NCT NCT05463133
Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2032-12-31 1 siteOther conditions: Chronic Granulomatous DiseaseView official trial listing → -
Recruiting NCT NCT05510323
Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
Not yet reported Air Force Military Medical University, China 208 participants Est. completion 2028-08 1 siteOther conditions: Glomerulonephritis, IGAView official trial listing → -
Recruiting NCT NCT05525507
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Not yet reported University of California, Los Angeles 10 participants Est. completion 2026-12 1 siteChronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and RejectionView official trial listing → -
Recruiting NCT NCT05698745
Immunological Characteristics of Preclinical IBD
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 450 participants Est. completion 2038-07-01 25 sitesOther conditions: Crohn Disease, Ulcerative Colitis, IBDView official trial listing → -
Recruiting NCT NCT05826535
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Not yet reported, Not yet reported Lyell Immunopharma, Inc. 270 participants Est. completion 2031-06-30 35 sitesOther conditions: Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Large B-cell LymphomaView official trial listing → -
Recruiting NCT NCT05832515
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis
Not yet reported St. Petersburg State Pavlov Medical University 200 participants Est. completion 2026-12-01 1 siteOther conditions: Multiple SclerosisView official trial listing → -
Recruiting NCT NCT05860400
Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study
Peking Union Medical College Hospital 39 participants Est. completion 2026-09 1 siteCardiovascular disease Other conditions: Coronary Artery Stenosis, Coronary Artery Restenosis, Inflammation, Inflammatory Disease, Inflammation VascularView official trial listing → -
Recruiting NCT NCT05888870
ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 50 participants Est. completion 2026-12-01 1 siteOther conditions: Hemophilia A With InhibitorView official trial listing → -
Recruiting NCT NCT05908331
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Not yet reported Concept Medical Inc. 492 participants Est. completion 2028-07 28 sitesCardiovascular disease Other conditions: In-Stent RestenosisView official trial listing → -
Recruiting NCT NCT05946564
A Trial to Evaluate the Efficacy of Pioglitazone to Promote Renal Tolerance in ANCA-associated Vasculitis - RENATO Trial
Not yet reported Assistance Publique - Hôpitaux de Paris 126 participants Est. completion 2028-11 25 sitesOther conditions: ANCA Associated Vasculitis, Rapidly Progressive Glomerulonephritis, Crescentic GlomerulonephritisView official trial listing → -
Recruiting NCT NCT05947669
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Not yet reported Odense University Hospital 195 participants Est. completion 2028-09 3 sitesOther conditions: ColitisView official trial listing → -
Recruiting NCT NCT05998759
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Not yet reported Beijing Hospital 296 participants Est. completion 2025-12 23 sitesOther conditions: Connective Tissue Diseases, ThrombocytopeniaView official trial listing → -
Recruiting NCT NCT06005493
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
Not yet reported, Not yet reported AstraZeneca 392 participants Est. completion 2029-03-16 25 sitesOther conditions: Gastric Cancer, Gastro-esophageal Junction Cancer, Pancreatic Ductal Adenocarcinoma, Esophageal AdenocarcinomaView official trial listing → -
Recruiting NCT NCT06047171
Rescue of Nephrons With ALE.F02 (RENAL-F02)
Not yet reported Alentis Therapeutics AG 80 participants Est. completion 2028-02-28 53 sites Stand-aloneOther conditions: Glomerulonephritis Rapidly ProgressiveView official trial listing → -
Recruiting NCT NCT06048484
Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
Not yet reported Gulam Manji 60 participants Est. completion 2027-04 5 sitesOther conditions: Pancreatic Ductal AdenocarcinomaView official trial listing → -
Recruiting NCT NCT06058078
RY_SW01 Cell Injection Therapy in Active Lupus Nephritis
Not yet reported Jiangsu Renocell Biotech Company 60 participants Est. completion 2028-12-31 1 siteOther conditions: Lupus NephritisView official trial listing → -
Recruiting NCT NCT06059989
InDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 158 participants Est. completion 2025-12 1 site Stand-aloneOther conditions: Inflammatory Disease, Disease Crohn, Bowel DiseaseView official trial listing → -
Recruiting NCT NCT06072482
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Not yet reported Amgen 300 participants Est. completion 2036-12-31 82 sitesOther conditions: Antineutrophil Cytoplasmic Antibody-associated VasculitisView official trial listing → -
Recruiting NCT NCT06193889
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Not yet reported, Not yet reported Kyverna Therapeutics 66 participants Est. completion 2028-09 22 sitesOther conditions: Myasthenia Gravis, Generalized Myasthenia GravisView official trial listing → -
Recruiting NCT NCT06213857
Beneficial Effect of Silymarin in Ulcerative Colitis
Not yet reported Tanta University 44 participants Est. completion 2025-06 2 sitesOther conditions: Ulcerative ColitisView official trial listing → -
Recruiting NCT NCT06249750
Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer
Not yet reported Pengyuan Liu 60 participants Est. completion 2026-12-31 1 siteOther conditions: Metastatic Castration-resistant Prostate Cancer (CRPC)View official trial listing → -
Recruiting NCT NCT06254248
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Not yet reported Assistance Publique - Hôpitaux de Paris 50 participants Est. completion 2030-01-01 10 sitesOther conditions: Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic TreatmentView official trial listing → -
Recruiting NCT NCT06262776
Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients
Not yet reported Central Adelaide Local Health Network Incorporated 160 participants Est. completion 2027-12 1 siteOther conditions: Immunosuppression, Vaccine Response ImpairedView official trial listing → -
Recruiting NCT NCT06271590
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels
Not yet reported Concept Medical Inc. 1605 participants Est. completion 2031-11 24 sitesCardiovascular disease Other conditions: Native Coronary Artery StenosisView official trial listing → -
Recruiting NCT NCT06327568
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens
European Institute of Oncology 200 participants Est. completion 2029-06-17 1 siteOther conditions: Anal Intraepithelial Neoplasia 2, Anal Intraepithelial Neoplasia 1, Anal Cancer, High-Risk CancerView official trial listing → -
Recruiting NCT NCT06347718
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease
Not yet reported, Not yet reported Miltenyi Biomedicine GmbH 24 participants Est. completion 2026-05-31 1 siteOther conditions: Systemic Lupus Erythematosus, Systemic Sclerosis, Dermatomyositis, PolymyositisView official trial listing → -
Recruiting NCT NCT06354179
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
Not yet reported University Hospital, Limoges 162 participants Est. completion 2028-04-15 18 sitesOther conditions: Liver Transplantation, ImmunosuppressionView official trial listing → -
Recruiting NCT NCT06358638
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
Not yet reported Children's National Research Institute 12 participants Est. completion 2054-09 1 siteOther conditions: Sickle Cell DiseaseView official trial listing → -
Recruiting NCT NCT06363006
Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular Cancer
Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2027-01-01 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Recruiting NCT NCT06371274
A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
Not yet reported First Affiliated Hospital of Zhejiang University 29 participants Est. completion 2026-04-30 1 siteOther conditions: Triple-negative Breast CancerView official trial listing → -
Recruiting NCT NCT06472219
PREDICATE Trial For Respiratory Tract Infections
Not yet reported The University of Hong Kong 1300 participants Est. completion 2028-12-08 1 siteOther conditions: Respiratory Tract InfectionsView official trial listing → -
Recruiting NCT NCT06552169
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Not yet reported Singulera Therapeutics Inc. 34 participants Est. completion 2031-12 7 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Recruiting NCT NCT06591260
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)
Scientific Institute San Raffaele 20 participants Est. completion 2030-12-31 1 siteOther conditions: Myocarditis, Ventricular Arrhythmia, Inflammatory Cardiomyopathy, Genetic Predisposition, Autoimmunity, Arrhythmia, Cardiomyopathies, Immunosuppresion, Catheter AblationView official trial listing → -
Recruiting NCT NCT06594068
Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Not yet reported AstraZeneca 16 participants Est. completion 2027-08-31 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Recruiting NCT NCT06609668
Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)
Centre Hospitalier Universitaire Dijon 78 participants Est. completion 2027-10 1 siteOther conditions: Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR)View official trial listing → -
Recruiting NCT NCT06646497
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years
Not yet reported Assistance Publique - Hôpitaux de Paris 52 participants Est. completion 2030-01-24 26 sitesOther conditions: Aplastic AnemiaView official trial listing → -
Recruiting NCT NCT06652126
Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria
University Hospital, Lille 1000 participants Est. completion 2029-12-01 1 siteOther conditions: Critically-ill PatientsView official trial listing → -
Recruiting NCT NCT06659029
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
AstraZeneca 442 participants Est. completion 2031-04-15 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Recruiting NCT NCT06682169
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease
Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 182 participants Est. completion 2030-12 41 sitesOther conditions: Graft-versus-host DiseaseView official trial listing → -
Recruiting NCT NCT06692426
Trial of Cell Based Therapy for DMD
Not yet reported Masonic Cancer Center, University of Minnesota 8 participants Est. completion 2027-03-03 1 siteOther conditions: Duchenne Muscular DystrophyView official trial listing → -
Recruiting NCT NCT06750172
Simplification of Oral Sodium Loading Test in the Diagnosis of Primary Aldosteronism: 2-day Replacing 3-day Method
Peking Union Medical College Hospital 33 participants Est. completion 2024-12-25 1 siteOther conditions: Primary AldosteronismView official trial listing → -
Recruiting NCT NCT06751992
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
Not yet reported Massachusetts General Hospital 92 participants Est. completion 2027-10-01 1 siteOther conditions: Kidney Transplant Recipients, Old AgeView official trial listing → -
Recruiting NCT NCT06753565
L-carnitine Supplementation in Rheumatoid Arthritis Patients
Not yet reported German University in Cairo 60 participants Est. completion 2025-06 1 siteOther conditions: Rheumatoid Arthritis (RA)View official trial listing → -
Recruiting NCT NCT06763848
Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder
Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 144 participants Est. completion 2026-12-31 1 siteOther conditions: Neuromyelitis Optica Spectrum DisordersView official trial listing → -
Recruiting NCT NCT06789172
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Not yet reported Epkin 146 participants Est. completion 2028-09 10 sitesObstructive sleep apnea Other conditions: Solid Tumours, Sarcoma, HNSCC, Non Small Cell Lung Cancer, NSCLC, Colorectal Cancer (CRC), Solitary Fibrous Tumors, Undifferentiated Pleomorphic Sarcoma (UPS), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic, Gastric / Gastroesophageal Junction AdenocarcinomaView official trial listing → -
Recruiting NCT NCT06795893
The Anifrolumab PRIM Program
AstraZeneca 240 participants Est. completion 2031-04-15 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Recruiting NCT NCT06801067
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Not yet reported Memorial Sloan Kettering Cancer Center 15 participants Est. completion 2027-01-24 7 sitesOther conditions: Diarrhea, EnterocolitisView official trial listing → -
Recruiting NCT NCT06817525
Nab-P+Cb+PD1 Inhibitors as Neoadjuvant Therapy for Early TNBC
Not yet reported Henan Cancer Hospital 64 participants Est. completion 2026-05-31 1 siteOther conditions: Triple-negative Breast CancerView official trial listing → -
Recruiting NCT NCT06821919
Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
Western Galilee Hospital-Nahariya 70 participants Est. completion 2031-12-30 1 siteOther conditions: Diabetes Mellitus, Kidney DiseaseView official trial listing → -
Recruiting NCT NCT06824714
Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation System
Nanjing Medical University 150 participants Est. completion 2028-07-01 1 siteOther conditions: Large Vessel VasculitisView official trial listing → -
Recruiting NCT NCT06829719
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
Not yet reported Hospices Civils de Lyon 600 participants Est. completion 2031-02-02 4 sitesOther conditions: Infection, Cancer, Rejection, Kidney TransplantationView official trial listing → -
Recruiting NCT NCT06829771
Clinical Trial of TQB2825 Injection Combined Immunochemotherapy in Subjects With Diffuse Large B Cell Lymphoma
Not yet reported, Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90 participants Est. completion 2026-12 25 sitesOther conditions: Diffuse Large B Cell LymphomaView official trial listing → -
Recruiting NCT NCT06834191
Relationship Between Immunosuppressive Treatment Status and Clinical Course of Parkinson's Disease
Medical University of Warsaw 80 participants Est. completion 2028-09 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06845410
Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study
Peking Union Medical College Hospital 120 participants Est. completion 2026-12 1 siteCardiovascular disease Other conditions: Coronary Artery Stenosis, Coronary Artery Restenosis, Inflammation, Inflammatory Disease, Inflammation VascularView official trial listing → -
Recruiting NCT NCT06859424
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Not yet reported Center for International Blood and Marrow Transplant Research 358 participants Est. completion 2028-06 13 sites Stand-aloneOther conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, MyelofibrosisView official trial listing → -
Recruiting NCT NCT06859437
Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department
Not yet reported Medical University of Silesia 300 participants Est. completion 2027-10-31 1 siteOther conditions: Clostridioides Difficile InfectionView official trial listing → -
Recruiting NCT NCT06864975
Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study)
Not yet reported Runhui WU 110 participants Est. completion 2028-06-21 1 siteOther conditions: Hemophilia a with InhibitorView official trial listing → -
Recruiting NCT NCT06866119
Effects of Estrogen on Heart Health in Women With Primary Ovarian Insufficiency
Massachusetts General Hospital 45 participants Est. completion 2029-06-30 1 siteOther conditions: Primary Ovarian Insufficiency, Premature Menopause, Metabolic Complications, Endothelial Function (FMD), Estrogen Replacement TherapyView official trial listing → -
Recruiting NCT NCT06873100
Efficacy, Safety and Immunological Evaluation of Upadacitinib for Relapsing Polychondritis
Not yet reported, Not yet reported Peking University People's Hospital 30 participants Est. completion 2026-12-31 1 siteOther conditions: Relapsing PolychondritisView official trial listing → -
Recruiting NCT NCT06874257
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20 participants Est. completion 2026-10-31 1 siteOther conditions: AML (Acute Myelogenous Leukemia)View official trial listing → -
Recruiting NCT NCT06881927
Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure
Not yet reported University Hospital, Strasbourg, France 212 participants Est. completion 2029-08-01 1 siteOther conditions: Sepsis and Septic Shock, Acute Respiratory Failure, Kidney Transplant Recipients, Immunosuppressive AgentsView official trial listing → -
Recruiting NCT NCT06885957
Monoclonal Antibody-Based Therapies for AQP4-Positive NMOSD
Tongji Hospital 200 participants Est. completion 2027-12-31 1 siteOther conditions: NMO Spectrum DisorderView official trial listing → -
Recruiting NCT NCT06900777
Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT
Not yet reported Xijing Hospital 90 participants Est. completion 2026-04-01 1 siteOther conditions: Vitiligo, Child, Progressive DiseaseView official trial listing → -
Recruiting NCT NCT06902896
Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy
Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 43 participants Est. completion 2028-12-31 1 siteHeart failure Other conditions: Dilated Cardiomyopathy (DCM)View official trial listing → -
Recruiting NCT NCT06962800
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
Not yet reported Biogen 180 participants Est. completion 2031-01-17 117 sitesOther conditions: Primary Membranous NephropathyView official trial listing → -
Recruiting NCT NCT06981767
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Oral Lichen Planus
Not yet reported Cairo University 42 participants Est. completion 2026-08-15 1 siteOther conditions: Oral Lichen PlanusView official trial listing → -
Recruiting NCT NCT07003997
JAK Signaling in Depression
Not yet reported Emory University 100 participants Est. completion 2030-02 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Recruiting NCT NCT07015684
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Not yet reported Columbia University 24 participants Est. completion 2032-03-12 1 siteOther conditions: Sickling Disorder Due to Hemoglobin SView official trial listing → -
Recruiting NCT NCT07021495
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Leiden University Medical Center 840 participants Est. completion 2029-12-31 8 sitesOther conditions: Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO), Atopic Dermatitis (AD), CTCL/ Mycosis FungoidesView official trial listing → -
Recruiting NCT NCT07042035
Study of Tacrolimus Melt-Dose® for Lung Transplant Patients
Chiesi España, S.A.U. 240 participants Est. completion 2026-12-31 2 sitesOther conditions: Lung Trasplant, Lung TransplantationView official trial listing → -
Recruiting NCT NCT07045467
Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
Not yet reported Qianfoshan Hospital 30 participants Est. completion 2027-06-01 1 siteChronic kidney disease Other conditions: Renal TransplantationView official trial listing → -
Recruiting NCT NCT07053462
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Not yet reported, Not yet reported AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90 participants Est. completion 2028-12-28 1 siteOther conditions: End-Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Renal Disease With Renal Transplant, Kidney Transplant Rejection, Kidney Tumor, Kidney Failure, Kidney IschemiaView official trial listing → -
Recruiting NCT NCT07053488
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Not yet reported, Not yet reported AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90 participants Est. completion 2028-12-28 1 siteOther conditions: Liver Diseases, Liver Cancer, Liver Cirrhosis, Liver Failure, Liver Metastases, Liver Transplant Rejection, Liver SteatosesView official trial listing → -
Recruiting NCT NCT07074951
Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy
Not yet reported St. Petersburg State Pavlov Medical University 240 participants Est. completion 2027-12-10 2 sitesOther conditions: Primary IgA-nephropathy, High-risk, CaucasiansView official trial listing → -
Recruiting NCT NCT07077486
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
Not yet reported Tongji Hospital 100 participants Est. completion 2027-03-25 1 siteOther conditions: Lupus or SLE, Interstitial Lung Disease, Systemic Lupus ErythematosusView official trial listing → -
Recruiting NCT NCT07084480
Giant Cell Arteritis - Ways to Precision Medicine
Wuerzburg University Hospital 400 participants Est. completion 2033-07-31 1 siteOther conditions: Giant Cell Arteritis, Polymyalgia Rheumatic (PMR)View official trial listing → -
Recruiting NCT NCT07104058
A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD
Not yet reported Luo Yaping 46 participants Est. completion 2027-12-01 1 siteOther conditions: IgG4-Related DiseasesView official trial listing → -
Recruiting NCT NCT07120464
Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations
Liaoning Chengda Biotechnology CO., LTD 180 participants Est. completion 2026-12-31 1 siteOther conditions: Rabies Exposure, Immunocompromised, Chronic DiseaseView official trial listing → -
Recruiting NCT NCT07138898
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Not yet reported NYU Langone Health 80 participants Est. completion 2028-01 1 siteOther conditions: Rheumatic DiseaseView official trial listing → -
Recruiting NCT NCT07143773
SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients
Not yet reported Odense University Hospital 88 participants Est. completion 2027-08-01 1 siteOther conditions: Kidney Transplantation Recipients, Sodium-Glucose Transporter 2 Inhibitors, Non-Diabetic Patients, Randomized Controlled Trial, Placebo Control DesignView official trial listing → -
Recruiting NCT NCT07173114
New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)
University Hospital, Montpellier 300 participants Est. completion 2026-09-22 2 sitesOther conditions: Hospitalization, All ConditionsView official trial listing → -
Recruiting NCT NCT07175285
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Bristol-Myers Squibb 223 participants Est. completion 2032-10-05 70 sitesOther conditions: Systemic Lupus Erythematosus (SLE)View official trial listing → -
Recruiting NCT NCT07214818
SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome
Not yet reported, Not yet reported Mansoura University 75 participants Est. completion 2026-09-06 1 siteOther conditions: Nephrotic SyndromeView official trial listing → -
Recruiting NCT NCT07242092
Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs
Not yet reported University of Sao Paulo General Hospital 192 participants Est. completion 2028-12-30 1 siteOther conditions: Autoimmune Rheumatic DiseasesView official trial listing → -
Recruiting NCT NCT07258524
PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis
University of Edinburgh 120 participants Est. completion 2029-01 1 siteOther conditions: ANCA Associated Vasculitis (AAV)View official trial listing → -
Recruiting NCT NCT07275632
The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients
Not yet reported, Not yet reported First Affiliated Hospital of Chongqing Medical University 47 participants Est. completion 2026-12-31 2 sitesOther conditions: Delayed Graft Function, Kidney TransplantationView official trial listing → -
Recruiting NCT NCT07276425
Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis
UMC Utrecht 40 participants Est. completion 2028-06-01 1 siteOther conditions: Prurigo Nodularis (PN)View official trial listing → -
Recruiting NCT NCT07288918
The Effect of Education on Quality of Life, Adherence to Immunosuppressive Therapy and Symptom Control in Organ Transplant Patients
Not yet reported Ondokuz Mayıs University 108 participants Est. completion 2027-05-30 1 siteOther conditions: Organ Transplantation, Mobile Applications, NursingView official trial listing → -
Recruiting NCT NCT07295535
Analysis of the Specificity and Persistence of Nasal Immune Responses to Respiratory Viral Antigens in Immunocompromised and Healthy Cohorts
Fondazione IRCCS Policlinico San Matteo di Pavia 40 participants Est. completion 2027-09-30 1 siteOther conditions: Immuno-modulation, Immuno-suppression, Immunocompromised Patients, Healthy Subjects, Oncological PatientsView official trial listing → -
Recruiting NCT NCT07319598
A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease
Not yet reported Peking University Third Hospital 100 participants Est. completion 2027-01-01 1 siteOther conditions: Interstitial Lung Disease (ILD), Connective Tissue Disease-associated Interstitial Lung DiseaseView official trial listing → -
Recruiting NCT NCT07340463
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Not yet reported Nanjing University School of Medicine 50 participants Est. completion 2029-06 1 siteOther conditions: Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)View official trial listing → -
Recruiting NCT NCT07383649
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection
Not yet reported The Methodist Hospital Research Institute 28 participants Est. completion 2030-05 1 siteOther conditions: Brain Cancer Metastatic, CMV ViremiaView official trial listing → -
Recruiting NCT NCT07410039
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
Not yet reported Chinese PLA General Hospital 200 participants Est. completion 2029-06-30 1 siteOther conditions: Neuromyelitis Optica Spectrum Disorder AttackView official trial listing → -
Recruiting NCT NCT07426484
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Not yet reported Dana-Farber Cancer Institute 80 participants Est. completion 2032-12-15 2 sitesOther conditions: Cutaneous Squamous Cell Carcinoma, Skin CancerView official trial listing → -
Recruiting NCT NCT07430306
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Not yet reported AstraZeneca 245 participants Est. completion 2029-01-26 108 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Recruiting NCT NCT07493395
Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy
Not yet reported University Hospital, Montpellier 6 participants Est. completion 2028-06-11 4 sitesOther conditions: Scleroderma, SystemicView official trial listing → -
Recruiting NCT NCT07503652
Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis
Not yet reported First Hospital of China Medical University 10 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Palmoplantar Pustulosis (PPP)View official trial listing → -
Recruiting NCT NCT07505199
Safety and Efficacy of FAP iCDC in Ischemic Cardiomyopathy
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 30 participants Est. completion 2029-04-01 1 siteOther conditions: Ischemic Cardiomyopathy, Cell TherapyView official trial listing → -
Recruiting NCT NCT07516288
Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 5 participants Est. completion 2027-12-31 1 siteHeart failure Other conditions: Dilated Cardiomyopathy (DCM)View official trial listing → -
Recruiting NCT NCT07529171
HBV Reactivation in Immunocompromised Patients (REANT STUDY)
Yaşar Bayındır, MD 490 participants Est. completion 2029-12-31 16 sitesOther conditions: HBVView official trial listing → -
Recruiting NCT NCT07548177
Clinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
Not yet reported Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33 participants Est. completion 2029-06 15 sitesOther conditions: Alveolar Soft Part SarcomaView official trial listing → -
Recruiting NCT NCT07572071
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease
Not yet reported Royan Institute 6 participants Est. completion 2030-08-01 3 sitesOther conditions: Parkinson Disease (PD)View official trial listing → -
Recruiting NCT NCT07581704
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
Not yet reported Christopher Strouse 10 participants Est. completion 2029-10-01 1 siteOther conditions: Multiple MyelomaView official trial listing → -
Recruiting NCT NCT07607873
TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal Liver Metastases
Not yet reported Niguarda Hospital 70 participants Est. completion 2031-06-15 1 siteOther conditions: Colorectal Liver MetastasesView official trial listing → -
Recruiting NCT NCT07679412
Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.
Not yet reported LucasBio 5 participants Est. completion 2027-08-14 1 siteOther conditions: CMV RetinitisView official trial listing → -
Recruiting NCT NCT07717281
PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 40 participants Est. completion 2028-03-31 1 siteOther conditions: Myasthenia Gravis GeneralizedView official trial listing → -
Recruiting NCT NCT07718204
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Not yet reported Nationwide Children's Hospital 25 participants Est. completion 2028-12-31 1 siteOther conditions: Hematopoietic Cell TransplantView official trial listing → -
Recruiting NCT NCT07775235
Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease
Singapore General Hospital 80 participants Est. completion 2029-07-01 1 siteOther conditions: Interstitial Lung Disease, MyositisView official trial listing → -
Recruiting NCT NCT07815834
FAPI-Guided Radiotherapy With Cadonilimab and Standard Chemotherapy for Colorectal Peritoneal Metastasis: A Phase III Randomized Controlled Trial (TORHC-PM02)
Not yet reported Fudan University 198 participants Est. completion 2031-03-01 1 siteOther conditions: Colon Rectal Cancer Adenocarcinoma, Peritoneal (Metastatic) Cancer, Second-line Treatment, Radiation Therapy, ImmunotherapyView official trial listing → -
Recruiting NCT NCT07843381
Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease
Peking University People's Hospital 60 participants Est. completion 2027-11-20 1 siteOther conditions: Sjögren's Disease, Interstitial Lung DiseaseView official trial listing → -
Recruiting NCT NCT07875595
Immune Biomarkers for Predicting Complications After Liver Transplantation
Hospital Italiano de Buenos Aires 60 participants Est. completion 2028-03 3 sitesOther conditions: Liver Transplantation (LT), Immuno-suppression, Biomarkers / Blood, Rejection, InfectionsView official trial listing → -
Recruiting NCT NCT07895394
Immunogenicity and Safety of Respiratory Syncytial Virus Vaccine in Lung Transplant Recipients
Not yet reported Seoul National University Hospital 80 participants Est. completion 2028-10 1 siteOther conditions: Vaccination, Respiratory Syncytial Virus (RSV), Lung Transplant RecipientView official trial listing → -
Recruiting NCT NCT07904546
ADBest TREAT Registry
Universitätsklinikum Hamburg-Eppendorf 5000 participants Est. completion 2032-12-31 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT00000880
A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 30 participants Est. completion 2000-05 12 sitesOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00001212
Drug Therapy in Lupus Nephropathy
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 45 participants Est. completion 2004-09 1 siteOther conditions: Nephrotic Syndrome, Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00001637
Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 28 participants Est. completion 2016-12-28 1 siteOther conditions: Chronic Lymphocytic Leukemia, Graft vs Host Disease, Leukemia, Myelodysplastic Syndrome, Myeloid LeukemiaView official trial listing → -
Completed NCT NCT00001764
Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2004-06 1 siteOther conditions: Vasculitis, Wegener's GranulomatosisView official trial listing → -
Completed NCT NCT00001839
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
Not yet reported National Institutes of Health Clinical Center (CC) 182 participants Est. completion 2000-05 1 siteOther conditions: Hematologic Diseases, Myelodysplastic SyndromesView official trial listing → -
Terminated NCT NCT00001962
A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 100 participants Est. completion 2010-09 1 siteOther conditions: Aplastic Anemia, Pure Red Cell Aplasia, Diamond Blackfan AnemiaView official trial listing → -
Completed NCT NCT00002657
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
Not yet reported SWOG Cancer Research Network 20 participants Est. completion 2011-07 86 sitesOther conditions: Lymphoma, Multiple Myeloma and Plasma Cell NeoplasmView official trial listing → -
Completed NCT NCT00003657
High-dose ICE With Amifostine
Not yet reported Dana-Farber Cancer Institute 24 participants Est. completion 2002-06 3 sitesOther conditions: Bladder Cancer, Brain and Central Nervous System Tumors, Carcinoma of Unknown Primary, Extragonadal Germ Cell Tumor, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Ovarian Cancer, Sarcoma, Testicular Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00004567
Comparison of Treatments to Maintain Disease Remission in Patients With Wegener's Granulomatosis and Related Vasculitis Syndromes
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2004-06 1 siteOther conditions: Vasculitis, Wegener's GranulomatosisView official trial listing → -
Completed NCT NCT00006178
Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12 participants Est. completion 2007-12 1 siteOther conditions: Kidney FailureView official trial listing → -
Completed NCT NCT00009009
Kidney Transplant for HIV-Infected Patients in Renal Failure
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10 participants Est. completion 2002-12 1 siteOther conditions: Chronic Kidney Failure, HIV InfectionView official trial listing → -
Completed NCT NCT00010283
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
Not yet reported, Not yet reported Fred Hutchinson Cancer Center Est. completion 2002-07 1 siteOther conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell TumorView official trial listing → -
Completed NCT NCT00016419
S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
Not yet reported SWOG Cancer Research Network 130 participants Est. completion 2007-01 94 sitesOther conditions: Leukemia, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00021645
Vitamin E to Treat Uveitis-Associated Macular Edema
Not yet reported National Eye Institute (NEI) 80 participants Est. completion 2004-06 1 siteOther conditions: Cystoid Macular Edema, UveitisView official trial listing → -
Terminated NCT NCT00023244
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 274 participants Est. completion 2005-06 19 sitesOther conditions: End-Stage Renal DiseaseView official trial listing → -
Terminated NCT NCT00023790
Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
Not yet reported Case Comprehensive Cancer Center 3 participants Est. completion 2006-02 1 siteOther conditions: Breast Cancer, Head and Neck Cancer, Lymphoma, Metastatic Cancer, Non-melanomatous Skin Cancer, SarcomaView official trial listing → -
Completed NCT NCT00027560
Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 51 participants Est. completion 2009-04 1 siteOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT00033475
Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation
Not yet reported University of Edinburgh 50 participants 12 sitesOther conditions: Lymphoproliferative DisorderView official trial listing → -
Completed NCT NCT00045305
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
Not yet reported Eastern Cooperative Oncology Group 17 participants Est. completion 2014-09 6 sitesOther conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT00049296
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Not yet reported Case Comprehensive Cancer Center 26 participants Est. completion 2006-01 1 siteOther conditions: CancerView official trial listing → -
Completed NCT NCT00056355
Extracorporeal Photopheresis to Maintain Symptoms Remission During Steroid Withdrawal in Patients With Steroid-Dependent Crohn's Disease
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2005-11 1 siteOther conditions: Crohn DiseaseView official trial listing → -
Completed NCT NCT00061360
Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 77 participants Est. completion 2015-09-08 1 siteOther conditions: Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT00064714
Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes
Not yet reported AstraZeneca 47 participants Est. completion 2008-03 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00075075
Infliximab to Treat Non-Infectious Scleritis
Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2007-09-06 1 siteOther conditions: ScleritisView official trial listing → -
Completed NCT NCT00078559
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
Not yet reported, Not yet reported University of Wisconsin, Madison 10 participants Est. completion 2010-02 1 siteOther conditions: Kidney Transplantation, Kidney DiseaseView official trial listing → -
Completed NCT NCT00080431
Daclizumab to Treat HIV-Infected Patients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2007-12-28 1 siteOther conditions: HIV InfectionsView official trial listing → -
Terminated NCT NCT00089141
Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)
Not yet reported Martin, Paul 151 participants Est. completion 2008-09 16 sitesOther conditions: CancerView official trial listing → -
Withdrawn NCT NCT00093678
Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
Not yet reported Eastern Cooperative Oncology GroupOther conditions: Cachexia, Lymphoma, Melanoma (Skin), Ovarian Cancer, Pain, Sarcoma, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00100178
New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 126 participants Est. completion 2008-04 11 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT00104338
Study of FK778 in Renal Transplant Recipients With Untreated BK Nephropathy
Not yet reported Astellas Pharma Inc 45 participants Est. completion 2006-08 21 sitesOther conditions: BK Polyomavirus, Kidney DiseasesView official trial listing → -
Completed NCT NCT00104858
Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Not yet reported Fred Hutchinson Cancer Center 66 participants Est. completion 2018-03-30 5 sitesOther conditions: Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia, Stage III Small Lymphocytic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Small Lymphocytic Lymphoma, T-Cell Large Granular Lymphocyte LeukemiaView official trial listing → -
Completed NCT NCT00105235
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 27 participants Est. completion 2011-03 9 sitesOther conditions: Liver Disease, Liver TransplantationView official trial listing → -
Completed NCT NCT00106392
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
Not yet reported Astellas Pharma Inc 131 participants Est. completion 2008-11 6 sitesOther conditions: Erectile Dysfunction, Prostate CancerView official trial listing → -
Completed NCT NCT00106639
A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients
Not yet reported Pfizer 61 participants Est. completion 2006-07 20 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00114530
Scleroderma: Cyclophosphamide or Transplantation
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2016-04 17 sitesOther conditions: Scleroderma, Systemic, Sclerosis, Autoimmune DiseaseView official trial listing → -
Completed NCT NCT00116090
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
National Eye Institute (NEI) 6300 participants Est. completion 2008-04-21 4 sitesOther conditions: Uveitis, Cancer, Infection, Mortality, ImmunosuppressionView official trial listing → -
Completed NCT NCT00125307
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
Not yet reported Chinese University of Hong Kong 20 participants Est. completion 2008-02 1 siteOther conditions: Lupus Nephritis, Lupus Erythematosus, SystemicView official trial listing → -
Completed NCT NCT00128193
Leprosy Skin Test Antigens Trial
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 260 participants Est. completion 2009-09 6 sitesOther conditions: LeprosyView official trial listing → -
Completed NCT NCT00132691
Multicenter Uveitis Steroid Treatment (MUST) Trial
Not yet reported JHSPH Center for Clinical Trials 255 participants Est. completion 2010-12 23 sitesOther conditions: UveitisView official trial listing → -
Completed NCT NCT00135954
Treatment of Patients With Idiopathic Membranous Nephropathy
Not yet reported Radboud University Medical Center 29 participants Est. completion 2008-07 1 siteOther conditions: Glomerulonephritis, MembranousView official trial listing → -
Completed NCT NCT00143845
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
Not yet reported University of Michigan Rogel Cancer Center 54 participants Est. completion 2013-02 1 siteOther conditions: Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-GradeView official trial listing → -
Terminated NCT NCT00148252
Lowering Total Immunosuppressive Load in Renal Transplant Recipients More Than 12 Months Posttransplant
Not yet reported University of Oslo School of Pharmacy 298 participants Est. completion 2007-02 9 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00149864
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302
Not yet reported Novartis 264 participants Est. completion 2003-12Other conditions: Renal TransplantView official trial listing → -
Completed NCT NCT00149916
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107
Not yet reported Novartis Pharmaceuticals 139 participantsOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT00149929
Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301
Not yet reported Novartis 246 participants Est. completion 2003-04Other conditions: Renal TransplantView official trial listing → -
Completed NCT NCT00150891
Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
University of Giessen 84 participants Est. completion 2006-01 1 siteOther conditions: Renal Failure, ChronicView official trial listing → -
Completed NCT NCT00154232
Study to Evaluate the Combination of Enteric-coated Mycophenolate Sodium (EC-MPS), Basiliximab, and C2-monitored Cyclosporine in de Novo Renal Transplant Recipients at Potential High Risk of Delayed Graft Function (DGF)
Not yet reported Novartis Pharmaceuticals 46 participantsOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00154284
Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients
Not yet reported Novartis 114 participants Est. completion 2008-07Other conditions: Organ Transplantation, Renal TransplantationView official trial listing → -
Completed NCT NCT00154297
Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients
Not yet reported Novartis Pharmaceuticals 139 participants 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00154310
Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients
Not yet reported Novartis 300 participants Est. completion 2008-09 3 sitesOther conditions: Renal TransplantationView official trial listing → -
Status unknown NCT NCT00159159
LOW CYCLO: Study Evaluating the Benefit of Two Doses of Ciclosporine in de Novo Cardiac Transplant
Not yet reported Hospices Civils de Lyon 106 participants 1 siteOther conditions: Cardiac TransplantionView official trial listing → -
Active, not recruiting NCT NCT00160732
Allogenic Islet Cell Transplantation
Not yet reported, Not yet reported University of Chicago 50 participants Est. completion 2030-10 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00160966
Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy
Not yet reported University of Giessen 108 participants Est. completion 2010-03 1 siteOther conditions: Polyomavirus InfectionsView official trial listing → -
Completed NCT NCT00163657
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
Not yet reported Baylor Research Institute 312 participants Est. completion 2007-01 1 siteOther conditions: End Stage Liver Disease, Hepatitis CView official trial listing → -
Status unknown NCT NCT00166816
The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
Not yet reported National Taiwan University Hospital 40 participants Est. completion 2003-06 1 siteOther conditions: Transplantation, Kidney Transplantation, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT00166829
The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus
Not yet reported National Taiwan University Hospital 40 participants 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT00166842
Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
Not yet reported National Taiwan University Hospital 40 participants 1 siteOther conditions: Transplantation, Kidney Transplantation, ImmunosuppressionView official trial listing → -
Completed NCT NCT00169910
VIP: Vascular Imaging Project. Study on the Progression of Cardiovascular Disease in Renal Transplant Recipients
Not yet reported Leiden University Medical Center 119 participants Est. completion 2010-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00171496
Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients
Not yet reported Novartis 693 participants Est. completion 2006-03Other conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00171509
Efficacy and Safety of Cyclosporine Microemulsion Given Once a Day in Adult Stable Liver Transplant Recipients
Not yet reported Novartis 61 participants Est. completion 2005-10Other conditions: Liver TransplantView official trial listing → -
Completed NCT NCT00171743
Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients
Not yet reported Novartis 47 participants Est. completion 2006-01Other conditions: Liver TransplantView official trial listing → -
Completed NCT NCT00183248
Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
Not yet reported, Not yet reported University of Miami 9 participants Est. completion 2009-11 1 siteOther conditions: Kidney Transplantation, Kidney Disease, Kidney FailureView official trial listing → -
Completed NCT NCT00189722
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
Not yet reported Astellas Pharma Inc 160 participants Est. completion 2005-07 28 sitesOther conditions: Asthma, Bronchial, Bronchial AsthmaView official trial listing → -
Completed NCT NCT00189787
Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
Not yet reported Astellas Pharma Inc 370 participants Est. completion 2005-08 49 sitesOther conditions: Asthma, Bronchial, Bronchial AsthmaView official trial listing → -
Completed NCT NCT00193648
Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)
Not yet reported Northwell Health 21 participants Est. completion 2007-10 2 sitesOther conditions: Focal GlomerulosclerosisView official trial listing → -
Completed NCT NCT00195429
A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 47 participants Est. completion 2007-10 1 siteOther conditions: Kidney Failure, Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT00195988
Comparison of Immunosuppression Protocols After LTx in Children
Not yet reported Children's Memorial Health Institute, Poland 40 participants Est. completion 2006-07 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00198224
Immunosuppressive Effects of Mycophenolate Mofetil and Valganciclovir in Kidney Transplant Recipients
Not yet reported Indiana University 50 participants Est. completion 2005-05 2 sitesOther conditions: Renal FailureView official trial listing → -
Status unknown NCT NCT00204191
Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
Not yet reported Uniwersytet Mikolaja Kopernika w Toruniu 300 participants Est. completion 2007-12 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00213590
Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients
Not yet reported University Hospital, Rouen 208 participants Est. completion 2006-11 1 siteOther conditions: Kidney Transplantation, Primary Prevention, Kidney FailureView official trial listing → -
Completed NCT NCT00221026
Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Crohn's Disease
Not yet reported Mallinckrodt 25 participants Est. completion 2006-06 15 sitesOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT00223054
Polymorphism of the Cytochrome P450-system in Renal Transplants
University Hospital Schleswig-Holstein 200 participants Est. completion 2006-10 1 siteOther conditions: Function of Renal TransplantView official trial listing → -
Completed NCT NCT00229619
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 11 participants Est. completion 2010-06 1 siteOther conditions: Anemia, Aplastic, Red-Cell Aplasia, Pure, Anemia, Diamond-BlackfanView official trial listing → -
Withdrawn NCT NCT00230035
Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Terminated NCT NCT00235781
Single Dose Thymoglobulin for Induction in Adult Renal Allograft Recipients
Not yet reported Washington University School of Medicine 90 participants Est. completion 2006-02 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00240955
Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients
Not yet reported Novartis 79 participants Est. completion 2006-05Other conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00240994
Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 35 participants Est. completion 2009-11 4 sitesOther conditions: Kidney Failure, Chronic, Kidney Transplantation, ImmunosuppressionView official trial listing → -
Completed NCT NCT00245037
Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Not yet reported, Not yet reported OHSU Knight Cancer Institute 147 participants Est. completion 2015-08 1 siteOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous ConditionView official trial listing → -
Status unknown NCT NCT00252655
Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients
Not yet reported Wayne State University 40 participants Est. completion 2009-06 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00254709
Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 66 participants Est. completion 2005-09Other conditions: Kidney Failure, Graft Rejection, AgedView official trial listing → -
Terminated NCT NCT00260208
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
Not yet reported Novartis Pharmaceuticals 361 participants 2 sitesOther conditions: Liver Transplant, Hepatitis CView official trial listing → -
Completed NCT NCT00260689
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 136 participants Est. completion 2016-05-04 1 siteOther conditions: Immunosuppresion, Thrombocytopenia, Pancytopenia, NeutropeniaView official trial listing → -
Completed NCT NCT00261820
Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 160 participants Est. completion 2005-01Other conditions: Graft Rejection, Kidney Failure, Kidney TransplantationView official trial listing → -
Completed NCT NCT00275522
The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.
Not yet reported Mayo Clinic 16 participants Est. completion 2007-12 1 siteOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00276250
Islet Transplantation Using Abatacept
Not yet reported Emory University 5 participants Est. completion 2014-12 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Terminated NCT NCT00284921
MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive
Not yet reported Novartis Pharmaceuticals 60 participantsOther conditions: De Novo Kidney TransplantView official trial listing → -
Completed NCT NCT00288626
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 25 participants Est. completion 2015-11 4 sitesOther conditions: Relapsing-Remitting Multiple SclerosisView official trial listing → -
Completed NCT NCT00294112
Prochymal™ Adult Human Mesenchymal Stem Cells for Treatment of Moderate-to-severe Crohn's Disease
Not yet reported Mesoblast, Inc. 10 participants Est. completion 2006-07-21 4 sitesOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT00296296
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
Not yet reported Stanford University 29 participants Est. completion 2014-10 1 siteType 2 diabetesChronic kidney disease Other conditions: Kidney TransplantView official trial listing → -
Terminated NCT NCT00303719
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Not yet reported Masonic Cancer Center, University of Minnesota 342 participants Est. completion 2019-05-08 1 siteOther conditions: Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00306397
Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients
Not yet reported University Hospital, Basel, Switzerland 100 participants Est. completion 2008-12 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00307593
RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides
Not yet reported Assistance Publique - Hôpitaux de Paris 20 participants Est. completion 2007-06 1 siteOther conditions: Wegener's Granulomatosis, Churg-Strauss Syndrome, Microscopic PolyangiitisView official trial listing → -
Terminated NCT NCT00307658
Intravenous Immunoglobulin After Relapse in Vasculitis
Not yet reported Assistance Publique - Hôpitaux de Paris 40 participants Est. completion 2006-07 2 sitesOther conditions: ANCA + Vasculitides Relapsing Either Under Corticosteroid, and Immunosuppressant Therapies or After One Year, Post Treatment.View official trial listing → -
Completed NCT NCT00307671
Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years
Not yet reported Assistance Publique - Hôpitaux de Paris 108 participants Est. completion 2011-07 1 siteObstructive sleep apnea Other conditions: Vasculitis, Wegener's Granulomatosis, Microscopic Polyangiitis, Churg-Strauss SyndromeView official trial listing → -
Status unknown NCT NCT00319657
Kidney and Blood Stem Cell Transplantation That Eliminates Requirement for Immunosuppressive Drugs
Not yet reported, Not yet reported Stanford University 15 participants Est. completion 2026-07 1 siteOther conditions: Immune ToleranceView official trial listing → -
Completed NCT NCT00320606
Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 20 participants Est. completion 2017-03-13 3 sitesOther conditions: Liver Transplant, Liver TransplantationView official trial listing → -
Completed NCT NCT00321113
Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
Not yet reported Astellas Pharma Inc 142 participants Est. completion 2008-03 14 sitesOther conditions: KIDNEY TRANSPLANTATIONView official trial listing → -
Completed NCT NCT00321906
Comparison of Sirolimus and Azathioprine in Lung Transplantation
Not yet reported University of Chicago 181 participants Est. completion 2011-08 1 siteOther conditions: Delayed Graft Function, Acute Graft RejectionView official trial listing → -
Terminated NCT NCT00346151
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2010-02 2 sitesOther conditions: Renal TransplantView official trial listing → -
Status unknown NCT NCT00348153
Adalimumab in Uveitis Refractory to Conventional Therapy (ADUR Trial)
Not yet reported, Not yet reported Heidelberg University 40 participants Est. completion 2013-03 1 siteOther conditions: UveitisView official trial listing → -
Completed NCT NCT00350181
Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT
Not yet reported Stanford University 11 participants Est. completion 2010-04 1 siteOther conditions: Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases, Acute GVHDView official trial listing → -
Terminated NCT NCT00354198
Efficacy of Pentoxifylline on Rapidly Progressive Glomerulonephritis
Not yet reported National Taiwan University Hospital 7 participants Est. completion 2010-06 1 siteOther conditions: GlomerulonephritisView official trial listing → -
Completed NCT NCT00355862
Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
Not yet reported University of Regensburg 525 participants Est. completion 2014-05 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT00359658
Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart Transplantation
Not yet reported Hannover Medical School 40 participants Est. completion 2008-06 1 siteOther conditions: Heart TransplantationView official trial listing → -
Completed NCT NCT00359814
Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation
Not yet reported Hannover Medical School 23 participants Est. completion 2008-06 1 siteOther conditions: Heart TransplantationView official trial listing → -
Completed NCT NCT00364650
Probiotic Prophylaxis for Immunosuppressant Associated Diarrhea (IAD) Following Kidney Transplantation
Not yet reported Swedish Medical Center 44 participants Est. completion 2009-12 1 siteOther conditions: Immunosuppressant Associated DiarrheaView official trial listing → -
Terminated NCT NCT00365274
SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma
Not yet reported National Cancer Institute (NCI) 6 participants Est. completion 2010-05 1 siteOther conditions: Anaplastic Large Cell LymphomaView official trial listing → -
Status unknown NCT NCT00365521
Prophylactic Photodynamic Therapy to Organ Transplant Patients
Not yet reported Bispebjerg Hospital 50 participants 1 siteOther conditions: Organ TransplantsView official trial listing → -
Completed NCT NCT00365846
"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"
Not yet reported University of Wisconsin, Madison 29 participants Est. completion 2006-07 1 siteOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT00371826
SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus
Not yet reported Novartis Pharmaceuticals 126 participants Est. completion 2012-06 7 sitesOther conditions: Renal Transplanted RecipientsView official trial listing → -
Completed NCT NCT00377962
Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation
Not yet reported Novartis Pharmaceuticals 282 participants Est. completion 2010-02 6 sitesOther conditions: Disorder Related to Cardiac TransplantationView official trial listing → -
Completed NCT NCT00378014
Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy
Not yet reported Novartis Pharmaceuticals 276 participants Est. completion 2013-01 16 sitesOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00384137
A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients
Not yet reported Astellas Pharma Inc 128 participants Est. completion 2007-07 13 sitesOther conditions: TransplantationView official trial listing → -
Completed NCT NCT00384202
A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients
Not yet reported Astellas Pharma Inc 112 participants Est. completion 2007-11 13 sitesOther conditions: TransplantationView official trial listing → -
Status unknown NCT NCT00399971
Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
Not yet reported, Not yet reported Shenzhen Zhongxing Yangfan Biotech Co. Ltd. 100 participants Est. completion 2009-12 1 siteOther conditions: Anemia, AplasticView official trial listing → -
Completed NCT NCT00400400
Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance
Not yet reported Novartis Pharmaceuticals 400 participants 53 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00402168
A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
Not yet reported Bristol-Myers Squibb 173 participants Est. completion 2013-06 44 sitesOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT00402532
Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation
Not yet reported Hannover Medical School 190 participants Est. completion 2011-12 1 siteOther conditions: Lung TransplantationView official trial listing → -
Completed NCT NCT00404794
A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
Not yet reported Hospital Authority, Hong Kong 20 participants Est. completion 2009-10 1 siteOther conditions: Lupus Nephritis, Glomerulonephritis, MembranousView official trial listing → -
Completed NCT NCT00404833
Mycophenolate Mofetil in Membranous Nephropathy and Focal Segmental
Not yet reported Hospital Authority, Hong Kong 16 participants Est. completion 2006-12 1 siteOther conditions: Glomerulonephritis, Membranous, Glomerulosclerosis, FocalView official trial listing → -
Completed NCT NCT00416546
Safety of AEB071 in Healthy Volunteers and to Compare the Ethnicity, Metabolic, and Safety Effects Between Caucasian and Japanese Healthy Subjects
Not yet reported Novartis 96 participants Est. completion 2007-10 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT00426049
Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation
Not yet reported German Heart Institute 484 participants 1 siteCardiovascular disease Other conditions: Coronary RestenosisView official trial listing → -
Completed NCT NCT00426517
Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2019-11-01 1 siteOther conditions: Inherited Immune DeficienciesView official trial listing → -
Completed NCT NCT00431119
Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid
Not yet reported University Hospital Muenster 70 participants Est. completion 2000-10 11 sitesOther conditions: Bullous PemphigoidView official trial listing → -
Completed NCT NCT00434811
Islet Transplantation in Type 1 Diabetes
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2014-05 8 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00434850
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 14 participants Est. completion 2013-11 3 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00438984
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Stage IV Melanoma
Not yet reported Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 11 participants Est. completion 2012-02 1 siteOther conditions: Recurrent Melanoma, Stage IV MelanomaView official trial listing → -
Completed NCT NCT00446264
Islet Allotransplantation With Steroid Free Immunosuppression
Not yet reported University Hospital, Lille 14 participants Est. completion 2009-02 1 siteOther conditions: Type 1 Diabetes, Hypoglycemia, Metabolic DiseasesView official trial listing → -
Terminated NCT NCT00447265
Etanercept for the Treatment of Lupus Nephritis
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 1 participants Est. completion 2009-03 6 sitesOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT00464555
Strategies to Improve Islet Survival
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-02 2 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00468117
Efficacy of Islet After Kidney Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2017-07-05 10 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00468403
LEA29Y (Belatacept) Emory Edmonton Protocol
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2013-04 2 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Terminated NCT NCT00468442
B-Lymphocyte Immunotherapy in Islet Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2011-09 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00468871
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
Not yet reported, Not yet reported Bausch & Lomb Incorporated 140 participants Est. completion 2006-06Other conditions: Non-infectious UveitisView official trial listing → -
Terminated NCT NCT00473824
Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation
Not yet reported ADMA Biologics, Inc. 7 participants Est. completion 2009-02 3 sites Stand-aloneOther conditions: Sequelae of Viral Hepatitis, Transplantation Infection, Evidence of Liver TransplantationView official trial listing → -
Completed NCT NCT00474994
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Not yet reported Memorial Sloan Kettering Cancer Center 53 participants Est. completion 2010-11 2 sitesOther conditions: Adult Malignant Fibrous Histiocytoma of Bone, Desmoid Tumor, Endometrial Cancer, Ovarian Cancer, Sarcoma, Small Intestine CancerView official trial listing → -
Completed NCT NCT00481481
Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects
Not yet reported Astellas Pharma Inc 346 participants Est. completion 2009-04 56 sitesOther conditions: TransplantationView official trial listing → -
Terminated NCT NCT00481832
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
Not yet reported Stanford University 50 participants Est. completion 2017-03-30 1 siteOther conditions: Lymphoma, Non-HodgkinView official trial listing → -
Status unknown NCT NCT00484965
Erythrocyte-Mediated Drug Delivery for the Prevention of Stent Restenosis
Not yet reported University of Rome Tor Vergata 100 participants Est. completion 2009-01 1 siteOther conditions: Atherosclerosis, Acute-Phase ReactionView official trial listing → -
Completed NCT NCT00489203
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Not yet reported Fred Hutchinson Cancer Center 140 participants 2 sitesObstructive sleep apnea Other conditions: Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Graft Versus Host Disease, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Disease, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic LymphomaView official trial listing → -
Completed NCT NCT00494741
MMF vs. AZA for Kidney Transplantation
Not yet reported Mario Negri Institute for Pharmacological Research 233 participants Est. completion 2017-11-29 6 sitesOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00501709
Prevention of Autoimmune Destruction and Rejection of Human Pancreatic Islets Following Transplantation for Insulin Dependent Diabetes Mellitus
Not yet reported, Not yet reported University of California, San Francisco 10 participants Est. completion 2016-12 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Withdrawn NCT NCT00514982
Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2011-03-08 1 siteOther conditions: Hermanski-Pudlak Syndrome, Colitis, Cytokines, Lymphocytes, Drug EvaluationView official trial listing → -
Completed NCT NCT00531063
This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus
Not yet reported Novartis Pharmaceuticals 237 participants 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00531440
This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.
Not yet reported Novartis Pharmaceuticals 256 participants 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00533624
Myfortic vs. Cellcept in Kidney Transplant Recipients
Not yet reported, Not yet reported University of Miami 150 participants Est. completion 2006-02 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Terminated NCT NCT00539838
A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)
Not yet reported Genentech, Inc. 33 participants Est. completion 2011-07-12Other conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00540423
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Not yet reported GlaxoSmithKline 23 participants Est. completion 2008-12 7 sitesOther conditions: Chronic Idiopathic Thrombocytopenic Purpura, Purpura, Thrombocytopenic, IdiopathicView official trial listing → -
Completed NCT NCT00542776
Impact of Immunosuppression in IBD Patients on Response to Influenza Vaccine
Boston Children's Hospital 146 participants Est. completion 2008-02 1 siteOther conditions: Inflammatory Bowel Disease (IBD), Immunosuppressed or Non-Immunosuppressed, Influenza Vaccine, Antibody Titers, Seroprotective TitersView official trial listing → -
Completed NCT NCT00546546
Early Immunosuppressants in Crohn's Disease
Not yet reported Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 120 participants Est. completion 2013-06 26 sitesOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT00554502
Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy
Not yet reported RWTH Aachen University 148 participants Est. completion 2015-02 34 sitesOther conditions: IgA NephropathyView official trial listing → -
Completed NCT NCT00556933
Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
Not yet reported University of Nebraska 180 participants Est. completion 2011-06-01 1 siteOther conditions: End-stage Renal DiseaseView official trial listing → -
Completed NCT NCT00565331
Rituximab for Prevention of Rejection After Renal Transplantation
Not yet reported, Not yet reported Radboud University Medical Center 280 participants Est. completion 2015-06 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00565773
Belatacept Post Depletional Repopulation to Facilitate Tolerance
Not yet reported Allan D Kirk, MD, PhD 40 participants Est. completion 2017-07-01 2 sitesOther conditions: Organ TransplantationView official trial listing → -
Completed NCT NCT00572585
Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis
Not yet reported Novartis Pharmaceuticals 60 participants Est. completion 2012-04 20 sitesOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT00578448
Belatacept Pharmacokinetic Trial in Renal Transplantation
Not yet reported Bristol-Myers Squibb 14 participants Est. completion 2012-09 5 sitesOther conditions: Renal TransplantationView official trial listing → -
Terminated NCT NCT00582738
Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection
Not yet reported Novartis Pharmaceuticals 43 participants Est. completion 2010-01 1 siteOther conditions: Recurrent Hepatitis CView official trial listing → -
Completed NCT NCT00587158
Oral Paricalcitol in Kidney Transplant Recipients
Not yet reported Mayo Clinic 100 participants Est. completion 2011-11 2 sitesOther conditions: Transplant; Failure, Kidney, Renal Disease, End Stage, Hyperparathyroidism, SecondaryView official trial listing → -
Completed NCT NCT00604201
Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 31 participants Est. completion 2021-09-14 1 siteOther conditions: Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA), Severe Aplastic Anemia (SAA)View official trial listing → -
Completed NCT NCT00611351
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Not yet reported University of Nebraska 5 participants Est. completion 2008-09-17 1 siteOther conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT00619645
Donor Peripheral Stem Cell Transplant, Fludarabine, and Busulfan in Treating Patients With Hematologic Cancers
Not yet reported University of California, Davis 8 participants Est. completion 2013-11 1 siteOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00634920
Evaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 204 participants Est. completion 2013-05 8 sitesOther conditions: Renal FunctionView official trial listing → -
Completed NCT NCT00636909
Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders
Not yet reported Beth Israel Deaconess Medical Center 25 participantsOther conditions: AML, ALL, CML Chronic Phase, Accelerated Phase, or Blast Crisis, CLL, MDS, RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA, APLASTIC ANEMIA, MULTIPLE MYELOMA, MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET)View official trial listing → -
Terminated NCT NCT00646425
The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis
Not yet reported Cerimon Pharmaceuticals 5 participants Est. completion 2008-11 6 sitesOther conditions: Non-infectious UveitisView official trial listing → -
Status unknown NCT NCT00647283
Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance
Not yet reported Hospital Clinic of Barcelona 80 participants Est. completion 2012-12 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00658073
Induction Therapy With Autologous Mesenchymal Stem Cells for Kidney Allografts
Not yet reported Fuzhou General Hospital 165 participants Est. completion 2010-10 1 siteOther conditions: Renal Transplant RejectionView official trial listing → -
Terminated NCT NCT00675441
Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)
Not yet reported M.D. Anderson Cancer Center 5 participants Est. completion 2011-08 1 siteOther conditions: Graft-versus-Host DiseaseView official trial listing → -
Completed NCT NCT00683046
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Not yet reported University of Chicago 204 participants Est. completion 2014-12 1 siteOther conditions: Acute Myelogenous Leukemia, Lymphoid Leukemia, Chronic Myelogenous Leukemia, Malignant Lymphoma, Hodgkin's Disease, Chronic Lymphocytic Leukemia, Myeloproliferative Disorder, Anemia, Aplastic, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00686556
Total Marrow Irradiation for Refractory Acute Leukemia
Not yet reported Masonic Cancer Center, University of Minnesota 12 participants Est. completion 2016-12 1 siteOther conditions: Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Multiple MyelomaView official trial listing → -
Terminated NCT NCT00694408
A Pilot Trial of Pediatric Liver Transplantation Without Steroids
Not yet reported Birmingham Women's and Children's NHS Foundation Trust 15 participants Est. completion 2011-08 1 siteOther conditions: Evidence of Liver TransplantationView official trial listing → -
Completed NCT NCT00694863
Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy
Not yet reported Radboud University Medical Center 20 participants Est. completion 2012-12 1 siteOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Completed NCT NCT00705484
European Safety Registry in Ulcerative Colitis (P04808)
Merck Sharp & Dohme LLC 2239 participants Est. completion 2016-10-20Other conditions: Ulcerative ColitisView official trial listing → -
Active, not recruiting NCT NCT00706420
Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen
Not yet reported City of Hope Medical Center 17 participants Est. completion 2027-09-13 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Status unknown NCT NCT00706680
Thymoglobulin in Calcineurin Inhibitor and Steroid Minimization Protocol
Not yet reported University Health Network, Toronto 30 participants Est. completion 2009-06 3 sitesOther conditions: Diabetes, Graft RejectionView official trial listing → -
Completed NCT NCT00708604
Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes
Not yet reported City of Hope Medical Center 3 participants Est. completion 2014-06 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00709722
Safety and Efficacy on Deoxyspergualin (NKT-01) in Patients With Lupus Nephritis
Not yet reported, Not yet reported Nippon Kayaku Co., Ltd. 21 participants Est. completion 2007-04 6 sitesOther conditions: Lupus NephritisView official trial listing → -
Active, not recruiting NCT NCT00716066
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases
Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2030-01-31 3 sitesOther conditions: Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune, Multiple Sclerosis Transplant, MS Stem Cell Transplant, Multiple Sclerosis Stem Cell Transplant, Stiff Person Syndrome, HCT for Neurologic Autoimmune Disorders, CIDP Transplant, Myasthenia Gravis Transplant, Autoimmune Nervous System Disorder, Central Nervous System Vasculitis, Cerebellar Degeneration, Chronic Inflammatory Demyelinating Polyneuropathy, Lambert Eaton Myasthenic Syndrome, Myasthenia Gravis, Neuromyelitis Optica, Opsoclonus Myoclonus Syndrome, Rasmussen Subacute EncephalitisView official trial listing → -
Completed NCT NCT00716573
Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure
Not yet reported Hospices Civils de Lyon 120 participants Est. completion 2014-04-17 1 siteOther conditions: Cardiac Transplantation, Chronic Renal InsufficiencyView official trial listing → -
Completed NCT NCT00717379
Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation
Not yet reported Astellas Pharma Inc 50 participants Est. completion 2008-10 6 sitesOther conditions: Kidney Transplantation, Kidney Failure, Chronic, Renal Insufficiency, ChronicView official trial listing → -
Completed NCT NCT00717470
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection
Not yet reported Astellas Pharma Inc 1252 participants Est. completion 2010-03-02 110 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00717678
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients
Not yet reported Astellas Pharma Inc 73 participants Est. completion 2010-04 5 sitesOther conditions: Kidney Transplantation, Transplantation Immunology, Host vs Graft ReactionView official trial listing → -
Completed NCT NCT00720408
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
Not yet reported Astellas Pharma Inc 48 participants Est. completion 2009-09 4 sitesOther conditions: Liver Transplantation, Transplantation Immunology, Host vs Graft ReactionView official trial listing → -
Terminated NCT NCT00722280
Human Upper Extremity (Hand and Forearm) Allotransplantation
Not yet reported University of Pittsburgh 38 participants Est. completion 2017-10 1 siteOther conditions: Amputation, TraumaticView official trial listing → -
Completed NCT NCT00724529
Post Marketing Surveillance of Remicade
Janssen Korea, Ltd., Korea 938 participants Est. completion 2011-08Other conditions: Crohn's Disease, Ankylosing SpondylitisView official trial listing → -
Terminated NCT NCT00727194
Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Not yet reported Alexion Pharmaceuticals, Inc. 14 participants Est. completion 2011-07 25 sitesOther conditions: Myasthenia GravisView official trial listing → -
Completed NCT NCT00727636
Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy
Not yet reported Boston Children's Hospital 53 participants Est. completion 2011-04 1 siteOther conditions: Inflammatory Bowel DiseaseView official trial listing → -
Completed NCT NCT00729248
The Differential Effects of 3 Different Immunosuppressive
Northwestern University 12 participants Est. completion 2010-01 1 siteOther conditions: Immunosuppression, Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT00729768
A Study to Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation
Not yet reported, Not yet reported Genentech, Inc.Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00732316
Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome
Not yet reported Asan Medical Center 54 participants Est. completion 2011-05 1 siteOther conditions: Leukemia, Myelodysplastic SyndromesView official trial listing → -
Status unknown NCT NCT00733733
Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor
Not yet reported Radboud University Medical Center 180 participants Est. completion 2010-06 1 siteOther conditions: Renal Transplant Patients, Recipients of a Kidney From a Non-Heart-Beating DonorView official trial listing → -
Completed NCT NCT00738257
A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
Not yet reported Novartis Pharmaceuticals 126 participants 1 siteOther conditions: Bone LossView official trial listing → -
Status unknown NCT NCT00750971
Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)
Not yet reported Charite University, Berlin, Germany 30 participants Est. completion 2020-08 8 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Terminated NCT NCT00752479
Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance
Not yet reported, Not yet reported Mario Negri Institute for Pharmacological Research 4 participants Est. completion 2013-12 1 siteOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00753103
Anti-Cytokine Therapy for Vasculitis
Not yet reported University Hospital Birmingham NHS Foundation Trust 37 participants Est. completion 2006-07 1 siteOther conditions: Wegener's Granulomatosis, Renal Limited Vasculitis, Microscopic PolyangiitisView official trial listing → -
Completed NCT NCT00755781
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
Not yet reported APT Pharmaceuticals, Inc. 284 participants Est. completion 2011-11 19 sitesOther conditions: Lung TransplantView official trial listing → -
Completed NCT NCT00767650
Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 7 participants Est. completion 2011-06-28 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Completed NCT NCT00787722
Hematopoietic Stem Cell Transplant in Devic's Disease
Not yet reported, Not yet reported Northwestern University 13 participants Est. completion 2018-11 1 siteOther conditions: Devic's DiseaseView official trial listing → -
Completed NCT NCT00788021
Protective Immunity Project 01
Emory University 124 participants Est. completion 2011-10 1 siteOther conditions: Kidney Transplantation, Immunity, ImmunosuppressionView official trial listing → -
Completed NCT NCT00788567
CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants
Not yet reported Hoffmann-La Roche 136 participants Est. completion 2008-05 9 sitesOther conditions: Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT00790439
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2009-10Other conditions: Diabetes Mellitus, Type IView official trial listing → -
Completed NCT NCT00795132
Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies
Not yet reported University of Utah 47 participants Est. completion 2009-07 1 siteOther conditions: Acute Leukaemia, Chronic Disease, Leukemia, Myelodysplasia, LymphomaView official trial listing → -
Completed NCT NCT00795886
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)
Not yet reported University of Utah 63 participants Est. completion 2010-03 1 siteOther conditions: Acute Lymphoblastic LeukemiaView official trial listing → -
Status unknown NCT NCT00799799
Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells
Not yet reported University of Bologna 15 participants Est. completion 2009-12 1 siteOther conditions: Myeloblastic LeukemiaView official trial listing → -
Status unknown NCT NCT00805428
Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group
Clinical Hospital Center, Split 32 participants 1 siteOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT00805571
Urinary Kidney Injury Molecule-1 (KIM-1) Excretion As Biomarker for Injury in Kidney Transplant Recipients
Northwell Health 120 participants 1 siteOther conditions: Kidney Transplant DysfunctionView official trial listing → -
Terminated NCT NCT00811590
Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
Not yet reported University of Utah 3 participants Est. completion 2011-03 1 siteOther conditions: Peutz-Jeghers SyndromeView official trial listing → -
Completed NCT NCT00812123
Calcineurin Free Immunosuppression in Renal Transplant Recipients
Not yet reported University Hospital, Basel, Switzerland 127 participants Est. completion 2005-07 1 siteChronic kidney disease Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00812786
Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients
Not yet reported University Hospital, Limoges 42 participants Est. completion 2012-05 12 sitesOther conditions: Heart TransplantView official trial listing → -
Terminated NCT NCT00813501
Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
City of Hope Medical Center 60 participants Est. completion 2010-06 1 siteOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic-Myeloproliferative Diseases, Neuroblastoma, Therapy-related ToxicityView official trial listing → -
Terminated NCT NCT00815633
A Pilot Study of Alefacept for the Treatment of Pityriasis Rubra Pilaris
Not yet reported Joshua Zeichner 1 participants Est. completion 2010-03 1 siteOther conditions: Pityriasis Rubra PilarisView official trial listing → -
Terminated NCT NCT00816478
Effect of Oral Galactose on Focal Segmental Glomerulosclerosis (FSGS) Permeability Factor
Not yet reported Northwell Health 15 participants Est. completion 2009-12Other conditions: Focal Segmental GlomerulosclerosisView official trial listing → -
Withdrawn NCT NCT00816504
Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5
Not yet reported Northwell Health Est. completion 2009-12 1 siteOther conditions: Focal Segmental GlomerulosclerosisView official trial listing → -
Status unknown NCT NCT00828503
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Not yet reported Marcus Saemann 40 participants Est. completion 2014-06 1 siteOther conditions: Cytomegalovirus DiseaseView official trial listing → -
Completed NCT NCT00829595
Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease
Not yet reported Cedars-Sinai Medical Center 69 participants Est. completion 2007-12 1 siteOther conditions: Inflammatory Bowel Disease, Crohn Disease, Ulcerative ColitisView official trial listing → -
Completed NCT NCT00833651
Protective Immunity Project 02
Emory University 97 participants Est. completion 2011-10 1 siteOther conditions: Kidney Transplant, Immunology, ImmunosuppressionView official trial listing → -
Terminated NCT NCT00838578
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 65 participants Est. completion 2012-10 12 sitesOther conditions: Colorectal CancerView official trial listing → -
Status unknown NCT NCT00856505
Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation
Not yet reported, Not yet reported University Hospital Freiburg 38 participants Est. completion 2011-03 1 siteOther conditions: Hematologic DiseasesView official trial listing → -
Completed NCT NCT00859586
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 8 participants Est. completion 2014-09 1 siteOther conditions: Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, ChronicView official trial listing → -
Terminated NCT NCT00866684
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Not yet reported Charite University, Berlin, Germany 44 participants Est. completion 2011-04-19 15 sitesOther conditions: Skin CancerView official trial listing → -
Completed NCT NCT00866879
Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients
Not yet reported Northwestern University 275 participants Est. completion 2019-03 1 siteOther conditions: Renal Transplant RejectionView official trial listing → -
Completed NCT NCT00890552
A Pilot Study of Lenalidomide, Melphalan and Dexamethasone in AL Amyloidosis
Not yet reported Stanford University 25 participants Est. completion 2012-10 1 siteOther conditions: Leukemia, AmyloidosisView official trial listing → -
Status unknown NCT NCT00895739
Alemtuzumab and Low-Dose Cyclosporine in Treating Patients With Severe Aplastic Anemia or Acquired Marrow Failure
Not yet reported Federico II University 50 participants 1 siteOther conditions: Nonmalignant NeoplasmView official trial listing → -
Completed NCT NCT00902980
Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics
Astellas Pharma Inc 264 participants Est. completion 2006-12 13 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00905515
Optima: Optimizing Prograf Therapy in Maintenance Allografts II
Not yet reported East Carolina University 63 participants Est. completion 2008-07 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00909571
Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus
Not yet reported Astellas Pharma Inc 10 participants Est. completion 2010-03 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00922883
A Pilot Study of the Thrombopoietin-Receptor Agonist Eltrombopag in Refractory Aplastic Anemia Patients
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 43 participants Est. completion 2018-04-24 1 siteOther conditions: Anemia, Aplastic, Anemia, Hypoplastic, ThrombocytopeniaView official trial listing → -
Completed NCT NCT00929695
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
Not yet reported Fred Hutchinson Cancer Center 164 participants Est. completion 2015-12-14 1 siteOther conditions: Graft Versus Host Disease, Recurrent Adult Acute Lymphoblastic LeukemiaView official trial listing → -
Completed NCT NCT00946790
To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets
Not yet reported Sandoz 72 participants Est. completion 1993-12Other conditions: Immunosuppression, RheumatismView official trial listing → -
Status unknown NCT NCT00947492
Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs
Not yet reported Assistance Publique Hopitaux De Marseille 60 participants Est. completion 2014-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00948883
Study of Cancers After Solid Organs Transplants
Assistance Publique - Hôpitaux de Paris 330 participants Est. completion 2011-07 1 siteOther conditions: Cancer, Organ TransplantationView official trial listing → -
Completed NCT NCT00965094
Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 36 participants Est. completion 2013-06 3 sitesOther conditions: Chronic Renal FailureView official trial listing → -
Completed NCT NCT00968162
Sickle Cell Disease Conditioning for Bone Marrow Transplant
Not yet reported Emory University 8 participants Est. completion 2016-01-11 10 sitesOther conditions: Bone Marrow Transplantation, Sickle Cell DiseaseView official trial listing → -
Status unknown NCT NCT00972660
Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease
Not yet reported Guangdong Provincial People's Hospital 52 participants Est. completion 2017-12 1 siteOther conditions: Graft Versus Host DiseaseView official trial listing → -
Terminated NCT NCT00975663
Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation
Not yet reported University Hospital, Limoges 180 participants Est. completion 2011-02 9 sitesOther conditions: Lung and Heart-lung TransplantationView official trial listing → -
Completed NCT NCT00981838
Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS)
Not yet reported Mario Negri Institute for Pharmacological Research 24 participants Est. completion 2011-04 7 sitesOther conditions: Nephrotic SyndromeView official trial listing → -
Completed NCT NCT00987831
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)
Not yet reported, Not yet reported Oklahoma Medical Research Foundation 158 participants Est. completion 2012-12 2 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT00995709
Phase III Study in Refractory Behcet's Disease
Not yet reported Novartis Pharmaceuticals 118 participants Est. completion 2010-07 49 sitesOther conditions: Behcet DiseaseView official trial listing → -
Completed NCT NCT00999362
Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus?
University of Aarhus 40 participants Est. completion 2009-10 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT01009957
Everolimus on CKD Progression in ADPKD Patients
Not yet reported, Not yet reported A. Manzoni Hospital 71 participants Est. completion 2015-06 7 sitesOther conditions: Polycystic Kidney DiseasesView official trial listing → -
Completed NCT NCT01011205
Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation
Not yet reported Astellas Pharma Inc 893 participants Est. completion 2013-01-04 72 sitesOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT01014234
Rapamycin and Regulatory T Cells in Kidney Transplantation
Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 56 participants Est. completion 2013-06 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT01017757
Interstitial Lung Abnormalities in Renal Transplant Recipients
University of Parma 63 participants Est. completion 2009-11 1 siteOther conditions: Renal Transplantation, Kidney-pancreas TransplantationView official trial listing → -
Completed NCT NCT01022476
Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Not yet reported, Not yet reported ANRS, Emerging Infectious Diseases 14 participants Est. completion 2013-05 1 siteOther conditions: HIV Infection, Liver Failure, Evidence of Liver TransplantationView official trial listing → -
Completed NCT NCT01022749
Efficacy Safety Study of Flu Vaccine in Immunodepression Patients
Not yet reported Assistance Publique - Hôpitaux de Paris 228 participants Est. completion 2013-07 1 siteOther conditions: Inflammatory Bowel Disease (IBD)View official trial listing → -
Completed NCT NCT01028092
mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
Not yet reported University Hospital, Brest 327 participants Est. completion 2014-07 18 sitesOther conditions: Renal TransplantView official trial listing → -
Withdrawn NCT NCT01033500
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Not yet reported University of Wisconsin, Madison Est. completion 2012-12 1 siteOther conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Kidney TransplantationView official trial listing → -
Status unknown NCT NCT01034345
Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients
Not yet reported Hospital Clinic of Barcelona 52 participants Est. completion 2011-11 1 siteOther conditions: Liver TransplantationView official trial listing → -
Withdrawn NCT NCT01038505
Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus
Not yet reported University of Miami Est. completion 2013-01Other conditions: Living Donor Kidney Transplants PatientsView official trial listing → -
Terminated NCT NCT01044745
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
Not yet reported University of Nebraska 20 participants Est. completion 2017-10-10 1 siteObstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Graft Versus Host Disease, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Waldenström MacroglobulinemiaView official trial listing → -
Terminated NCT NCT01052259
Efficacy and Safety of Deoxyspergualin in Renal Transplant Patient With Chronic Rejection
Not yet reported Nippon Kayaku Co., Ltd. 35 participants Est. completion 2012-12 8 sitesOther conditions: Chronic RejectionView official trial listing → -
Terminated NCT NCT01053221
Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
Not yet reported University of Wisconsin, Madison 16 participants Est. completion 2012-08 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01065285
Vaccination Against Influenza in Autoimmune Diseases
Not yet reported Assistance Publique - Hôpitaux de Paris 234 participants Est. completion 2012-02 1 siteOther conditions: Autoimmune DiseasesView official trial listing → -
Completed NCT NCT01079143
Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2012-06 23 sitesOther conditions: Renal Interstitial FibrosisView official trial listing → -
Terminated NCT NCT01093846
38 Week Extension Study to CAIN457C2303
Not yet reported Novartis Pharmaceuticals 59 participants Est. completion 2011-01 25 sitesOther conditions: UveitisView official trial listing → -
Status unknown NCT NCT01109498
Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
Not yet reported, Not yet reported Amsterdam Molecular Therapeutics 14 participants Est. completion 2013-06 1 siteOther conditions: Familial Lipoprotein Lipase DeficiencyView official trial listing → -
Completed NCT NCT01109914
Mucosal Response in Immunocompromised Host
Not yet reported Leiden University Medical Center 51 participants Est. completion 2015-03 1 siteOther conditions: Kidney Transplantation, ImmunityView official trial listing → -
Completed NCT NCT01131910
TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs
Not yet reported Sormland County Council, Sweden 68 participants Est. completion 2011-05 6 sitesOther conditions: Rheumatoid Arthritis, Exposed to TBE-virus, ImmunosuppressionView official trial listing → -
Completed NCT NCT01134510
Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection
Not yet reported, Not yet reported Stanley Jordan, MD 20 participants Est. completion 2013-11 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01135641
Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)
Not yet reported Nantes University Hospital 25 participants Est. completion 2014-03 1 siteOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT01136395
Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
Not yet reported University of Giessen 85 participants Est. completion 2019-06-18 1 siteOther conditions: Kidney Transplantation, Rituximab (RTx), Living Donors, Immunology, VirusView official trial listing → -
Status unknown NCT NCT01154387
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
Not yet reported, Not yet reported Tolera Therapeutics, Inc 85 participants Est. completion 2013-06 12 sitesOther conditions: End Stage Renal Disease, Renal TransplantView official trial listing → -
Status unknown NCT NCT01165762
Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.
Not yet reported Everett Meyer 25 participants Est. completion 2025-06-14 2 sitesOther conditions: ESRDView official trial listing → -
Completed NCT NCT01183247
An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens
Not yet reported University Hospital, Basel, Switzerland 63 participants Est. completion 2010-06 1 siteOther conditions: Comparative Study, Immunosuppressive AgentsView official trial listing → -
Completed NCT NCT01183403
CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives 80 participants Est. completion 2012-07 18 sitesOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT01187017
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 1 participants Est. completion 2012-07 1 siteOther conditions: Aplastic Anemia, Neutropenia, Pancytopenia, Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT01195194
Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.
Not yet reported Josep M Grinyo 61 participants Est. completion 2013-06 2 sitesOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT01196091
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
Not yet reported Eli Lilly and Company 1164 participants Est. completion 2015-06 192 sitesOther conditions: Systemic Lupus Erythematosus, Connective Tissue Disease, Autoimmune DiseaseView official trial listing → -
Status unknown NCT NCT01198314
Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients
Not yet reported The Catholic University of Korea 20 participants Est. completion 2013-03 1 siteOther conditions: Liver TransplantationView official trial listing → -
Terminated NCT NCT01213329
Immunophenotyping of Peripheral T Cells After T Cell Depletion With Alemtuzumab
Not yet reported Northwestern University 52 participants Est. completion 2009-04 1 siteOther conditions: Kidney TransplantView official trial listing → -
Terminated NCT NCT01213394
Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients
Not yet reported Ramesh Prasad 2 participants Est. completion 2011-12 1 siteCardiovascular disease Other conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT01220297
Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT
Not yet reported Stanford University 3 participants Est. completion 2011-08 1 siteOther conditions: Hematologic Diseases, Acute-graft-versus-host Disease, Leukemia, Non-Hodgkin Lymphoma (NHL), Hodgkin LymphomaView official trial listing → -
Completed NCT NCT01231841
Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia
Not yet reported The Cleveland Clinic 20 participants Est. completion 2010-12 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Completed NCT NCT01232920
First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial
Not yet reported University of California, San Francisco 80 participants Est. completion 2012-06 2 sitesOther conditions: UveitisView official trial listing → -
Withdrawn NCT NCT01244659
A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment
Not yet reported EMS Est. completion 2014-12 1 siteOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT01256294
Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients
Not yet reported Novartis 71 participants Est. completion 2011-05 2 sitesOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT01264315
Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant
Not yet reported Fondazione EMN Italy Onlus 53 participants Est. completion 2023-02 1 siteOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT01265537
A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf
Not yet reported University of British Columbia 30 participants Est. completion 2019-10-11 1 siteOther conditions: Acute Graft Rejection, DiabetesView official trial listing → -
Completed NCT NCT01266148
SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2012-12 6 sitesOther conditions: Renal Function and Chronic Allograft VasculopathyView official trial listing → -
Terminated NCT NCT01268995
Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation
Not yet reported Medical University of Vienna 32 participants Est. completion 2010-12 1 siteOther conditions: New Onset Diabetes Mellitus After Renal TransplantationView official trial listing → -
Terminated NCT NCT01276834
Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation
Not yet reported Dianet Dialysis Centers 13 participants Est. completion 2012-07 1 siteOther conditions: Renal TransplantationView official trial listing → -
Terminated NCT NCT01279616
A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease
Not yet reported Nationwide Children's Hospital 8 participants Est. completion 2015-01 1 siteOther conditions: Sickle Cell DiseaseView official trial listing → -
Withdrawn NCT NCT01284257
Observational Registry Study of Renal Transplant Patients
Novartis Pharmaceuticals Est. completion 2010-05 8 sitesOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT01284725
Weaning of Immunosuppression in Nephritis of Lupus
Not yet reported Assistance Publique Hopitaux De Marseille 100 participants Est. completion 2018-12-31 1 siteOther conditions: Nephritis of LupusView official trial listing → -
Status unknown NCT NCT01289301
Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant
Not yet reported Hannover Medical School 124 participants Est. completion 2018-10 4 sitesOther conditions: Disorder Related to Renal Transplantation, Immunosuppression Related Infectious Disease, Virus DiseasesView official trial listing → -
Completed NCT NCT01294020
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Not yet reported Astellas Pharma Europe Ltd. 81 participants Est. completion 2025-11-03 16 sitesOther conditions: Intestine Transplantation, Kidney Transplantation, Lung Transplantation, Liver Transplantation, Heart TransplantationView official trial listing → -
Terminated NCT NCT01296061
Kidney Transplant Failure
Ottawa Hospital Research Institute 270 participants Est. completion 2017-07 1 siteOther conditions: Acute Graft Rejection, Renal Failure Chronic Requiring DialysisView official trial listing → -
Completed NCT NCT01297972
Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
Not yet reported, Not yet reported University of Sao Paulo 9 participants Est. completion 2013-11 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Completed NCT NCT01298492
A Study To Monitor Long-Term Treatment With PF-00547659
Not yet reported Shire 268 participants Est. completion 2016-07-27 112 sitesOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT01300416
Measurement of Patient Reported Outcomes in Renal Transplant Patients With And Without Gastrointestinal (GI) Symptoms
Novartis Pharmaceuticals 101 participants Est. completion 2012-07 9 sitesOther conditions: Kidney Transplantation, GI Symptoms SeverityView official trial listing → -
Completed NCT NCT01304836
A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids
Not yet reported Astellas Pharma Inc 1166 participants Est. completion 2013-05-22 100 sitesOther conditions: Kidney TransplantationView official trial listing → -
No Longer Available NCT NCT01309022
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
National Institute of Allergy and Infectious Diseases (NIAID) 3 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT01312064
De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction
Not yet reported National Taiwan University Hospital 2 participants Est. completion 2012-04 1 siteOther conditions: Renal InsufficiencyView official trial listing → -
Terminated NCT NCT01324934
Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids
Not yet reported Neovii Biotech 40 participants Est. completion 2011-01 10 sitesOther conditions: Renal Transplant RejectionView official trial listing → -
Completed NCT NCT01325571
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
Not yet reported Astellas Pharma Inc 83 participants Est. completion 2014-05 9 sitesOther conditions: Myasthenia GravisView official trial listing → -
Completed NCT NCT01332201
Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®
Not yet reported Astellas Pharma Inc 17 participants Est. completion 2013-11 8 sitesOther conditions: Heart Transplantation, Lung Transplantation, Pancreas (Including SPK) TransplantationView official trial listing → -
Status unknown NCT NCT01332526
FFT, Inflammation, Lipid Metabolism, Blood Pressure and Organ Damage in Patients With Obesity, Chronic Kidney Disease (CKD).
Collegium Medicum w Bydgoszczy 70 participantsChronic kidney diseaseMetabolic syndrome Other conditions: ObesityView official trial listing → -
Completed NCT NCT01338779
Study of Tolerant Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 197 participants Est. completion 2015-08 4 sitesOther conditions: Transplant Rejection, Kidney Transplantation, Renal Transplantation, Renal Transplant, Transplant ToleranceView official trial listing → -
Completed NCT NCT01339468
A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation
Not yet reported Astellas Pharma Inc 100 participants Est. completion 2014-05-27 1 siteOther conditions: Liver TransplantationView official trial listing → -
Terminated NCT NCT01342016
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Not yet reported Astellas Pharma Inc 84 participants Est. completion 2013-05 12 sitesOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT01343953
Cord Blood Transplantation in Severe Aplastic Anemia
Not yet reported Assistance Publique - Hôpitaux de Paris 26 participants Est. completion 2017-06 1 siteOther conditions: Hereditary Diseases, Acquired Aplastic Anemia, Relapse, Absence of an HLA Identical DonorView official trial listing → -
Completed NCT NCT01346085
Calcineurin Inhibitor (CNI)-Free Immunosuppressive Regimen in T1D Patients Receiving Islet Transplantation
Not yet reported, Not yet reported Ospedale San Raffaele 10 participants Est. completion 2012-06 2 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Status unknown NCT NCT01353053
Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
Federal University of São Paulo 82 participants 1 siteOther conditions: Disorder of Transplanted Kidney, Cytomegalovirus InfectionsView official trial listing → -
Completed NCT NCT01356277
Intervention to Improve Adherence in Teen Kidney Transplant
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 170 participants Est. completion 2016-06 8 sitesOther conditions: Kidney Transplantation, Medication AdherenceView official trial listing → -
Completed NCT NCT01363752
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Not yet reported Astellas Pharma Inc 853 participants Est. completion 2013-09-18 58 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01364896
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
University of Pittsburgh 46 participants Est. completion 2015-12 1 siteOther conditions: Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease (CD), Anal Human PapillomavirusView official trial listing → -
Completed NCT NCT01369082
Extended Follow-Up After Islet Transplantation in T1D
National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2017-07 8 sitesOther conditions: Type 1 Diabetes (T1D), Islet TransplantationView official trial listing → -
Completed NCT NCT01370746
Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 502 participants Est. completion 2014-04 15 sitesOther conditions: Organ TransplantationView official trial listing → -
Completed NCT NCT01370824
Clinical Diagnosis of Basal Cell Carcinoma Subtype
Maastricht University Medical Center 150 participants Est. completion 2013-02 2 sitesOther conditions: Basal Cell CarcinomaView official trial listing → -
Terminated NCT NCT01371344
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
Not yet reported Astellas Pharma Europe Ltd. 47 participants Est. completion 2017-04-02 12 sitesOther conditions: Heart Transplantation, Kidney Transplantation, Liver TransplantationView official trial listing → -
Completed NCT NCT01374750
Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)
Not yet reported Seoul National University Hospital 45 participants Est. completion 2016-05 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT01378091
Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer
Not yet reported Columbia University 64 participants Est. completion 2013-09 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT01392872
Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
Not yet reported University Hospital, Clermont-Ferrand 48 participants Est. completion 2016-01 1 siteOther conditions: Multiple Sclerosis, Relapsing-RemittingView official trial listing → -
Completed NCT NCT01394640
Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
Paolo Corradini 124 participants Est. completion 2011-01 1 siteOther conditions: Lymphoma, Multiple Myeloma, Myeloproliferative DiseaseView official trial listing → -
Completed NCT NCT01404325
Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients
Not yet reported Novartis Pharmaceuticals 130 participants Est. completion 2017-01-05 9 sitesOther conditions: Lung TransplantationView official trial listing → -
Status unknown NCT NCT01423552
Pharmacology of Immunosuppressants Following Heart Transplantation
Nigel E. Drury 100 participants 2 sitesOther conditions: Heart TransplantationView official trial listing → -
Terminated NCT NCT01424345
The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient
Not yet reported CAMC Health System 4 participants Est. completion 2012-07 1 siteOther conditions: Kidney Transplant ImmunosuppressionView official trial listing → -
Status unknown NCT NCT01428973
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens
Not yet reported University of Liege 200 participants Est. completion 2024-12 13 sitesOther conditions: Graft-Versus-Host Disease, Hematological MalignanciesView official trial listing → -
Completed NCT NCT01429038
Mesenchymal Stem Cells After Renal or Liver Transplantation
Not yet reported, Not yet reported University of Liege 40 participants Est. completion 2019-03-11 1 siteOther conditions: Liver Failure, Kidney FailureView official trial listing → -
Terminated NCT NCT01436305
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 19 participants Est. completion 2015-04 3 sitesOther conditions: Kidney Transplantation, Renal TransplantationView official trial listing → -
Terminated NCT NCT01445236
Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance
Not yet reported Hospital Clinic of Barcelona 25 participants Est. completion 2013-01 1 siteOther conditions: Liver TransplantationView official trial listing → -
Terminated NCT NCT01445821
Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
Not yet reported Northwestern University 44 participants Est. completion 2019-10-10 1 siteOther conditions: Scleroderma, SystemicView official trial listing → -
Terminated NCT NCT01446211
Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis
Not yet reported Nordic Pharma SAS 4 participants Est. completion 2015-01 1 siteOther conditions: Wegeners GranulomatosisView official trial listing → -
Status unknown NCT NCT01446484
Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
Not yet reported, Not yet reported Pirogov Russian National Research Medical University 30 participants Est. completion 2014-11 2 sitesOther conditions: End-Stage Renal Disease, Kidney FailureView official trial listing → -
Completed NCT NCT01449955
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
Not yet reported University of Texas Southwestern Medical Center 54 participants Est. completion 2010-07 1 siteOther conditions: Posttraumatic Stress DisorderView official trial listing → -
Completed NCT NCT01450033
Peers for Promoting Adolescent Transplant Health
Not yet reported Children's Hospital of Philadelphia 74 participants Est. completion 2017-03-29 1 siteOther conditions: Behavior and Behavior MechanismsView official trial listing → -
Terminated NCT NCT01467505
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Not yet reported Vertex Pharmaceuticals Incorporated 61 participants Est. completion 2014-04 22 sitesOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT01467986
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Not yet reported University of Regensburg 130 participants Est. completion 2020-09-30 1 site Stand-aloneOther conditions: Neuroblastoma RecurrentView official trial listing → -
Completed NCT NCT01479881
A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus
Not yet reported Tibotec Pharmaceuticals, Ireland 29 participants Est. completion 2011-12 1 siteOther conditions: Hepatitis C VirusView official trial listing → -
Completed NCT NCT01481142
Adacolumn in Refractory UC Patients Trial
Not yet reported Otsuka Pharmaceutical Europe Ltd 100 participants Est. completion 2015-07 1 siteOther conditions: Ulcerative Colitis, Active ModerateView official trial listing → -
Completed NCT NCT01484496
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)
Not yet reported Human Genome Sciences Inc., a GSK Company 839 participants Est. completion 2015-10-01 207 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT01496417
Belatacept in Renal Transplantation With Intermediate Risk Maryland Aggregate Pathology Index (MAPI) Scores
Not yet reported University of Maryland 20 participants Est. completion 2018-03-01 1 siteOther conditions: End-Stage Renal DiseaseView official trial listing → -
Completed NCT NCT01505855
Efficacy Study of Pneumococcal Vaccination in Crohn's Disease
Not yet reported Kyunghee University Medical Center 197 participants Est. completion 2013-06 15 sitesOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT01507103
Tecemotide (L-BLP25) in Rectal Cancer
Not yet reported Merck KGaA, Darmstadt, Germany 124 participants Est. completion 2014-06 1 siteOther conditions: Rectal CancerView official trial listing → -
Completed NCT NCT01508468
Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy
Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2016-08-31 1 siteOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Terminated NCT NCT01517984
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 52 participants Est. completion 2015-05 11 sitesOther conditions: Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT01526889
Safety,Tolerability and Efficacy of Intravitreal LFG316 in Patients With Active Non-infectious Intermediate-, posterior-or Panuveitis ,
Not yet reported Novartis Pharmaceuticals 25 participants Est. completion 2017-08-24 8 sitesOther conditions: Non-infectious Intermediate Uveitis, Non-infectious Posterior Uveitis, Non-infectious PanuveitisView official trial listing → -
Completed NCT NCT01529138
Study of Axitinib and Temsirolimus in Solid Tumors
Not yet reported Emory University 13 participants Est. completion 2014-03 1 siteOther conditions: CancerView official trial listing → -
Status unknown NCT NCT01539902
Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
Not yet reported CytoMed & Beike 25 participants Est. completion 2013-05 1 siteOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT01541280
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Not yet reported Nantes University Hospital 30 participants Est. completion 2015-07 1 siteOther conditions: Acute Myeloid Leukemia, Myelodysplastic SyndromeView official trial listing → -
Terminated NCT NCT01547143
Pilot Study of Etoposide-based Therapy and Hematopoietic Cell Transplantation for Hemophagocytic Lymphohistiocytosis
Not yet reported Asan Medical Center 12 participants Est. completion 2016-05 1 siteOther conditions: Hemophagocytic LymphohistiocytosisView official trial listing → -
Completed NCT NCT01560572
Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen
Not yet reported University Medical Center Groningen 305 participants Est. completion 2016-04 3 sitesOther conditions: Renal Insufficiency, Kidney TransplantationView official trial listing → -
Terminated NCT NCT01561404
Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise
Not yet reported Josep M Cruzado 3 participants Est. completion 2013-12 1 siteOther conditions: Disorder Related to Renal Transplantation, Exercise, Aerobic, Muscle StrengthView official trial listing → -
Terminated NCT NCT01562951
Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
Not yet reported Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 15 participants Est. completion 2014-03 30 sitesObstructive sleep apnea Other conditions: Crohn's DiseaseView official trial listing → -
Terminated NCT NCT01570348
Crohn's Allogeneic Transplant Study
Not yet reported Fred Hutchinson Cancer Center 2 participants Est. completion 2019-10-30 1 siteOther conditions: Crohn DiseaseView official trial listing → -
Completed NCT NCT01598987
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
Not yet reported Novartis Pharmaceuticals 56 participants Est. completion 2016-06 32 sitesOther conditions: Renal Function, Liver TransplantView official trial listing → -
Terminated NCT NCT01609673
Study of Everolimus in de Novo Renal Transplant Recipients
Not yet reported Helady Pinheiro, MD, PhD 1 participants Est. completion 2013-05 4 sitesOther conditions: End Stage Renal Failure With Renal TransplantView official trial listing → -
Status unknown NCT NCT01613963
Causes of Visual Loss in Retinal Disease
Royal Surrey County Hospital NHS Foundation Trust 2000 participants Est. completion 2012-12 2 sitesOther conditions: Uveitis, ScleritisView official trial listing → -
Completed NCT NCT01614665
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Not yet reported Astellas Pharma Europe Ltd. 44 participants Est. completion 2021-04-21 10 sitesOther conditions: Heart Transplantation, Kidney Transplantation, Liver TransplantationView official trial listing → -
Terminated NCT NCT01621477
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
Not yet reported St. Jude Children's Research Hospital 34 participants Est. completion 2015-12 1 siteOther conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hodgkin or Non-Hodgkin Lymphoma, Sarcoma, MyeloidView official trial listing → -
Status unknown NCT NCT01627236
Efficacy of Short-term Immunosuppressive Therapy and Anti-allergenic Therapy in Severe Acute Exacerbation of Chronic Hepatitis B
Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 120 participants Est. completion 2014-11 1 siteOther conditions: Severe Acute Exacerbation of Chronic Hepatitis BView official trial listing → -
Status unknown NCT NCT01631058
Renal Transplantation in the Elderly - nEverOld Study
Not yet reported University of Sao Paulo General Hospital 90 participants Est. completion 2019-06 2 sitesOther conditions: Chronic Renal Failure (CRF), Graft Failure, Transplant; Failure, Kidney, Renal Transplant RejectionView official trial listing → -
Completed NCT NCT01632241
Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Not yet reported Human Genome Sciences Inc., a GSK Company 503 participants Est. completion 2019-01-28 96 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Terminated NCT NCT01636466
The Everolimus-Transplant Exit Strategy Trial (E-TEST)
Not yet reported Ashtar Chami 1 participants Est. completion 2014-05 1 siteOther conditions: Kidney Failure, ChronicView official trial listing → -
Completed NCT NCT01638559
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 161 participants Est. completion 2018-06-11 12 sitesOther conditions: Liver Transplant Recipients, Liver Transplantation, ImmunosuppressionView official trial listing → -
Completed NCT NCT01640743
Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation
Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 58 participants Est. completion 2014-04 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT01649388
A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients
Not yet reported Talaris Therapeutics Inc. Est. completion 2023-02-28 3 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01650662
CYCLosporinE A in Reperfused Acute Myocardial Infarction
Not yet reported Mario Negri Institute for Pharmacological Research 410 participants Est. completion 2014-10 31 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01653847
Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
Not yet reported Northwestern University 88 participants Est. completion 2020-05 1 siteOther conditions: End Stage Renal Failure With Renal TransplantView official trial listing → -
Completed NCT NCT01655563
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation
Not yet reported The Hospital for Sick Children 75 participants Est. completion 2016-02 1 siteOther conditions: Heart Transplantation, Liver Transplantation, Kidney TransplantationView official trial listing → -
Completed NCT NCT01660607
Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell
Not yet reported, Not yet reported Stanford University 68 participants Est. completion 2023-12-20 1 siteOther conditions: Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, Myelodysplastic Syndromes (MDS), Lymphoma, Non-Hodgkin, Acute Lymphoblastic Leukemia (ALL), Myeloproliferative Syndrome, Acute Myeloid Leukemia, Acute Leukemia, Chronic Myelogenous LeukemiaView official trial listing → -
Completed NCT NCT01672957
An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil
Hoffmann-La Roche 128 participants Est. completion 2015-07 2 sitesOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT01675947
Intravitreal Injections of Sirolimus in the Treatment of Geographic Atrophy
Not yet reported National Eye Institute (NEI) 52 participants Est. completion 2016-02 13 sitesOther conditions: Geographic AtrophyView official trial listing → -
Completed NCT NCT01678937
Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents
Northwestern University 31 participants Est. completion 2008-09 1 siteOther conditions: Liver Transplant Rejection, ImmunosuppressionView official trial listing → -
Completed NCT NCT01687192
Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy.
Not yet reported University Hospital, Bordeaux 37 participants Est. completion 2016-10-20 9 sitesOther conditions: Transplantation, Systemic Lupus Erythematosus, Systemic Immune DiseaseView official trial listing → -
Status unknown NCT NCT01690247
Human Mesenchymal Stem Cells Induce Liver Transplant Tolerance
Not yet reported Beijing 302 Hospital 50 participants Est. completion 2015-02 1 siteOther conditions: Evidence of Liver TransplantationView official trial listing → -
Completed NCT NCT01692808
Bioavailability of Vitamin D in Children and Adolescents With Crohn's Disease
Not yet reported St. Justine's Hospital 20 participants Est. completion 2014-11 1 siteOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT01695668
Treatment of Ocular Graft-versus-Host Disease (GVHD) With Topical Loteprednol Etabonate 0.5%
Not yet reported University of Michigan 75 participants Est. completion 2015-02Other conditions: Dry EyesView official trial listing → -
Status unknown NCT NCT01699360
The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
Not yet reported Central South University 600 participants Est. completion 2013-12 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Suspended NCT NCT01705899
Islet Allotransplantation in Type 1 Diabetes
Not yet reported Ohio State University 20 participants Est. completion 2033-10 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT01705977
Belimumab Assessment of Safety in SLE
Not yet reported GlaxoSmithKline 4019 participants Est. completion 2022-08-10 250 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT01707550
An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients
Hoffmann-La Roche 414 participants Est. completion 2011-01 3 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01707849
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation
Not yet reported Hospital Vall d'Hebron 18 participants Est. completion 2016-08 1 siteOther conditions: Hepatitis C Recurrence After Liver TransplantView official trial listing → -
Completed NCT NCT01729455
Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry
GlaxoSmithKline 3138 participants Est. completion 2025-02-28 179 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT01733056
Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression
Not yet reported Emory University 43 participants Est. completion 2013-01 2 sitesOther conditions: ImmunosuppressionView official trial listing → -
Completed NCT NCT01739803
Behavioral Contract Adherence Intervention
Not yet reported University of Tennessee 150 participants Est. completion 2013-06 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT01742624
Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation
Not yet reported Astellas Pharma Korea, Inc. 60 participants Est. completion 2012-06 3 sitesOther conditions: de Novo Kidney TransplantationView official trial listing → -
Completed NCT NCT01743560
An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis
Not yet reported Novartis Pharmaceuticals 52 participants Est. completion 2016-08-15 11 sitesOther conditions: Oestrogen Receptor Positive Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT01744470
Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)
Not yet reported University Hospital, Tours 286 participants Est. completion 2015-03 16 sitesOther conditions: De Novo Transplant DiseaseView official trial listing → -
Withdrawn NCT NCT01752790
Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease
Not yet reported University of Roma La Sapienza Est. completion 2015-12 1 site Stand-aloneOther conditions: Pediatric Crohn's DiseaseView official trial listing → -
Completed NCT NCT01764581
Randomized Controlled Trial of ImmuKnow in Liver Transplantation
Not yet reported University of Bologna 206 participants Est. completion 2012-03Other conditions: Liver DiseaseView official trial listing → -
Terminated NCT NCT01764607
Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma
Not yet reported University of Florida 1 participants Est. completion 2014-06 1 siteOther conditions: Squamous Cell Skin CarcinomaView official trial listing → -
Terminated NCT NCT01765842
Comparison of the Efficacy of Two Rituximab Treatment Regimens in Patients With Lupus Nephropathy
Not yet reported Fundación Pública Andaluza Progreso y Salud 9 participants Est. completion 2015-12 3 sitesOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT01767350
Determinants of Immunosuppressive Dose Requirements in Children After Solid Organ Transplantation
Universitaire Ziekenhuizen KU Leuven 60 participants Est. completion 2015-01 1 siteOther conditions: Transplantation InfectionView official trial listing → -
Completed NCT NCT01771809
Long-Term Safety Of PF-00547659 In Ulcerative Colitis
Not yet reported Shire 330 participants Est. completion 2017-12-13 99 sitesOther conditions: Ulcerative ColitisView official trial listing → -
Terminated NCT NCT01775397
A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System
Not yet reported Astellas Pharma Europe Ltd. 12 participants Est. completion 2013-04-15 16 sitesOther conditions: Clostridium DifficileView official trial listing → -
Terminated NCT NCT01797315
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Not yet reported University Hospital of Berlin 40 participants Est. completion 2013-06Other conditions: Renal Transplant Patients at High-risk for Skin CancerView official trial listing → -
Status unknown NCT NCT01799460
Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
Shanghai University of Traditional Chinese Medicine 80 participants Est. completion 2013-08 1 siteOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Completed NCT NCT01801280
Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS
Not yet reported Klemens Budde 20 participants Est. completion 2014-03 1 siteOther conditions: Transplantation, Immunosuppression, Drug InteractionView official trial listing → -
Completed NCT NCT01802268
Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients
Not yet reported Helio Tedesco Silva Junior 320 participants Est. completion 2012-10 6 sitesOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT01804829
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Not yet reported Biotest Pharmaceuticals Corporation 80 participants Est. completion 2016-06 23 sitesOther conditions: Hepatitis C Infection, Viruses, Hepatocellular Carcinoma, Hepatitis, Viral, Human, Liver CirrhosisView official trial listing → -
Completed NCT NCT01813617
Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis
Karolinska University Hospital 72 participants 1 siteOther conditions: Polymyositis, DermatomyositisView official trial listing → -
Completed NCT NCT01817504
Systematic Transplantectomy Versus Conventional Care After Kidney Graft Failure
Not yet reported Hospices Civils de Lyon 56 participants Est. completion 2021-11 9 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT01817959
Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation
Not yet reported Dompé Farmaceutici S.p.A 51 participants Est. completion 2017-12 9 sitesOther conditions: Islet Transplantation in Diabetes Mellitus Type 1View official trial listing → -
Terminated NCT NCT01818726
Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Not yet reported Novartis Pharmaceuticals 15 participants Est. completion 2016-10-17 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Completed NCT NCT01834690
Uses of Immunosuppression Therapy in Patients With Liver Transplantation
Chang Gung Memorial Hospital 314 participants Est. completion 2014-12 1 siteOther conditions: Evidence of Liver TransplantationView official trial listing → -
Completed NCT NCT01839929
A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF
Not yet reported Astellas Pharma Korea, Inc. 138 participants Est. completion 2013-02 4 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01849939
Eradication of Residual Disease by Preemptive Immunointervention After Allogeneic Hematopoietic Stem Cells Transplantation in Chronic Lymphocytic Leukemia
Not yet reported University Hospital, Clermont-Ferrand 43 participants Est. completion 2017-02-15 1 siteOther conditions: Chronic Lymphocytic Leukemia, Lymphocytic LymphomaView official trial listing → -
Terminated NCT NCT01856257
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 71 participants Est. completion 2016-04 3 sitesOther conditions: Primary Renal Allograft Candidate, Kidney TransplantationView official trial listing → -
Status unknown NCT NCT01858259
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
Gabriela Riemekasten 1372 participants Est. completion 2016-06 11 sitesOther conditions: Systemic Sclerosis, Interstitial Lung DiseasesView official trial listing → -
Completed NCT NCT01859832
Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 19 participants Est. completion 2013-12 1 siteOther conditions: Renal Transplant RecipientsView official trial listing → -
Completed NCT NCT01860170
Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis
Not yet reported, Not yet reported Corewell Health West 28 participants Est. completion 2018-03 1 siteOther conditions: Hematological MalignancyView official trial listing → -
Completed NCT NCT01860963
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Not yet reported Stanford University 310 participants Est. completion 2013-06 1 siteOther conditions: Anal Squamous Intraepithelial Lesion (ASIL), HPV DNAView official trial listing → -
Completed NCT NCT01868269
Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)
Not yet reported Institut Curie 102 participants Est. completion 2025-01-17 36 sitesOther conditions: Opsoclonus Myoclonus Syndrome, NeuroblastomaView official trial listing → -
Status unknown NCT NCT01877746
CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)
Not yet reported St. Anne's University Hospital Brno, Czech Republic 234 participants Est. completion 2015-09 2 sitesOther conditions: Inflammatory CardiomyopathyView official trial listing → -
Terminated NCT NCT01878786
A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
Not yet reported, Not yet reported Matthew Cooper 25 participants Est. completion 2017-12 1 siteOther conditions: Delayed Graft FunctionView official trial listing → -
Status unknown NCT NCT01881802
Study of Opioid Immunosuppressive Effects
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50 participantsOther conditions: Opioid Abuse or DependenceView official trial listing → -
Completed NCT NCT01882322
A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects
Not yet reported Astellas Pharma Korea, Inc. 36 participants Est. completion 2017-01-03 1 siteOther conditions: de Novo Liver Transplant SubjectsView official trial listing → -
Status unknown NCT NCT01889017
Generic Immunosuppressive Drugs After Lung Transplantation
Hannover Medical School 600 participants Est. completion 2014-09 1 siteOther conditions: Immunosuppressive After Lung TransplantationView official trial listing → -
Terminated NCT NCT01889992
Cardiac Allograft Remodeling and Effects of Sirolimus
Not yet reported University of Nebraska 42 participants Est. completion 2018-09-27 1 siteOther conditions: Cardiac Hypertrophy, ImmunosuppressionView official trial listing → -
Completed NCT NCT01895049
Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria
Not yet reported Helio Tedesco Silva Junior 171 participants Est. completion 2017-03-07 1 siteOther conditions: Kidney Transplantation, CytomegalovirusView official trial listing → -
Completed NCT NCT01895894
Mycophenolate Mofetil in Pediatric Steroid Dependent Nephrotic Syndrome
Not yet reported Seoul National University Hospital 34 participants Est. completion 2016-12 1 siteOther conditions: Nephrotic SyndromeView official trial listing → -
Terminated NCT NCT01896986
HPV Vaccination in Special Risk Groups: 5 Year Follow-up
Murdoch Childrens Research Institute 37 participants Est. completion 2012-03 1 siteOther conditions: PRD (Paediatric Rheumatological Disease), IBD (Inflammatory Bowel Disease)View official trial listing → -
Withdrawn NCT NCT01901471
Cyclosporine in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Not yet reported Hospices Civils de Lyon Est. completion 2015-10 18 sitesCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01903473
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Not yet reported University of Liege 19 participants Est. completion 2022-09-12 2 sitesOther conditions: Chronic Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Steroid Refractory Graft-Versus-Host DiseaseView official trial listing → -
Completed NCT NCT01903798
A Safety and Efficacy Study of Mycophenolate Mofetil and Rilonacept in Patients With Alcoholic Hepatitis
Not yet reported Southern California Institute for Research and Education 4 participants Est. completion 2016-04 3 sitesOther conditions: Alcoholic HepatitisView official trial listing → -
Status unknown NCT NCT01905514
ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients
Not yet reported Seoul National University Hospital 140 participants Est. completion 2019-12-31 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01908283
Induction of Immunity Against Streptococcus Pneumoniae in Adults With Inflammatory Bowel Disease
Not yet reported Klara M. Pósfay Barbe 300 participants Est. completion 2016-12 1 siteOther conditions: Inflammatory Bowel Diseases, Crohn Disease, Colitis, UlcerativeView official trial listing → -
Active, not recruiting NCT NCT01909245
Islet Cell Transplant for Type 1 Diabetes
Not yet reported City of Hope Medical Center 10 participants Est. completion 2027-08-31 1 site Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT01909492
Measurement of Relaxin Peptide in Multiple Sclerosis (MS)
Providence Health & Services 30 participants Est. completion 2023-10-05 1 siteOther conditions: Multiple Sclerosis, Relapsing-RemittingView official trial listing → -
Completed NCT NCT01913392
Effect of Laparoscopic Sleeve Gastrectomy in the Morbidly Obese, Kidney Transplant Candidate
Maisonneuve-Rosemont Hospital 15 participants Est. completion 2018-05 1 siteOther conditions: Obesity, Morbid, Transplant; Failure, KidneyView official trial listing → -
Completed NCT NCT01914770
Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76
GlaxoSmithKline 1016 participants Est. completion 2010-11Other conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT01927588
Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients
Not yet reported Fundação Pró Rim 50 participants Est. completion 2015-11Other conditions: Cytomegalovirus InfectionsView official trial listing → -
Completed NCT NCT01936519
Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.
Not yet reported Milton S. Hershey Medical Center 24 participants Est. completion 2019-07-31 1 siteOther conditions: Immunosuppression, Renal FailureView official trial listing → -
Completed NCT NCT01938625
A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Not yet reported Janssen R&D Ireland 35 participants Est. completion 2015-07-28 6 sitesOther conditions: Hepatitis C, ChronicView official trial listing → -
Enrolling by invitation NCT NCT01957696
The Norwegian Pancreas Transplantation (PTx) Study
Oslo University Hospital 80 participants Est. completion 2028-10 1 siteOther conditions: Diabetes Mellitus, Pancreas Transplantation, Allograft Rejection, Surgical Complication Nec, Allograft BiopsiesView official trial listing → -
Status unknown NCT NCT01959308
Adherence to Immunosuppressive Therapy Liver Transplant Recipients
National University Hospital, Singapore 100 participants Est. completion 2014-06 1 siteOther conditions: Focus : To Study the Differences in Patient Compliance to Immunosuppressive Treatments and Patient Preference.View official trial listing → -
Terminated NCT NCT01962636
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
Not yet reported Masonic Cancer Center, University of Minnesota 200 participants Est. completion 2026-05-14 1 siteOther conditions: Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myelofibrosis, Myelodysplasia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Lymphoblastic Lymphoma, Burkitt's Lymphoma, Non-Hodgkin Lymphoma, Multiple MyelomaView official trial listing → -
Status unknown NCT NCT01974674
Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes
Not yet reported Assistance Publique - Hôpitaux de Paris 19 participants Est. completion 2022-01 1 siteOther conditions: Patients With Type 1 DiabetesView official trial listing → -
Completed NCT NCT01976182
Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia
Not yet reported Rennes University Hospital 166 participants Est. completion 2024-10-07 59 sitesOther conditions: Large Granular Lymphocytes LeukemiaView official trial listing → -
Status unknown NCT NCT01995331
Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
Not yet reported Xiaofan Zhu 30 participants Est. completion 2015-03 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT01997372
Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia
Not yet reported Chinese Academy of Medical Sciences 100 participants Est. completion 2015-11 1 siteOther conditions: Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT02004860
Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis
Not yet reported University Hospital, Rouen 120 participants Est. completion 2017-10 1 siteOther conditions: Severe Seborrheic DermatitisView official trial listing → -
Completed NCT NCT02015351
Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study
Not yet reported University of Sao Paulo 9 participants Est. completion 2018-10 1 siteOther conditions: Choroidal NeovascularizationView official trial listing → -
Completed NCT NCT02016625
Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus
Not yet reported Boehringer Ingelheim 32 participants Est. completion 2014-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT02027805
Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD
Not yet reported, Not yet reported Xenikos 20 participants Est. completion 2016-11-03 2 sitesOther conditions: Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT02034747
A Study to Assess the Efficacy and Safety of Advagraf® Switching From Cyclosporine Between the Group That Was Treated With a 50% Reduced Corticosteroid and the Group With Maintained Corticosteroid for Stable Kidney Transplant Recipients
Not yet reported Astellas Pharma Korea, Inc. 150 participants Est. completion 2015-11-07 9 sitesOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT02038088
The Effect of General Anesthesia Immunosuppressive on Hepatitis B Virus Replication
Lu KZ 30 participants Est. completion 2015-01 1 siteOther conditions: HBV InfectionView official trial listing → -
Status unknown NCT NCT02044185
Clinical Implications of HMGB1 in Patients Treated With Chemotherapy or Hematopoietic Stem Cell Transplantation
Seoul St. Mary's Hospital 100 participants Est. completion 2015-12 1 siteOther conditions: Acute Graft-versus-host DiseaseView official trial listing → -
Completed NCT NCT02049476
Study of the Effectiveness of Ozurdex for the Control of Uveitis
Not yet reported Johns Hopkins University 20 participants Est. completion 2018-06-30 1 siteOther conditions: Uveitis, Intermediate, Uveitis, PosteriorView official trial listing → -
Completed NCT NCT02058719
Immunosuppressive Effects of Smoking and HIV-1 on the Development of Lung Disease
University of Colorado, Denver 210 participants Est. completion 2019-12 1 siteOther conditions: HIV, Smoking, COPDView official trial listing → -
Withdrawn NCT NCT02058875
Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring
Not yet reported University of Saskatchewan Est. completion 2015-10 2 sitesCardiovascular disease Other conditions: Cardiovascular Outcomes, Kidney Transplant Recipients, Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT02062892
Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients
Not yet reported University of Colorado, Denver Est. completion 2014-06Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02062944
SRL (Sirolimus) Withdrawal
Not yet reported Northwestern University 21 participants Est. completion 2020-07 1 siteOther conditions: Acute Rejection of Liver Transplant, Effects of Immunosuppressant TherapyView official trial listing → -
Completed NCT NCT02066935
Non-adherence to Immunosuppressives in Kidney Transplantation in Brazil Multicenter Study
Fundação Instituto Mineiro de Estudo Pesquisa Em Nefrologi 1105 participants Est. completion 2017-09-30 1 siteOther conditions: Medication AdherenceView official trial listing → -
Status unknown NCT NCT02075242
TO Compare the Triple Drug Therapy and Dual Therapy .
Not yet reported Asan Medical Center 170 participants Est. completion 2016-01 1 siteOther conditions: HEPATITISView official trial listing → -
Enrolling by invitation NCT NCT02081755
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Not yet reported Baylor Research Institute 336 participants Est. completion 2027-03 9 sitesOther conditions: Carcinoma, HepatocellularView official trial listing → -
Completed NCT NCT02083991
Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation
Not yet reported Vastra Gotaland Region 224 participants Est. completion 2017-12 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Status unknown NCT NCT02091973
MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation
Not yet reported Chulalongkorn University 50 participants Est. completion 2015-12 1 siteOther conditions: microRNA ProfilesView official trial listing → -
Terminated NCT NCT02092389
Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo
AbbVie 10 participants Est. completion 2016-03Other conditions: Moderate to Severe Ulcerative ColitisView official trial listing → -
Completed NCT NCT02094417
A Phase 2 Study to Evaluate the Efficacy and Safety of AMG531 in Aplastic Anemia
Not yet reported Kyowa Kirin Korea Co., Ltd. 35 participants Est. completion 2017-11-07 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Completed NCT NCT02103049
The Impact of Ezetimibe on Biochemical Markers of Cardiovascular Risk in Kidney Transplant Patients
Not yet reported University Medical Centre Ljubljana 80 participants Est. completion 2015-12 1 siteOther conditions: Dyslipidemia, TransplantsView official trial listing → -
Active, not recruiting NCT NCT02105766
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 56 participants Est. completion 2027-12-31 1 siteOther conditions: Sickle Cell Disease, Thalassemia, Stem Cell Transplantation, Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT02107807
Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Not yet reported Seqirus 539 participants Est. completion 2015-05 17 sitesOther conditions: Influenza, Human, Flu, Human, Flu, Avian, Influenza, Influenza A Virus, H5N1 SubtypeView official trial listing → -
Completed NCT NCT02108600
Tocilizumab for Renal Graft Inflammation
Not yet reported Flavio Vincenti 33 participants Est. completion 2018-12-16 1 siteOther conditions: Late Complication From Kidney TransplantView official trial listing → -
Completed NCT NCT02108860
Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)
Not yet reported University of South Florida 65 participants Est. completion 2023-12-20 20 sitesOther conditions: Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis, Wegener's Granulomatosis, ANCA-Associated VasculitisView official trial listing → -
Completed NCT NCT02115113
REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy
Not yet reported Novartis Pharmaceuticals 78 participants Est. completion 2016-09-30 14 sitesOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT02118896
Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant
Not yet reported Astellas Pharma Europe Ltd. 850 participants Est. completion 2009-10-07 105 sitesOther conditions: Heart Transplantation, Liver Transplantation, Kidney TransplantationView official trial listing → -
Completed NCT NCT02120157
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2020-10-01 9 sitesOther conditions: Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival, Transplantation, Bone MarrowView official trial listing → -
Status unknown NCT NCT02123836
Natural Killer Cells in Acute Leukaemia and Myelodysplastic Syndrome
Not yet reported National University Hospital, Singapore 20 participants Est. completion 2020-10 1 siteOther conditions: Acute Leukaemia, Myelodysplastic SyndromeView official trial listing → -
Terminated NCT NCT02128503
Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease
Not yet reported Chinese University of Hong Kong 430 participants Est. completion 2015-10-16 1 siteOther conditions: Inflammatory Bowel Disease, Crohn Disease, Ulcerative Colitis, Rheumatic Diseases, Hepatitis B, ChronicView official trial listing → -
Active, not recruiting NCT NCT02130362
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
AbbVie 1446 participants Est. completion 2030-11 148 sitesOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT02130414
PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects
Not yet reported Sigmoid Pharma 48 participants Est. completion 2015-02Other conditions: HealthyView official trial listing → -
Terminated NCT NCT02134288
Belatacept for Renal Transplant Recipients With Delayed Graft Function
Not yet reported Ohio State University 8 participants Est. completion 2019-01-18 1 siteOther conditions: Delayed Graft FunctionView official trial listing → -
Completed NCT NCT02134314
C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
Not yet reported, Not yet reported Cedars-Sinai Medical Center 70 participants Est. completion 2017-03-13 1 siteOther conditions: End Stage Renal Disease, Kidney Failure, Delayed Graft Function, Ischemic Reperfusion InjuryView official trial listing → -
Status unknown NCT NCT02135380
Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis
Not yet reported, Not yet reported Kasiak Research Pvt. Ltd. 60 participants 1 siteOther conditions: Idiopathic Pulmonary FibrosisView official trial listing → -
Completed NCT NCT02152345
Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients
Not yet reported Columbia University 57 participants Est. completion 2016-12-31 1 siteOther conditions: Implant or Graft; RejectionView official trial listing → -
Status unknown NCT NCT02154854
Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)
Not yet reported University Hospital, Tours 104 participants Est. completion 2015-03 11 sitesOther conditions: De Novo Transplant DiseaseView official trial listing → -
Completed NCT NCT02160054
Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)
Astellas Pharma Inc 289 participants Est. completion 2016-03-31 30 sitesOther conditions: the Maintenance Phase After Kidney TransplantationView official trial listing → -
Status unknown NCT NCT02179229
Effect of Pre- and Probiotics on P-cresol Plasma Levels in Patients Bearing a Kidney Allograft
Not yet reported Federico II University 30 participants Est. completion 2015-08 1 siteOther conditions: Renal Insufficiency, ChronicView official trial listing → -
Active, not recruiting NCT NCT02181257
Extracorporeal Photopheresis for Medicare Recipients of Lung Allografts
Not yet reported Washington University School of Medicine 280 participants Est. completion 2028-12 22 sitesOther conditions: Bronchiolitis Obliterans Syndrome (BOS)View official trial listing → -
Completed NCT NCT02182986
Biomarkers for Post-Transplant Lymphoproliferative Disorders in Children
National Institute of Allergy and Infectious Diseases (NIAID) 944 participants Est. completion 2019-05-15 7 sitesOther conditions: Heart Transplant, Small Intestine Transplant, Kidney Transplant, Liver Transplant, EBV-Related PTLD, PTLDsView official trial listing → -
Completed NCT NCT02186275
The Vitamin D in Pediatric Crohn's Disease
Not yet reported St. Justine's Hospital 25 participants Est. completion 2019-12-20 10 sites Stand-aloneOther conditions: Crohn's DiseaseView official trial listing → -
Completed NCT NCT02199145
Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy
Not yet reported Centre Hospitalier Universitaire de Nice 52 participants Est. completion 2020-06-04 3 sitesOther conditions: Membranous NephropathyView official trial listing → -
Completed NCT NCT02201576
Bortezomib in Rejection of Kidney Transplants
Not yet reported Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2020-07-16 1 siteOther conditions: Chronic Antibody-mediated Transplant RejectionView official trial listing → -
Completed NCT NCT02203396
A Single-Arm Phase 2 Study With Optimized Standard Protocol for Severe Aplastic Anemia
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 40 participants Est. completion 2017-09 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Completed NCT NCT02213068
Belatacept 3 Month Post Transplant Conversion Study
Not yet reported Lorenzo Gallon 28 participants Est. completion 2020-09 1 siteOther conditions: Transplant; Failure, Kidney, EBVView official trial listing → -
Completed NCT NCT02221583
Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy
Not yet reported University of Cincinnati 26 participants Est. completion 2015-02 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT02229604
Electroacupuncture for Diminished Ovarian Reserve
Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 57 participants Est. completion 2016-09Other conditions: Irregular MensesView official trial listing → -
Completed NCT NCT02240888
Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response
Not yet reported Region Skane 300 participants Est. completion 2018-05-31 1 siteOther conditions: RA, SLE, Vasculitis, Scleroderma, Sjögrens, SyndromeView official trial listing → -
Status unknown NCT NCT02251691
Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant
Not yet reported National Taiwan University Hospital 90 participants Est. completion 2020-03-31 1 siteOther conditions: Adherence to Medication RegimeView official trial listing → -
Status unknown NCT NCT02252328
Use of Simvastatin as a Steroid Sparing Agent for Uveitis Patients
Not yet reported, Not yet reported University College, London 50 participants Est. completion 2019-08 1 siteOther conditions: UveitisView official trial listing → -
Status unknown NCT NCT02254668
Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography
Not yet reported University of Zurich 278 participants Est. completion 2023-02 1 siteOther conditions: Intimal Proliferation, ImmunosuppressionView official trial listing → -
Terminated NCT NCT02255227
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD
Not yet reported Centre Hospitalier Universitaire de Saint Etienne 104 participants Est. completion 2022-07-06 8 sitesOther conditions: Infections, Pneumococcal, Bowel Diseases, InflammatoryView official trial listing → -
Terminated NCT NCT02268201
A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule
Not yet reported Astellas Pharma China, Inc. 17 participants Est. completion 2015-03-31 7 sitesOther conditions: Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT02270957
Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches
Not yet reported Oklahoma Medical Research Foundation 66 participants Est. completion 2021-12 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT02280902
Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases
University Hospital, Bordeaux 72 participants Est. completion 2021-11-19 7 sitesOther conditions: Immunologic and Inflammatory DiseasesView official trial listing → -
Terminated NCT NCT02282514
Stem Cell Transplantation for Stiff Person Syndrome (SPS)
Not yet reported, Not yet reported Northwestern University 23 participants Est. completion 2019-08-30 1 siteOther conditions: Stiff-Person SyndromeView official trial listing → -
Completed NCT NCT02286609
A Single Dose Evaluation of the Effects of Moderate Hepatic Impairment on Deflazacort Pharmacokinetics
Not yet reported PTC Therapeutics 16 participants Est. completion 2015-02 2 sitesOther conditions: Hepatic ImpairmentView official trial listing → -
Completed NCT NCT02286622
A Single Dose Evaluation of the Effects of Renal Impairment on Deflazacort Pharmacokinetics
Not yet reported PTC Therapeutics 16 participants Est. completion 2015-02 2 sitesOther conditions: Renal ImpairmentView official trial listing → -
Completed NCT NCT02286635
Evaluate Effects of Multiple Doses of Rifampin and Clarithromycin on the Single Dose Pharmacokinetics of Deflazacort
Not yet reported PTC Therapeutics 58 participants Est. completion 2014-12 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Active, not recruiting NCT NCT02287311
Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)
Not yet reported Baylor College of Medicine 38 participants Est. completion 2029-03 2 sitesOther conditions: Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus, T/NK-lymphoproliferative Disease, Nasopharyngeal Carcinoma, Smooth Muscle TumorView official trial listing → -
Completed NCT NCT02294032
The Role of B Cells in Kidney Allograft Dysfunction
Loma Linda University 180 participants Est. completion 2023-04-24 1 siteOther conditions: Kidney; Complications, Allograft, Transplantation InfectionView official trial listing → -
Status unknown NCT NCT02294097
Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation
Not yet reported Chulalongkorn University 100 participants Est. completion 2016-12 1 siteOther conditions: Surveillance Protocol BiopsyView official trial listing → -
Completed NCT NCT02294552
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
Not yet reported Ivan S Moiseev 200 participants Est. completion 2017-11 1 siteOther conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Lymphoma, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Immune System DiseasesView official trial listing → -
Completed NCT NCT02295748
An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort
Not yet reported PTC Therapeutics 24 participants Est. completion 2017-08-24 4 sitesOther conditions: Duchenne Muscular DystrophyView official trial listing → -
Completed NCT NCT02307643
Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients
Not yet reported Tanabe Pharma Corporation 17 participants Est. completion 2017-05 14 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT02311010
Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism
Not yet reported Université Catholique de Louvain 150 participants Est. completion 2015-01 1 siteOther conditions: Kidney DiseasesView official trial listing → -
Status unknown NCT NCT02314312
Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors
Not yet reported Mahidol University 48 participants Est. completion 2015-06Other conditions: Transplantation of Kidney, Expanded Criteria Donor, ECDView official trial listing → -
Completed NCT NCT02319525
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus
Not yet reported University of Alabama at Birmingham 301 participants Est. completion 2016-12 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT02328963
Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Not yet reported University Hospital, Bordeaux 186 participants Est. completion 2018-10-10 9 sitesOther conditions: Transplantation Infection, Cytomegalovirus InfectionView official trial listing → -
Completed NCT NCT02329808
Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics
Radboud University Medical Center 93 participants Est. completion 2021-12-03 1 siteOther conditions: Hematologic Diseases, Oncology Problem, Kidney Diseases, Transplantation InfectionView official trial listing → -
Completed NCT NCT02334488
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
Not yet reported Poitiers University Hospital 329 participants Est. completion 2020-07-03 14 sitesChronic kidney diseaseView official trial listing → -
Completed NCT NCT02339441
Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
University of Manchester 320 participants Est. completion 2016-03Other conditions: Early Diffuse Cutaneous Systemic SclerosisView official trial listing → -
Status unknown NCT NCT02342028
The Number and Function of Regular T Cell in Patients With Obstructive Sleep Apnea
Taipei Veterans General Hospital, Taiwan 80 participants Est. completion 2015-12 1 siteObstructive sleep apneaView official trial listing → -
Completed NCT NCT02347371
Heart Transplant Registry of Városmajor
Semmelweis University Heart and Vascular Center 11 participants Est. completion 2020-05 1 siteOther conditions: Disorder Related to Cardiac TransplantationView official trial listing → -
Status unknown NCT NCT02356445
Use of Immunosuppressive Therapy for Sarcoidosis
University of Cincinnati 2000 participants Est. completion 2018-12 1 siteOther conditions: SarcoidosisView official trial listing → -
Completed NCT NCT02371434
The ONE Study nTreg Trial (ONEnTreg13)
Not yet reported, Not yet reported Prof. Dr. Petra Reinke 17 participants Est. completion 2017-11-01 1 site Stand-aloneOther conditions: Immunosuppressive Treatment of Living-donor Renal TransplantationView official trial listing → -
Status unknown NCT NCT02388802
Human Clinical Trial of Uterine Transplantation in the United Kingdom
Not yet reported Womb Transplant UK 10 participants Est. completion 2020-01 Stand-aloneOther conditions: InfertilityView official trial listing → -
Completed NCT NCT02397018
Cord Blood Infusion for Ischemic Stroke
Not yet reported Joanne Kurtzberg, MD 10 participants Est. completion 2017-02-23 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02401932
Retrospective Analysis for Patients With Hemophagocytosis in Bone Marrow
Samsung Medical Center 300 participants Est. completion 2015-09 1 siteOther conditions: HemophagocytosisView official trial listing → -
Completed NCT NCT02402140
Influence of Pharmaceutical Care on the Intraindividual Variability of Tacrolimus Concentrations
Not yet reported Hospital do Rim e Hipertensão 128 participants Est. completion 2014-12Other conditions: Renal Transplant Graft FailureView official trial listing → -
Completed NCT NCT02404025
Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects
Not yet reported Novartis Pharmaceuticals 10 participants Est. completion 2017-09-06 11 sitesOther conditions: Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT02409576
Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas
Not yet reported, Not yet reported National University Hospital, Singapore 20 participants Est. completion 2020-09 1 siteObstructive sleep apnea Other conditions: Ewing SarcomaView official trial listing → -
Status unknown NCT NCT02416674
Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects
Not yet reported Brigham and Women's Hospital 10 participants Est. completion 2025-02 1 site Stand-aloneOther conditions: Abdominal Wall DefectView official trial listing → -
Status unknown NCT NCT02426502
Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
Not yet reported University of British Columbia 76 participants Est. completion 2024-12 3 sitesOther conditions: End-Stage Renal DiseaseView official trial listing → -
Status unknown NCT NCT02432339
Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress
Not yet reported, Not yet reported Augusta University 50 participants Est. completion 2019-11-30 1 siteOther conditions: Psychological Stress, Hypertension, RenalView official trial listing → -
Completed NCT NCT02435901
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
Not yet reported, Not yet reported Northwell Health 29 participants Est. completion 2019-12 1 siteOther conditions: Sickle Cell Disease, Beta Thalassemia-MajorView official trial listing → -
Completed NCT NCT02444429
3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation
Not yet reported Hospices Civils de Lyon 346 participants Est. completion 2024-06-21 8 sitesOther conditions: Renal TransplantationView official trial listing → -
Status unknown NCT NCT02452697
Ph2 NK Cell Enriched DCIs w/wo RLR9 Agonist, DUK-CPG-001 From Donors Following Allogeneic SCT
Not yet reported Cristina Gasparetto 36 participants Est. completion 2024-10 1 siteOther conditions: Myeloid Malignancies, Lymphoid MalignanciesView official trial listing → -
Status unknown NCT NCT02453867
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
Not yet reported Klemens Budde 400 participants Est. completion 2019-07Other conditions: Immunosuppression After Renal TransplantationView official trial listing → -
Status unknown NCT NCT02458196
Study of Treatment Response on IgG4 Related Disease (IgG4RD)
Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2018-06 1 siteOther conditions: Autoimmune DiseaseView official trial listing → -
Completed NCT NCT02461758
Trial of High Dose vs. Standard Dose Influenza Vaccine in Inflammatory Bowel Disease Patients
Not yet reported University of Wisconsin, Madison 81 participants Est. completion 2018-07 1 siteOther conditions: Inflammatory Bowel Disease (IBD)View official trial listing → -
Completed NCT NCT02474199
Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2019-12-16 3 sitesOther conditions: Liver Transplant Recipient, Living Donor (of the Respective Liver Transplant Recipient)View official trial listing → -
Completed NCT NCT02505542
Study to Evaluate Maintenance of Sustained Remission of axSpA With CZP Compared to Placebo
Not yet reported UCB BIOSCIENCES GmbH 736 participants Est. completion 2019-04 108 sitesOther conditions: Axial Spondyloarthrithis, Ankylosing SpondylitisView official trial listing → -
Terminated NCT NCT02523768
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
Not yet reported Centre Hospitalier Universitaire de Saint Etienne 117 participants Est. completion 2020-02-24 15 sitesOther conditions: Glomerulonephritis, IgANView official trial listing → -
Terminated NCT NCT02531308
Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)
Not yet reported Rush University Medical Center 5 participants Est. completion 2016-07 1 siteOther conditions: Diffuse Large B-Cell LymphomaView official trial listing → -
Completed NCT NCT02540395
Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation
Not yet reported Prof. Dr. Petra Reinke 184 participants Est. completion 2020-10-31 8 sitesOther conditions: Disorder Related to Renal Transplantation, Effects of Immunosuppressant TherapyView official trial listing → -
Terminated NCT NCT02546492
Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar
Not yet reported University of Maryland, Baltimore 6 participants Est. completion 2021-05-27 2 sites Stand-aloneOther conditions: Transplant GlomerulopathyView official trial listing → -
Completed NCT NCT02552212
Multicenter Study Evaluating Certolizumab Pegol Compared to Placebo in Subjects With axSpA Without X-ray Evidence of AS
Not yet reported UCB BIOSCIENCES GmbH 317 participants Est. completion 2020-05 105 sitesOther conditions: Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis, Nr-axSpAView official trial listing → -
Status unknown NCT NCT02554578
Impact of mHealth in Heart Transplant Management
Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 158 participantsOther conditions: Heart TransplantView official trial listing → -
Completed NCT NCT02560220
MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients
Not yet reported Heidelberg University 14 participants Est. completion 2017-04-18 1 siteOther conditions: Kidney Failure, ChronicView official trial listing → -
Completed NCT NCT02560558
Bela 8 Week Dosing
Not yet reported Emory University 166 participants Est. completion 2019-08-29 2 sitesOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT02561767
Effect of BM-MSCs in DCD Kidney Transplantation
Not yet reported, Not yet reported First Affiliated Hospital, Sun Yat-Sen University 120 participants Est. completion 2017-10 1 siteOther conditions: Kidney Transplantation, Acute Kidney Tubular NecrosisView official trial listing → -
Withdrawn NCT NCT02563782
Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD
Not yet reported Astellas Institute for Regenerative Medicine Est. completion 2017-05-05 1 siteOther conditions: Age-Related Macular DegenerationView official trial listing → -
Completed NCT NCT02581436
Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR
Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 70 participants Est. completion 2018-02-01 1 siteOther conditions: Disorder Related to Renal Transplantation, Renal Transplant Rejection, Acute Graft RejectionView official trial listing → -
Terminated NCT NCT02584647
PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Not yet reported, Not yet reported Gulam Manji 39 participants Est. completion 2024-10-01 5 sitesOther conditions: Sarcoma, Malignant Peripheral Nerve Sheath TumorsView official trial listing → -
Approved For Marketing NCT NCT02592941
Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy
PTC Therapeutics 42 sitesOther conditions: Duchenne Muscular DystrophyView official trial listing → -
Completed NCT NCT02596828
Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma
Not yet reported University of Regensburg 4 participants Est. completion 2021-04 1 site Stand-aloneOther conditions: PineoblastomaView official trial listing → -
Completed NCT NCT02623075
Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients
Northwestern University 19 participants Est. completion 2023-12 1 siteOther conditions: InfluenzaView official trial listing → -
Terminated NCT NCT02627573
Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT
Not yet reported St. Petersburg State Pavlov Medical University 32 participants Est. completion 2019-04-03 1 siteOther conditions: Leukemia, Chronic Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeView official trial listing → -
Active, not recruiting NCT NCT02629120
High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2028-12-30 1 siteOther conditions: Chronic Granulomatous Disease TransplantView official trial listing → -
Completed NCT NCT02639949
Measuring and Improving Medication Adherence in Kidney Transplant Patients
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 45 participants Est. completion 2017-07Other conditions: Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT02646657
An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
Not yet reported Geert D'Haens 120 participants Est. completion 2020-08 20 sitesOther conditions: Colitis, UlcerativeView official trial listing → -
Terminated NCT NCT02647255
Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy
Not yet reported, Not yet reported Peking University First Hospital 10 participants Est. completion 2020-10 2 sitesOther conditions: Glomerulonephritis, IGA, Kidney Diseases, Acute Renal Insufficiency, Rapidly Progressive GlomerulonephritisView official trial listing → -
Completed NCT NCT02654964
Cancer Stem Cell High-Throughput Drug Screening Study
Not yet reported Swedish Medical Center 9 participants Est. completion 2023-06 1 siteOther conditions: Glioblastoma MultiformeView official trial listing → -
Completed NCT NCT02667132
Granulomatous Mastitis Current Approach and Treatment
Granulomatous Mastitis Working Group 400 participants Est. completion 2018-01-04 1 siteOther conditions: Granulomatous, MastitisView official trial listing → -
Status unknown NCT NCT02682459
ACE-inhibitors in Extracapillary Glomerulonephritis
Not yet reported Monia Lorini 22 participants Est. completion 2019-12 2 sitesOther conditions: Extracapillary GlomerulonephritisView official trial listing → -
Completed NCT NCT02684734
Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis
University of British Columbia 50 participants Est. completion 2019-12 1 siteOther conditions: Ulcerative Colitis, Cytomegalovirus InfectionsView official trial listing → -
Status unknown NCT NCT02707822
The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration
National Taiwan University Hospital 440 participants Est. completion 2018-12 1 siteOther conditions: Kidney Transplantation, Liver TransplantationView official trial listing → -
Completed NCT NCT02711202
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Not yet reported Institute for Clinical and Experimental Medicine 20 participants Est. completion 2009-03Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02711826
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2023-08-04 6 sitesOther conditions: Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant, Living Kidney DonorView official trial listing → -
Terminated NCT NCT02723786
Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation
Not yet reported GlaxoSmithKline 7 participants Est. completion 2018-03-06 4 sitesOther conditions: Kidney Transplantation (Status Post)View official trial listing → -
Completed NCT NCT02741960
The Effect of Metformin on Reducing Lupus Flares
Not yet reported RenJi Hospital 180 participants Est. completion 2018-12-07 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Terminated NCT NCT02743793
A Cohort Study of Operationally Tolerant Allograft Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 41 participants Est. completion 2020-03-24 5 sitesOther conditions: Kidney Transplant, Liver TransplantView official trial listing → -
Completed NCT NCT02745717
The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia
Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2021-12 1 siteOther conditions: Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT02773290
Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 46 participants Est. completion 2020-07-28 3 sitesOther conditions: Aplastic AnemiaView official trial listing → -
Completed NCT NCT02799147
GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
Not yet reported, Not yet reported St. Petersburg State Pavlov Medical University 27 participants Est. completion 2020-11 1 siteOther conditions: Leukemia, Acute Lymphoblastic, Acute Myeloid Leukemia, Mixed-Lineage Acute LeukemiasView official trial listing → -
Status unknown NCT NCT02799316
Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?
Not yet reported Sherief Abd-Elsalam 100 participants Est. completion 2018-01 1 siteOther conditions: Hepatitis BView official trial listing → -
Completed NCT NCT02806375
PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis
Not yet reported, Not yet reported St. Petersburg State Pavlov Medical University 20 participants Est. completion 2019-04 1 siteOther conditions: Primary Myelofibrosis, Myeloproliferative DisordersView official trial listing → -
Completed NCT NCT02821026
Omental Islet Transplant
Not yet reported, Not yet reported University of Alberta 4 participants Est. completion 2019-11-13 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02827227
Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)
Hospices Civils de Lyon 99 participants Est. completion 2016-02 1 siteOther conditions: HIV-infected PatientsView official trial listing → -
Status unknown NCT NCT02838992
ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia
Not yet reported Jinan Military General Hospital 130 participants Est. completion 2019-07 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT02839941
Iguratimod in Kidney Transplant Recipients
Not yet reported The First Affiliated Hospital with Nanjing Medical University 60 participants Est. completion 2019-07 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT02843841
Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation
Not yet reported Centre Hospitalier Universitaire de Besancon 63 participants Est. completion 2017-03-01 1 siteOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT02845596
Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia
Not yet reported Michael Pulsipher 40 participants Est. completion 2023-07-19 13 sitesOther conditions: Severe Aplastic AnemiaView official trial listing → -
Terminated NCT NCT02855359
Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma
Not yet reported Seagen Inc. 24 participants Est. completion 2018-05-15 35 sitesOther conditions: Diffuse, Large B-Cell, Lymphoma, Follicular Lymphoma, Grade 3b, Transformed Lymphoma / DLBCLView official trial listing → -
Completed NCT NCT02857907
Anti-thymocyte Globulin-induced Immune Senescence
Centre Hospitalier Universitaire de Besancon 97 participants Est. completion 2013-01 1 siteOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Status unknown NCT NCT02874586
Plasma Exchange Combination of Immunosuppressive Regimens for Auto-immune Hepatitis
Not yet reported Xiaoli Fan 20 participants Est. completion 2021-09 1 siteOther conditions: Hepatitis, AutoimmuneView official trial listing → -
Completed NCT NCT02875743
King's Invasive Aspergillosis Study II
Not yet reported King's College Hospital NHS Trust 120 participants Est. completion 2019-10-31 1 siteOther conditions: Aplastic Anemia, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Bone Marrow TransplantationView official trial listing → -
Status unknown NCT NCT02875990
Characterization of Immunosuppressive Signing of Cervical Cancer
Not yet reported Assistance Publique Hopitaux De Marseille 50 participants Est. completion 2024-09 1 siteOther conditions: Cervical CancerView official trial listing → -
Status unknown NCT NCT02877212
Association of FcγRIIIA Polymorphism and THPO Expression With Response to Eltrombopag in Refractory ITP Patients
Not yet reported National Institute of Blood and Marrow Transplant (NIBMT), Pakistan 75 participants Est. completion 2017-09 1 siteOther conditions: Immune Thrombocytopenic Purpura (ITP)View official trial listing → -
Completed NCT NCT02877628
Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation
Rennes University Hospital 110 participants Est. completion 2018-12 1 siteOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT02878018
Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis
Liaoning University of Traditional Chinese Medicine 600 participants Est. completion 2020-05 1 siteOther conditions: Henoch-Schonlein Purpura NephritisView official trial listing → -
Completed NCT NCT02878603
Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)
Not yet reported Sanofi 104 participants Est. completion 2020-10-23 45 sites Stand-aloneOther conditions: Acquired Thrombotic Thrombocytopenic PurpuraView official trial listing → -
Completed NCT NCT02885610
Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
Not yet reported RemeGen Co., Ltd. 249 participants Est. completion 2019-07-09 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT02888080
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis
Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2019-03-04 8 sitesOther conditions: Pulmonary SarcoidosisView official trial listing → -
Status unknown NCT NCT02896270
Valproic Acid for Idiopathic Nephrotic Syndrome
Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 15 participants Est. completion 2019-12 2 sitesOther conditions: Idiopathic Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, Minimal Change DiseaseView official trial listing → -
Withdrawn NCT NCT02904772
Alipogene Tiparvovec for the Treatment of LPLD Patients
Not yet reported UniQure Biopharma B.V. Est. completion 2020-09 2 sitesOther conditions: LPL DeficiencyView official trial listing → -
Completed NCT NCT02917577
Hepatitis A Vaccine Dosing Regimens Among Pediatric Patients on Immunosuppressive Therapy
Not yet reported University of Calgary 19 participants Est. completion 2023-06 1 siteOther conditions: Autoimmune Rheumatologic DiseaseView official trial listing → -
Status unknown NCT NCT02931942
Changing Over Time of Ascorbic Acid After Chemotherapy
Maastricht University Medical Center 150 participants Est. completion 2023-12 1 siteOther conditions: Leukemia (Both ALL and AML), Cancer of Lung, MyelomaView official trial listing → -
Status unknown NCT NCT02936505
Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.
Not yet reported Vastra Gotaland Region 249 participants Est. completion 2026-10-30 5 sitesOther conditions: Lung Transplantation, AllograftsView official trial listing → -
Status unknown NCT NCT02936596
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
Not yet reported Xiaoli Fan 53 participants Est. completion 2022-06-01 1 site Stand-aloneOther conditions: Hepatitis, Autoimmune, Cholangitis, Liver Cirrhosis, Biliary, CholestasisView official trial listing → -
Status unknown NCT NCT02938741
ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors
Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 130 participants Est. completion 2022-12 2 sites Stand-aloneOther conditions: Lymphoblastic LymphomaView official trial listing → -
Terminated NCT NCT02949492
Low-dose IL-2 for Treg Expansion and Tolerance (LITE)
Not yet reported King's College London 6 participants Est. completion 2019-01-31 1 siteOther conditions: Transplantation, Liver DiseasesView official trial listing → -
Status unknown NCT NCT02957552
Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation
Not yet reported University Hospital Tuebingen 7 participants Est. completion 2021-12 1 siteOther conditions: Pediatric Liver TransplantationView official trial listing → -
Terminated NCT NCT02963103
A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen
Not yet reported Astellas Pharma Korea, Inc. 13 participants Est. completion 2012-10 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Active, not recruiting NCT NCT02979873
Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 84 participants Est. completion 2030-06-30 1 siteOther conditions: Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT02990286
Evaluation of Efficacy and Safety of Rituximab With Mycophenolate Mofetil in Patients With Interstitial Lung Diseases
Not yet reported University Hospital, Tours 122 participants Est. completion 2020-02-17 5 sitesOther conditions: Lung Disease, InterstitialView official trial listing → -
Status unknown NCT NCT03009565
Does the Human Gut Microbiome Serve as a Novel Personalized Therapeutic Target for Coronary Atherosclerosis?
Rabin Medical Center 800 participants Est. completion 2019-01Other conditions: Coronary (Artery) DiseaseView official trial listing → -
Completed NCT NCT03025698
A Phase II Dose-escalation Study Characterizing the PK of Eltrombopag in Pediatric Patients With Previously Untreated or Relapsed Severe Aplastic Anemia or Recurrent Aplastic Anemia
Not yet reported Novartis Pharmaceuticals 51 participants Est. completion 2025-01-27 20 sitesOther conditions: Aplastic AnemiaView official trial listing → -
Terminated NCT NCT03031470
Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation
Not yet reported Dompé Farmaceutici S.p.A 40 participants Est. completion 2017-03-31 7 sitesOther conditions: Ischemia-reperfusion Injury in Liver Transplant, Early Allograft DysfunctionView official trial listing → -
Completed NCT NCT03035422
Sequential Conditioning in Haploidentical Transplantation for Refractory Acute Myeloid Leukemia
Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 24 participants Est. completion 2021-12-18 1 siteOther conditions: Refractory Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT03043300
A Pilot Study Assessing Intestinal Microbiota Diversification and Changes After Travel to South(East) Asia From the US
Emory University 10 participants Est. completion 2018-12-01 2 sitesOther conditions: DysbiosisView official trial listing → -
Completed NCT NCT03056924
Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab
Boston Medical Center 173 participants Est. completion 2019-01-15 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT03062579
A Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSD
Not yet reported, Not yet reported Fu-Dong Shi 10 participants Est. completion 2018-05-15 1 siteOther conditions: Neuromyelitis Optica Spectrum Disorders, Neuromyelitis Optica, Devic's DiseaseView official trial listing → -
Completed NCT NCT03079089
Sequential Conditioning in Haploidentical Transplantation for Hematopoietic Stem Cells in Patients With Relapsed or Refractory Lymphoid Hematological Disorders
Not yet reported Association for Training, Education, and Research in Hematology, Immunology, and Transplantation 40 participants Est. completion 2023-09-11 1 siteOther conditions: Refractory or Relapsed Lymphoid HaemopathyView official trial listing → -
Completed NCT NCT03082677
Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies
Not yet reported Memorial Sloan Kettering Cancer Center 20 participants Est. completion 2021-09-02 1 siteOther conditions: Myeloid Hematologic Malignancy, Lymphoid Hematologic MalignancyView official trial listing → -
Completed NCT NCT03083769
Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation.
Southern Medical University, China 1502 participants Est. completion 2019-08-01 2 sitesOther conditions: TransplantationView official trial listing → -
Status unknown NCT NCT03088280
Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen
Not yet reported Hospital Geral de Fortaleza 200 participants Est. completion 2020-01 1 siteOther conditions: Thymoglobulin DoseView official trial listing → -
Status unknown NCT NCT03096717
Dysplasia in Inflammatory Chronic Idiopathic Colitis Long-standing
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 300 participants Est. completion 2021-01-21 1 siteOther conditions: Dysplasia in IBDView official trial listing → -
Completed NCT NCT03125772
Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics
Not yet reported Fortis Escorts Heart Institute 1830 participants Est. completion 2016-05 1 siteType 2 diabetes Other conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT03131934
Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant
Not yet reported University College, London 4 participants Est. completion 2026-03-12 2 sitesOther conditions: Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic MalignancyView official trial listing → -
Completed NCT NCT03136588
Information and Communication Technology (ICT) Based Centralized Clinical Trial Monitoring System for Drug Adherence
Not yet reported Kyungpook National University Hospital 114 participants Est. completion 2018-12-31 2 sitesOther conditions: Kidney TransplantationView official trial listing → -
Suspended NCT NCT03139747
UPCC 36315 A Phase II Study Of Everolimus (RAD001) And Lenvatinib (E7080) In Patients With Metastatic Differentiated Thyroid Cancer Who Have Progressed on Lenvatinib Alone
Not yet reported Thomas Jefferson University 5 participants Est. completion 2022-05-30 1 siteOther conditions: Thyroid CancerView official trial listing → -
Completed NCT NCT03147183
Kinetic Study of CD8+ CMV-specific Cellular Immunity in Renal Transplant Patients After Receiving Thymoglobulin
Maimónides Biomedical Research Institute of Córdoba 150 participants Est. completion 2019-10-21 1 siteOther conditions: Renal Transplant InfectionView official trial listing → -
Status unknown NCT NCT03150134
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients
Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 100 participants Est. completion 2021-01-01 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Disorder Related to Bone Marrow TransplantationView official trial listing → -
Completed NCT NCT03161886
A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD).
Not yet reported Azienda Policlinico Umberto I 48 participants Est. completion 2017-01-10 Stand-aloneOther conditions: Inflammatory Bowel Diseases, Children, OnlyView official trial listing → -
Terminated NCT NCT03172195
Detection of Herpesvirus DNA (CMV, EBV, HHV-6 and HSV) in Colonic Tissue: Impact on Ulcerative Colitis Flare-up
Not yet reported Centre Hospitalier Universitaire de Saint Etienne 80 participants Est. completion 2024-05-16 1 siteOther conditions: Colitis, UlcerativeView official trial listing → -
Status unknown NCT NCT03192878
Infliximab Biosimilar in Takayasu's Arteritis
Ospedale San Raffaele 30 participants Est. completion 2019-07 1 siteOther conditions: Takayasu ArteritisView official trial listing → -
Suspended NCT NCT03193073
Anemia Correction and Fibroblast Growth Factor 23 Levels in Chronic Kidney Disease , and Renal Transplant Patient
Not yet reported Omnia Mohammed Hashem 80 participants Est. completion 2020-12-01 1 siteChronic kidney disease Other conditions: Endothelial Dysfunction, Left Ventricular Hypertrophy, Fibroblast Growth Factor 23View official trial listing → -
Status unknown NCT NCT03216447
A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant
Not yet reported Chang Gung Memorial Hospital 150 participants Est. completion 2025-09-30 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT03222687
Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis
Not yet reported Shandong University 25 participants Est. completion 2017-05-31Other conditions: Henoch-Schönlein Purpura NephritisView official trial listing → -
Completed NCT NCT03232268
HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies
Not yet reported Institut Paoli-Calmettes 25 participants Est. completion 2026-01-07 1 siteOther conditions: Acute Myeloid Leukemia, Myelodysplastic SyndromesView official trial listing → -
Status unknown NCT NCT03235128
Clinical Significance of Assesment of Serum miRNA-30a in Childhood Nephrotic Syndrome
Assiut University 50 participants Est. completion 2019-10-01Other conditions: Nephrotic Syndrome Steroid-ResistantView official trial listing → -
Completed NCT NCT03243656
Eltrombopag & Cyclosporine in Children With Sever Aplastic Anemia
Not yet reported Assiut University 20 participants Est. completion 2020-01-05 1 siteOther conditions: EltrombopagView official trial listing → -
Active, not recruiting NCT NCT03249831
A Blood Stem Cell Transplant for Sickle Cell Disease
Not yet reported City of Hope Medical Center 3 participants Est. completion 2027-01-25 1 siteOther conditions: Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies, Thalassemia, Anemia, Sickle CellView official trial listing → -
Completed NCT NCT03277703
Flu Vaccine Response in Patients on Biologic Therapies
Not yet reported Stony Brook University 30 participants Est. completion 2019-12-30 1 siteOther conditions: Rheumatologic Disorder, Inflammatory Bowel Diseases, Immune Complex DiseasesView official trial listing → -
Withdrawn NCT NCT03279094
Haploidentical Transplantation With Pre-Transplant Immunosuppressive Therapy for Patients With Sickle Cell Disease
Not yet reported City of Hope Medical Center Est. completion 2027-01-25Other conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT03283085
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Not yet reported Shire 557 participants Est. completion 2023-12-13 419 sitesOther conditions: Crohn's Disease, Ulcerative ColitisView official trial listing → -
Completed NCT NCT03289650
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
Not yet reported Lorenzo Gallon 29 participants Est. completion 2021-02-23 1 siteOther conditions: End Stage Renal Disease, Rejection of Renal TransplantView official trial listing → -
Status unknown NCT NCT03292445
Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation
Not yet reported Samuel Strober 24 participants Est. completion 2024-02-14 2 sitesOther conditions: Immune ToleranceView official trial listing → -
Enrolling by invitation NCT NCT03292861
The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
Not yet reported Cedars-Sinai Medical Center 60 participants Est. completion 2026-03-31 2 sitesOther conditions: Heart TransplantationView official trial listing → -
Completed NCT NCT03301350
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
Not yet reported University of Wisconsin, Madison 29 participants Est. completion 2022-02-07 6 sitesOther conditions: Breast Cancer, Triple Negative Breast CancerView official trial listing → -
Completed NCT NCT03304626
Budesonide for Liver Transplant Immune Suppression
Not yet reported University of Cincinnati 40 participants Est. completion 2019-12-31 1 siteOther conditions: Acute Cellular Graft Rejection, New Onset Diabetes After TransplantView official trial listing → -
Completed NCT NCT03312907
A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE
Not yet reported GlaxoSmithKline 292 participants Est. completion 2021-07-07 79 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT03314909
Initial Hemopurification Strategy for Acute Paraquat Poisoning in Adults
Not yet reported Peking Union Medical College Hospital 360 participants Est. completion 2022-02-28Other conditions: PoisoningView official trial listing → -
Withdrawn NCT NCT03315052
Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects
Not yet reported Montefiore Medical Center Est. completion 2022-01Other conditions: Acute Cellular Graft Rejection, Liver Transplant RejectionView official trial listing → -
Active, not recruiting NCT NCT03323476
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
Not yet reported Centre Hospitalier Departemental Vendee 136 participants Est. completion 2031-03 57 sitesOther conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, End Stage Renal DiseaseView official trial listing → -
Terminated NCT NCT03342638
Maximizing Outcome of Multiple Sclerosis Transplantation
Not yet reported Northwestern University 66 participants Est. completion 2019-10-09 1 siteOther conditions: Multiple Sclerosis, Relapsing-RemittingView official trial listing → -
Completed NCT NCT03349450
DPX-Survivac and Checkpoint Inhibitor in DLBCL
Not yet reported Sunnybrook Health Sciences Centre 25 participants Est. completion 2023-07-18 6 sitesOther conditions: Adult Diffuse Large Cell Lymphoma, Recurrent, Adult Refractory Diffuse Large B-Cell LymphomaView official trial listing → -
Status unknown NCT NCT03360175
Correlation of Eicosanoid and Proresolving Lipid Mediator Temporal Profiles and Resolution of Pain After Thoracic Surgery
Brigham and Women's Hospital 40 participants Est. completion 2019-12-01Other conditions: Pain, PostoperativeView official trial listing → -
Status unknown NCT NCT03368105
Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain
Not yet reported Medical University of Silesia 300 participants Est. completion 2021-07-01Other conditions: Clostridium DifficileView official trial listing → -
Terminated NCT NCT03370601
Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases
Not yet reported University Hospital, Lille 9 participants Est. completion 2019-01 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT03371095
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
Not yet reported Assistance Publique - Hôpitaux de Paris 53 participants Est. completion 2022-04-11 27 sitesOther conditions: Behcet's Disease, VasculitisView official trial listing → -
Completed NCT NCT03393013
A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
Not yet reported, Not yet reported Kezar Life Sciences, Inc. 69 participants Est. completion 2022-08-04 36 sitesOther conditions: Lupus Nephritis, Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT03408210
Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia
Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 191 participants Est. completion 2022-08 1 siteOther conditions: Myelodysplastic Syndromes, Acute LeukemiaView official trial listing → -
Status unknown NCT NCT03408223
Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia
Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 100 participants Est. completion 2022-12 1 siteOther conditions: Acute LeukemiaView official trial listing → -
Completed NCT NCT03414086
Predictor of Clinical Response to Acthar in Myositis
University of Pittsburgh 20 participants Est. completion 2022-07-30 1 siteOther conditions: Myositis, Dermatomyositis, PolymyositisView official trial listing → -
Active, not recruiting NCT NCT03414658
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
Not yet reported Adrienne G. Waks 100 participants Est. completion 2027-05-31 17 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT03418779
Treatment Effects of Chinese Medicine (Yi-Qi-Qing-Jie Herbal Compound) Combined With Immunosuppression Therapies in IgA Nephropathy Patients With High-risk of ESRD
Not yet reported, Not yet reported Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60 participants Est. completion 2024-12-31 1 siteOther conditions: IgA Nephropathy at High Risk of Developing ESRDView official trial listing → -
Withdrawn NCT NCT03427008
A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Kidney Transplant Recipients
Not yet reported Johns Hopkins University Est. completion 2020-11-12 1 siteOther conditions: Medication Adherence, Transplant; KidneyView official trial listing → -
Status unknown NCT NCT03438773
Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients
Not yet reported California Institute of Renal Research 50 participants Est. completion 2023-12 1 siteOther conditions: Kidney Transplant; Complications, Kidney Transplant Failure and RejectionView official trial listing → -
Status unknown NCT NCT03452735
Fertility Study of Women With Chronic Inflammatory Rheumatism
University Hospital, Toulouse 2900 participants Est. completion 2019-07 1 siteOther conditions: Arthritis, Psoriatic, Arthritis, Rheumatoid, Ankylosing Spondylitis, Chronic Juvenile ArthritisView official trial listing → -
Terminated NCT NCT03454932
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
Bone Therapeutics S.A 30 participants Est. completion 2017-06-04Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, SpondylarthritisView official trial listing → -
Status unknown NCT NCT03465397
Individualization of the Immunological Risk Based on Selective Biomarkers in Living-donor Renal Recipients
Not yet reported ORIOL BESTARD 164 participants Est. completion 2021-11 6 sitesOther conditions: Kidney Transplant Failure and RejectionView official trial listing → -
Terminated NCT NCT03466801
The Efficacy of Prednisone and Combination Therapy With Methylprednisolone and Cyclophosphamide on IMN in Stage I.
Not yet reported Wenhu Liu 6 participants Est. completion 2019-06-30 1 siteOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Status unknown NCT NCT03468972
Effect of Immunosuppression in IgA Nephropathy
Not yet reported Yonsei University 174 participants Est. completion 2023-05 1 siteOther conditions: Biopsy-proven IgA NephropathyView official trial listing → -
Completed NCT NCT03483675
Discontinuation or Continuation of Immunosuppressive Therapy in Participants With Chronic Graft Versus Host Disease
Not yet reported Fred Hutchinson Cancer Center 21 participants Est. completion 2021-03-03 1 siteOther conditions: Chronic Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT03487666
OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease
Not yet reported Georgetown University 45 participants Est. completion 2024-05-02 4 sitesOther conditions: Triple Negative Breast CancerView official trial listing → -
Completed NCT NCT03504137
A Pilot Study of mDOT for Immunosuppressant Adherence in Adolescent Kidney Transplant Recipients
Not yet reported Johns Hopkins University 1 participants Est. completion 2020-08-28 1 siteOther conditions: Medication Adherence, Kidney TransplantView official trial listing → -
Withdrawn NCT NCT03515330
A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients
Not yet reported Johns Hopkins University Est. completion 2020-11-12 1 siteOther conditions: Medication Adherence, Liver TransplantView official trial listing → -
Completed NCT NCT03517982
Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan
Hikma Pharmaceuticals LLC 12 participants Est. completion 2016-09 1 siteOther conditions: Acute Transplant Rejection in Patients Receiving Allogeneic Renal TransplantView official trial listing → -
Completed NCT NCT03530215
Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)
Groupe Hospitalier Pitie-Salpetriere 500000 participants Est. completion 2023-04-08 1 siteOther conditions: Cardiac Disease, CancerView official trial listing → -
Completed NCT NCT03558373
The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients
Chiesi Farmaceutici S.p.A. 158 participants Est. completion 2020-02-26 12 sitesOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT03562845
Evaluation of Immunobiogram® as a Tool in Adjustment of Immunosuppressant Therapy for Renal Transplant
Biohope Scientific Solutions for Human Health, S.L. 164 participants Est. completion 2019-05-31 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT03562975
Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With Ocrevus
University of South Florida 18 participants Est. completion 2023-01-11 1 siteOther conditions: Multiple Sclerosis, Pathologic Processes, Demyelinating Diseases, Nervous System Diseases, Autoimmune Diseases, Immune System Diseases, Primary Progressive Multiple Sclerosis, Relapsing Remitting Multiple SclerosisView official trial listing → -
Completed NCT NCT03567161
Ultrasonic Surgical Aspirator to Treat Deep Infrabony Defects
Not yet reported University of Milan 11 participants Est. completion 2017-09-01 1 siteOther conditions: PeriodontitisView official trial listing → -
Completed NCT NCT03577431
Liver Transplantation With Tregs at MGH
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 9 participants Est. completion 2026-02-05 1 siteOther conditions: Liver TransplantView official trial listing → -
Status unknown NCT NCT03587493
T-lymphocytes CD8+/HLA-DR+ and Acute Rejection After Lung Transplantation
Not yet reported Assistance Publique Hopitaux De Marseille 110 participants Est. completion 2022-09 1 siteOther conditions: Transplant FailureView official trial listing → -
Terminated NCT NCT03591770
Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib
Not yet reported Boston Medical Center 15 participants Est. completion 2024-07-04 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Withdrawn NCT NCT03596970
Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.
Not yet reported Novartis Pharmaceuticals Est. completion 2020-12Other conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT03603418
Role Of Dexamethasone In Induction Of Labor
Not yet reported Ain Shams University 80 participants Est. completion 2019-02 1 siteOther conditions: Dexamethasone Effect on Induction of LaborView official trial listing → -
Withdrawn NCT NCT03605654
Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants
Not yet reported, Not yet reported Medeor Therapeutics, Inc. Est. completion 2026-10Other conditions: Kidney Transplant RejectionView official trial listing → -
Completed NCT NCT03626714
Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study
Not yet reported Auritec Pharmaceuticals 8 participants Est. completion 2019-01-05 1 siteOther conditions: Organ Transplant Rejection, PsoriasisView official trial listing → -
Completed NCT NCT03627026
Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients
Not yet reported Institut Claudius Regaud 78 participants Est. completion 2024-06-03 2 sitesOther conditions: MelanomaView official trial listing → -
Status unknown NCT NCT03631563
ATG-F VS ATG for the Prevention of GVHD
Not yet reported, Not yet reported Fujian Medical University 120 participants Est. completion 2020-12-01 1 siteOther conditions: GVHD in the Setting of Haplo-HSCTView official trial listing → -
Completed NCT NCT03656926
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Not yet reported Zambon SpA 169 participants Est. completion 2024-03-12 40 sitesOther conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft DysfunctionView official trial listing → -
Completed NCT NCT03657004
Immunosuppressive Regimen on Changes in Renal Function and Transplant Rejection Rate in Patients With Lung Transplant
University of Giessen 145 participants Est. completion 2019-08-29 1 siteChronic kidney disease Other conditions: Lung Transplant; ComplicationsView official trial listing → -
Completed NCT NCT03657342
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
Not yet reported Zambon SpA 62 participants Est. completion 2024-04-16 39 sitesOther conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft DysfunctionView official trial listing → -
Status unknown NCT NCT03662087
HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT
Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 100 participants Est. completion 2022-10 1 siteOther conditions: Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell TransplantationView official trial listing → -
Completed NCT NCT03663335
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients
Not yet reported Novartis Pharmaceuticals 418 participants Est. completion 2021-10-29 74 sitesOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT03671174
Immunosuppressant Regimens for Living Fetuses Study
Not yet reported RenJi Hospital 420 participants Est. completion 2023-02 1 siteOther conditions: Undifferentiated Connective Tissue Disease, Recurrent Pregnancy LossView official trial listing → -
Status unknown NCT NCT03672110
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
Not yet reported Technische Universität Dresden 400 participants Est. completion 2025-12 1 siteOther conditions: Renal Failure, Renal Insufficiency, Renal Disease, Renal Insufficiency, ChronicView official trial listing → -
Active, not recruiting NCT NCT03726307
Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study
Not yet reported Angus W. Thomson PhD DSc 28 participants Est. completion 2028-05 1 site Stand-aloneOther conditions: Kidney Transplant, Renal Transplant RecipientsView official trial listing → -
Completed NCT NCT03732248
Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders
Not yet reported Medical University of South Carolina 21 participants Est. completion 2020-01-20 1 siteAlcohol use disorderView official trial listing → -
Completed NCT NCT03760003
Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis
Not yet reported Abivax S.A. 355 participants Est. completion 2021-04-16 130 sitesOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT03760263
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Not yet reported Sentara Norfolk General Hospital 46 participants Est. completion 2023-11-01 1 siteOther conditions: Transplant;Failure,KidneyView official trial listing → -
Completed NCT NCT03773666
A Feasibility Study of Durvalumab +/- Oleclumab as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer (BLASST-2)
Not yet reported Dana-Farber Cancer Institute 12 participants Est. completion 2021-08-02 2 sitesOther conditions: Muscle Invasive Bladder CancerView official trial listing → -
Completed NCT NCT03775824
Faecal Analyses in Rheumatoid Arthritis Therapy
Region Skane 50 participants Est. completion 2019-06-01Other conditions: Rheumatoid ArthritisView official trial listing → -
Withdrawn NCT NCT03781830
mDOT for Immunosuppressant Adherence in Adolescent Liver Transplant Recipients
Not yet reported Johns Hopkins University Est. completion 2020-11-12 1 siteOther conditions: Medication Adherence, Liver TransplantationView official trial listing → -
Active, not recruiting NCT NCT03797196
RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
Not yet reported University Medical Center Groningen 374 participants Est. completion 2026-12 7 sitesOther conditions: Renal Transplant Recipients, Elderly Patients, ImmunosuppressionView official trial listing → -
Completed NCT NCT03800576
Clinical Outcome of Liver Transplant Patients With Tacrolimus-based Immunosuppression
National Taiwan University Hospital 113 participants Est. completion 2020-09-22 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT03812419
Esomeprazole or Pantoprazole in Renal Transplantation
Not yet reported Future University in Egypt 47 participants Est. completion 2016-12-30Other conditions: Kidney Transplant; ComplicationsView official trial listing → -
Completed NCT NCT03828019
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Not yet reported JHSPH Center for Clinical Trials 227 participants Est. completion 2024-09-09 26 sitesOther conditions: UveitisView official trial listing → -
Active, not recruiting NCT NCT03844061
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Not yet reported Hospital for Special Surgery, New York 30 participants Est. completion 2027-12-30 1 site Stand-aloneOther conditions: Systemic SclerosisView official trial listing → -
Terminated NCT NCT03848585
Medicine Adherence and Effects on Transplants With Pilloxa's Electronic Pillbox
Not yet reported Pilloxa 25 participants Est. completion 2020-10-12 1 siteOther conditions: Kidney Transplant; Complications, Liver Transplant; ComplicationsView official trial listing → -
Completed NCT NCT03864796
Role of CD11a in Pathogenesis of Primary ITP and Effect of Immunosuppressive Therapy on Its Level
Assiut University 80 participants Est. completion 2021-01-01 1 siteOther conditions: Idiopathic Thrombocytopenic PurpuraView official trial listing → -
Completed NCT NCT03864926
Envarsus in Delayed Graft Function (E-DGF)
Not yet reported University of Wisconsin, Madison 100 participants Est. completion 2022-07-22 1 siteOther conditions: Delayed Graft FunctionView official trial listing → -
Active, not recruiting NCT NCT03867617
Cell Therapy for Immunomodulation in Kidney Transplantation
Not yet reported, Not yet reported Thomas Wekerle 12 participants Est. completion 2028-06 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT03871361
Abatacept in Patients With Birdshot HLA A29 Uveitis
Not yet reported Universitaire Ziekenhuizen KU Leuven 15 participants Est. completion 2023-12-01 1 siteOther conditions: Eye Diseases, UveitisView official trial listing → -
Completed NCT NCT03881566
Presepsin as Detective Marker of Sepsis in Immunodeficiency ICU Patients
Jongmin Lee 119 participants Est. completion 2020-12-31 1 siteOther conditions: Sepsis, Immune DeficiencyView official trial listing → -
Status unknown NCT NCT03886233
Treatment Outcome of Uveitis in Autoimmune Diseases
Assiut University 1 participants Est. completion 2021-02Other conditions: Autoimmune UveitisView official trial listing → -
Status unknown NCT NCT03889808
Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients.
Hospital Universitari de Bellvitge 500 participants Est. completion 2021-12 1 siteOther conditions: Clostridium Difficile, Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT03892317
Improving Adherence in Nonadherent Kidney Transplant Patients
Not yet reported Imperial College London 42 participants Est. completion 2020-07-27 1 siteOther conditions: Medication Adherence, Kidney TransplantationView official trial listing → -
Completed NCT NCT03896971
Combination of Thrombopoietin Mimetic and Immunosuppressive Therapy in Aplastic Anaemia
Not yet reported Safaa AA Khaled 66 participants Est. completion 2021-06-01 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Active, not recruiting NCT NCT03910452
Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 4 participants Est. completion 2034-06-15 1 siteOther conditions: Chronic Granulomatous DiseaseView official trial listing → -
Status unknown NCT NCT03932539
Improving Immunosuppressive Therapy in Heart Transplantation
Fondazione IRCCS Policlinico San Matteo di Pavia 25 participants Est. completion 2021-12 4 sitesOther conditions: Rejection Heart Transplant, ImmunosuppressionView official trial listing → -
Active, not recruiting NCT NCT03935893
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers
Not yet reported Udai Kammula 20 participants Est. completion 2038-06-30 1 siteObstructive sleep apnea Other conditions: Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Sarcoma, Mesothelioma, Neuroendocrine Tumors, Squamous Cell Cancer, Merkel Cell Carcinoma, Mismatch Repair DeficiencyView official trial listing → -
Completed NCT NCT03951259
Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Not yet reported RenJi Hospital 32 participants Est. completion 2023-10-19 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT03957694
Study of AMG531(Romiplostim) in Patients With Aplastic Anemia
Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 17 participants Est. completion 2021-05-26 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT03964844
Clostridium Difficile Infection (CDI) in Hematologic Patients.
Hospital General Universitario Gregorio Marañon 450 participants Est. completion 2020-12-31 1 siteOther conditions: C.Difficile DiarrheaView official trial listing → -
Completed NCT NCT03977051
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
Imperial College London 26 participants Est. completion 2017-06-20 1 siteOther conditions: Adherence, Medication, Transplantation, KidneyView official trial listing → -
Terminated NCT NCT03995901
A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
Not yet reported Talaris Therapeutics Inc. 15 participants Est. completion 2023-02-16 18 sitesOther conditions: Transplanted Organ RejectionView official trial listing → -
Terminated NCT NCT03999580
The Vitamin D in Pediatric Crohn's Disease ( ViDiPeC-2 )
Not yet reported Jantchou Prevost 55 participants Est. completion 2023-09-29 7 sites Stand-aloneOther conditions: Crohn DiseaseView official trial listing → -
Status unknown NCT NCT04013646
Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients
Not yet reported, Not yet reported Bundang CHA Hospital 24 participants Est. completion 2021-11-02 1 siteCardiovascular disease Other conditions: Umbilical Cord Blood, Erythropoietin, Safety, Treatment OutcomeView official trial listing → -
Status unknown NCT NCT04020328
Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency
Not yet reported Shenzhen Second People's Hospital 70 participants Est. completion 2022-05-31 1 siteOther conditions: Glomerulonephritis, IGA, Renal Insufficiency, ChronicView official trial listing → -
Completed NCT NCT04023760
Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients
Not yet reported University of Saskatchewan 14 participants Est. completion 2020-03-30 1 siteOther conditions: Pharmacokinetics, Kidney Transplant, Lung TransplantView official trial listing → -
Active, not recruiting NCT NCT04028063
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
Not yet reported University of Colorado, Denver 65 participants Est. completion 2027-12-31 1 siteOther conditions: Metastatic Soft Tissue Sarcoma, Advanced Soft Tissue SarcomaView official trial listing → -
Terminated NCT NCT04032756
Tofacitinib Registry of Patients With Ulcerative Colitis in Germany
Ced Service GmbH 50 participants Est. completion 2020-11-15 1 siteOther conditions: Colitis, Ulcerative, Biologics, Tofacitiniib, Chronic Inflammatory Small Bowel Disease, Bowel Diseases, Inflammatory, Bowel Disease, CEDView official trial listing → -
Completed NCT NCT04034316
Reduce Immunosuppression With Atmp in NS ChildrEn
Not yet reported Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20 participants Est. completion 2023-08-31 1 siteOther conditions: Nephrotic Syndrome in Children, Steroid-Dependent Nephrotic Syndrome, Idiopathic Nephrotic SyndromeView official trial listing → -
Completed NCT NCT04036097
Prospective Stratification of Infectious Risks in Multiple Sclerosis
University Hospital, Basel, Switzerland 298 participants Est. completion 2023-12-31 1 siteOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT04039425
Effects of Chemotherapy on the Concentration of Minerals in Hair
Loma Linda University 5 participants Est. completion 2020-04-27 1 siteOther conditions: CancerView official trial listing → -
Completed NCT NCT04042272
Evaluation of s100β, NSE and GFAP Levels in Renal Transplantation
Akdeniz University 80 participants Est. completion 2021-01-15 1 siteOther conditions: Kidney Transplant; Complications, Neurologic Manifestations, Uremic EncephalopathyView official trial listing → -
Terminated NCT NCT04044560
Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant
Not yet reported University of British Columbia 8 participants Est. completion 2022-02-02 3 sitesOther conditions: B-cell Adult Acute Lymphoblastic Leukemia, Stem Cell Leukemia, Minimal Residual DiseaseView official trial listing → -
Completed NCT NCT04057092
Perioperative Immunonutrition in Patients Undergoing Gynecologic or General Elective Surgery (PURPOSE)
Not yet reported Hamilton Health Sciences Corporation 72 participants Est. completion 2020-12-31 1 siteOther conditions: Surgical Site Infection, Post-Op ComplicationView official trial listing → -
Completed NCT NCT04066114
Treg Modulation With CD28 and IL-6 Receptor Antagonists
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2023-09-14 7 sitesOther conditions: Living-Donor Kidney Transplant, Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT04074187
A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Not yet reported, Not yet reported Sanofi 21 participants Est. completion 2021-05-19 12 sitesOther conditions: Thrombotic Thrombocytopenic PurpuraView official trial listing → -
Status unknown NCT NCT04078750
PLATO - Medication Adherence in Transplant Recipients
Not yet reported University of British Columbia 99 participants Est. completion 2024-12-31 2 sitesOther conditions: Kidney Disease, Chronic, Medication Adherence, Renal Disease, Kidney Rejection TransplantView official trial listing → -
Completed NCT NCT04082416
Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
Not yet reported RemeGen Co., Ltd. 335 participants Est. completion 2022-06-30 1 siteOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT04095936
Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia
Not yet reported, Not yet reported Kyowa Kirin Co., Ltd. 24 participants Est. completion 2021-10-29 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT04101578
Clinical Prognosis and Progression of Myasthenia Gravis Patients
Da, Yuwei, M.D. 2000 participants Est. completion 2024-12-31 1 siteOther conditions: Myasthenia GravisView official trial listing → -
Status unknown NCT NCT04124861
Withdraw Drug in Stable IgG4-Related Disease
Not yet reported Peking Union Medical College Hospital 138 participants Est. completion 2023-06-30 1 siteOther conditions: Autoimmune DiseasesView official trial listing → -
Completed NCT NCT04136587
The Bacterial Secretome in IBD
Medical University of Graz 74 participants Est. completion 2024-07-31 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT04145440
Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)
Not yet reported, Not yet reported HI-Bio, A Biogen Company 31 participants Est. completion 2022-08-02 45 sitesOther conditions: Glomerulonephritis, Membranous, antiPLA2R PositiveView official trial listing → -
Status unknown NCT NCT04152356
Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma
Guangxi Medical University 50 participants Est. completion 2020-09-01 1 siteOther conditions: HepatoCellular CarcinomaView official trial listing → -
Terminated NCT NCT04156204
Immunosuppressant Medication Dosed Daily After Kidney Transplant
Not yet reported University of Colorado, Denver 1 participants Est. completion 2020-11-27 1 siteOther conditions: Kidney Transplant Rejection, Medication AdherenceView official trial listing → -
Status unknown NCT NCT04163237
Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
Not yet reported Guangxi Medical University 50 participants Est. completion 2020-11-30 1 siteOther conditions: Advanced Liver CancerView official trial listing → -
Status unknown NCT NCT04168944
Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma
Not yet reported, Not yet reported RenJi Hospital 108 participants Est. completion 2022-09Other conditions: Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT04188639
Emicizumab in Acquired Hemophilia A
Not yet reported GWT-TUD GmbH 47 participants Est. completion 2023-01-04 16 sitesOther conditions: Hemophilia A, AcquiredView official trial listing → -
Completed NCT NCT04191707
Metabolomic Markers of Fatigue in Inflammatory Bowel Disease
Corporacion Parc Tauli 18 participants Est. completion 2019-12-01Other conditions: Fatigue, Inflammatory Bowel Disease, Ulcerative Colitis, Crohn DiseaseView official trial listing → -
Completed NCT NCT04199715
Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients
Not yet reported Baylor Research Institute 10 participants Est. completion 2022-01-20 1 siteOther conditions: Hepatitis BView official trial listing → -
Terminated NCT NCT04200365
A Study of Itacitinib for the Treatment of Chronic Graft Versus Host Disease (cGVHD)
Not yet reported SCRI Development Innovations, LLC 15 participants Est. completion 2023-09-07 5 sitesOther conditions: Chronic Graft-versus-host-diseaseView official trial listing → -
Status unknown NCT NCT04203459
The Mechanism of Enhancing the Anti-tumor Effects of CAR-T on PC by Gut Microbiota Regulation
First Affiliated Hospital of Harbin Medical University 80 participants Est. completion 2022-12-31 1 siteOther conditions: Pancreatic Cancer, Gut Microbiota, CAR-TView official trial listing → -
Status unknown NCT NCT04207177
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
Not yet reported Oslo University Hospital 100 participants Est. completion 2025-12-31 1 siteOther conditions: Kidney Transplant; Complications, Immune SuppressionView official trial listing → -
Completed NCT NCT04233164
Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus
Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 47 participants Est. completion 2022-05-03 1 siteOther conditions: Systemic Lupus Erythematous (SLE)View official trial listing → -
Completed NCT NCT04247490
Autoimmune Hepatitis in Pediatric Patients
University Hospital of Ferrara 109 participants Est. completion 2019-12-31 1 siteOther conditions: Autoimmune HepatitisView official trial listing → -
Completed NCT NCT04259138
Determination of the Optimal Treatment Target in Ulcerative Colitis
Not yet reported Alimentiv Inc. 672 participants Est. completion 2026-04-13 58 sitesOther conditions: Colitis, UlcerativeView official trial listing → -
Withdrawn NCT NCT04262375
A Phase 2 Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Multi-Cancer Populations With Correlation to Clinical, Molecular and Immunologic Parameters With DNA MethylaTION
Not yet reported University Health Network, Toronto Est. completion 2024-01 1 siteOther conditions: Non Small Cell Lung Cancer, Renal Cell CarcinomaView official trial listing → -
Withdrawn NCT NCT04262388
A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA Methylation
Not yet reported University Health Network, Toronto Est. completion 2023-01 1 siteOther conditions: Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and NeckView official trial listing → -
Active, not recruiting NCT NCT04262843
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
Not yet reported City of Hope Medical Center 33 participants Est. completion 2027-05-11 1 siteOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic SyndromeView official trial listing → -
Withdrawn NCT NCT04263519
A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.
Not yet reported Massachusetts General Hospital Est. completion 2023-01-01Other conditions: Alzheimer Disease, Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT04272788
Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease
Second Affiliated Hospital of Wenzhou Medical University 32 participants Est. completion 2019-09-29 1 siteOther conditions: Crohn DiseaseView official trial listing → -
Completed NCT NCT04288271
Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 96 participants Est. completion 2023-06-30 8 sitesOther conditions: Medication Adherence, Kidney TransplantationView official trial listing → -
Completed NCT NCT04294641
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Not yet reported National Cancer Institute (NCI) 10 participants Est. completion 2024-10-01 2 sitesOther conditions: Chronic GVHDView official trial listing → -
Status unknown NCT NCT04295928
Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients
Not yet reported University Hospital, Tours 1716 participants Est. completion 2025-09-11 12 sitesOther conditions: Personalized Pharmaceutical Plan After TranspantationView official trial listing → -
Terminated NCT NCT04305444
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
Not yet reported Zhejiang DTRM Biopharma 55 participants Est. completion 2024-12-31 8 sitesOther conditions: Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Richter's TransformationView official trial listing → -
Status unknown NCT NCT04317248
"Cocktail" Therapy for Hepatitis B Related Hepatocellular Carcinoma
Not yet reported Yuehua Huang 600 participants Est. completion 2022-04-30 4 sitesOther conditions: Hepatocellular CarcinomaView official trial listing → -
Status unknown NCT NCT04324866
Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy
Universita di Verona 300 participants Est. completion 2020-12Other conditions: Coronavirus InfectionView official trial listing → -
Completed NCT NCT04328727
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
Not yet reported Novartis Pharmaceuticals 36 participants Est. completion 2024-12-06 12 sitesOther conditions: Severe Aplastic Anemia (SAA)View official trial listing → -
Status unknown NCT NCT04345315
Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent.
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 500 participants Est. completion 2022-03 2 sitesOther conditions: COVID-19, SARS-CoV-2View official trial listing → -
Completed NCT NCT04350606
A Study to Assess Efficacy and Safety of PF-06462700 in Japanese Participants With Aplastic Anemia
Not yet reported Pfizer 3 participants Est. completion 2021-04-19 3 sitesOther conditions: Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT04354818
Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
Kirby Institute 27 participants Est. completion 2022-04-27 11 sitesOther conditions: HIV-1-infection, Cancer, Primary Immune Deficiency Disorder, Immunosuppression Disorders, COVID-19View official trial listing → -
Status unknown NCT NCT04355806
Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors
Shanghai Pulmonary Hospital, Shanghai, China 160 participants Est. completion 2023-05-31 2 sitesOther conditions: Non Small Cell Lung Cancer, Influenza VaccineView official trial listing → -
Terminated NCT NCT04356404
Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients
Chinese University of Hong Kong 68 participants Est. completion 2022-01-12 1 siteOther conditions: Occult Hepatitis B, Biological Substance; Adverse Effect, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT04360031
The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation
Université Catholique de Louvain 100 participants Est. completion 2021-03 1 siteOther conditions: Kidney Transplant; Complications, Immunosuppression, Transplant FailureView official trial listing → -
Withdrawn NCT NCT04370795
Matched Related and Unrelated Donor Stem Cell Transplantation for Severe Combined Immune Deficiency (SCID): Busulfan-based Conditioning With h-ATG, Radiation, and Sirolimus
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2025-11-26 1 siteOther conditions: Severe Combined Immune Deficiency (SCID)View official trial listing → -
Status unknown NCT NCT04376528
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
Not yet reported West China Hospital 89 participants Est. completion 2021-12-30 1 site Stand-aloneOther conditions: Hepatitis, Autoimmune, Primary Biliary Cholangitis, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT04382781
Immunosupressive Treatment in COVID-19 Patients
Spanish Network for Research in Infectious Diseases 500 participants Est. completion 2020-05 1 siteOther conditions: COVID-19 InfectionView official trial listing → -
Status unknown NCT NCT04385641
Study on the Safety and Effectiveness of UCB-NK Cell Infusion in the Treatment of Advanced Gastric Cancer and Gastroesophageal Cancer
Not yet reported Shandong Golden Brick Biotechnology Co., Ltd. 18 participants Est. completion 2022-10-08 1 siteOther conditions: Advanced Gastric Cancer, Gastroesophageal CancerView official trial listing → -
Status unknown NCT NCT04401228
Predictive Models for Intensive Care Admission and Death of COVID-19
Clinique Saint Pierre Ottignies 60 participants Est. completion 2021-01-01 1 siteOther conditions: COVID19, Pneumonia, Viral, Inflammatory ResponseView official trial listing → -
Terminated NCT NCT04409080
REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
Not yet reported Regeneron Pharmaceuticals 17 participants Est. completion 2024-10-17 10 sitesOther conditions: Severe Aplastic Anemia (SAA)View official trial listing → -
Completed NCT NCT04420195
Envarsus XR in Lung Transplant
Not yet reported NYU Langone Health 41 participants Est. completion 2022-11-30 1 siteOther conditions: Lung TransplantView official trial listing → -
Terminated NCT NCT04426279
Morbimortality of Covid-19 in Patients With Chronic Inflammatory Rheumatism Treated With Immunosuppressants
University Hospital, Lille 539 participants Est. completion 2021-08-30 1 siteOther conditions: Sars-CoV2, Rheumatoid Arthritis, Rheumatic DiseasesView official trial listing → -
Completed NCT NCT04431219
First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients
Not yet reported, Not yet reported Xenothera SAS 10 participants Est. completion 2022-03-28 1 siteOther conditions: Kidney TransplantView official trial listing → -
Active, not recruiting NCT NCT04431245
Stopping Antiviral Treatment in Chronic Hepatitis B
The University of Hong Kong 54 participants Est. completion 2026-12-31 1 siteOther conditions: Chronic Hepatitis bView official trial listing → -
Completed NCT NCT04436367
Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy
National Heart, Lung, and Blood Institute (NHLBI) 38 participants Est. completion 2022-03-15 1 siteOther conditions: Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT04436380
Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy
National Heart, Lung, and Blood Institute (NHLBI) 173 participants Est. completion 2023-03-15 1 siteOther conditions: Severe Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT04438603
The Applicaiton of Immune Repertoire in the Diagnosis and Disease Monitoring of IgA Nephropathy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 180 participants Est. completion 2022-09-30 1 siteOther conditions: IgA NephropathyView official trial listing → -
Status unknown NCT NCT04444843
Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-12-31 1 siteOther conditions: Kidney Transplant RecipientsView official trial listing → -
Status unknown NCT NCT04447144
Nutritional Habits, and Coronavirus Disease 2019 (COVID-19) Outcome
Cairo University 200 participants Est. completion 2020-09-01 1 siteOther conditions: Covid19, Chronic Inflammation, Non-Communicable Chronic DiseasesView official trial listing → -
Completed NCT NCT04464434
Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis
Not yet reported UMC Utrecht 60 participants Est. completion 2026-03-19 8 sitesOther conditions: Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma, Scleroderma, Diffuse, Autologous Stem Cell Transplantation, Cyclophosphamide, Mycophenolate Mofetil, Treatment StrategyView official trial listing → -
Status unknown NCT NCT04473131
Immune Profiling of COVID19-patients Admitted to ICU
Hamad Medical Corporation 300 participants Est. completion 2022-06 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT04474392
Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins
University of Colorado, Denver 340 participants Est. completion 2026-01-14 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT04481633
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
Not yet reported University Hospital, Toulouse 547 participants Est. completion 2022-12-06 12 sitesOther conditions: COVID-19View official trial listing → -
Active, not recruiting NCT NCT04483466
Methotrexate Treatment of Arthritis Caused by Chikungunya Virus (MARCH)
Not yet reported George Washington University 150 participants Est. completion 2027-08-30 1 siteOther conditions: Investigate the Effect(s) of Methotrexate Treatment on Arthritis Disease SeverityView official trial listing → -
Completed NCT NCT04487457
Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy
University Hospital, Tours 31 participants Est. completion 2022-09-29 2 sitesOther conditions: Non Small Cell Lung Cancer, Bladder Cancer, ENT CancerView official trial listing → -
Status unknown NCT NCT04492267
Inflammatory Bowel Disease (IBD) and Covid-19 Infection
University Hospital, Strasbourg, France 700 participants Est. completion 2021-01-07 1 siteOther conditions: Inflammatory Bowel DiseaseView official trial listing → -
Status unknown NCT NCT04528056
Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension
Not yet reported, Not yet reported RenJi Hospital 80 participants Est. completion 2022-10-31 1 siteOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Status unknown NCT NCT04558268
Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
Not yet reported, Not yet reported Soroka University Medical Center 242 participants Est. completion 2021-10 1 siteOther conditions: Recurrent Pregnancy Loss(RPL), Recurrent MiscarriageView official trial listing → -
Status unknown NCT NCT04559048
Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients
The Second Hospital of Tangshan 300 participants Est. completion 2024-06-30 1 siteOther conditions: Chronic Pain, Liver TransplantationView official trial listing → -
Completed NCT NCT04568421
Argentinian Registry of Patients With Rheumatic Diseases and COVID-19 Infection
Sociedad Argentina de Reumatologia 2982 participants Est. completion 2022-12-31 1 siteOther conditions: Rheumatic DiseasesView official trial listing → -
Completed NCT NCT04576819
Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis
University of Florida 58 participants Est. completion 2023-04-01 1 siteOther conditions: Sepsis, Shock, SepticView official trial listing → -
Terminated NCT NCT04584541
SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism
Not yet reported Assistance Publique - Hôpitaux de Paris 150 participants Est. completion 2022-02-21 1 siteOther conditions: Spondyloarthritis, Rheumatoid Arthritis, Covid19View official trial listing → -
Completed NCT NCT04587024
A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients
Not yet reported Johns Hopkins University 75 participants Est. completion 2023-08-31 2 sitesOther conditions: Medication Adherence, Liver Transplantation, Kidney TransplantationView official trial listing → -
Completed NCT NCT04596579
SARS-CoV-2 (COVID-19) Immune Surveillance Among a Population Based Sample of Adults in Florida
H. Lee Moffitt Cancer Center and Research Institute 1135 participants Est. completion 2021-07-25 1 siteOther conditions: Coronavirus InfectionView official trial listing → -
Status unknown NCT NCT04610476
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
Not yet reported University of Erlangen-Nürnberg Medical School 270 participants Est. completion 2025-10-19 1 siteOther conditions: Psoriatic Arthritis, Withdrawal, ReductionView official trial listing → -
Status unknown NCT NCT04615962
Topical Cream SNG100 for Treatment in Moderate Atopic Dermatitis Subjects.
Not yet reported Seanergy Dermatology Ltd. 66 participants Est. completion 2022-01Other conditions: Atopic DermatitisView official trial listing → -
Status unknown NCT NCT04630782
Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease
Singapore General Hospital 70 participants Est. completion 2023-01-31 5 sitesOther conditions: Systemic Sclerosis, SclerodermaView official trial listing → -
Status unknown NCT NCT04657562
The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma
National Science Centre, Poland 380 participants Est. completion 2023-05 1 siteOther conditions: Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications, Liver Transplant Rejection, Liver Transplant; Complications, Metabolism Medication Toxicity, Genetic PredispositionView official trial listing → -
Completed NCT NCT04660539
A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Not yet reported Hoffmann-La Roche 119 participants Est. completion 2024-05-28 53 sitesOther conditions: Neuromyelitis Optica Spectrum DisorderView official trial listing → -
Completed NCT NCT04670094
Comorbidities and Risk Score in COVID-19 Patients
University of Milano Bicocca 4555 participants Est. completion 2021-05-29 5 sitesOther conditions: Covid19View official trial listing → -
Completed NCT NCT04672161
Education Intervention on Vaccination Adherence Among Inflammatory Bowel Disease (IBD) Patients
Not yet reported Weill Medical College of Cornell University 200 participants Est. completion 2023-06-30 1 siteOther conditions: Crohn Disease (CD), Ulcerative Colitis (UC), Indeterminate ColitisView official trial listing → -
Completed NCT NCT04688216
Developing a Risk Assessment System of Multidrug-resistant Organisms Infection
Second Affiliated Hospital, Zhejiang University, School of Medicine 917 participants Est. completion 2022-12-30 1 siteOther conditions: Bacterial InfectionsView official trial listing → -
Status unknown NCT NCT04696250
Evaluation of Reporting of AdVerse Events Associated With AnTicAncer theRapy (AVATAR)
University Hospital, Caen 5000000 participants Est. completion 2025-01-01 1 siteOther conditions: CancerView official trial listing → -
Status unknown NCT NCT04698213
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
Not yet reported Consorzio Oncotech 75 participants Est. completion 2024-10 20 sitesOther conditions: Renal Carcinoma MetastaticView official trial listing → -
Completed NCT NCT04701528
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients
Not yet reported Leiden University Medical Center 20 participants Est. completion 2022-10-25 1 siteOther conditions: Covid19, Kidney Transplant InfectionView official trial listing → -
Completed NCT NCT04715412
Clinical Pharmacy Guided Patient Counselling and Adherence Support on Renal Transplant Recipients
Not yet reported Future University in Egypt 60 participants Est. completion 2020-12-31 1 siteOther conditions: Transplant;Failure,KidneyView official trial listing → -
Completed NCT NCT04720326
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
Not yet reported Edward Geissler 268 participants Est. completion 2026-10-29 15 sitesOther conditions: Prophylaxis Against Liver Transplant RejectionView official trial listing → -
Status unknown NCT NCT04733131
Long-term Outcomes After Conversion to Belatacept
Paris Translational Research Center for Organ Transplantation 324 participants Est. completion 2021-12Other conditions: Kidney Transplant Failure and Rejection, Immunosuppression, Graft Loss, Drug Effect ProlongedView official trial listing → -
Completed NCT NCT04734197
A Research Study To See How Well an Eye Drop, SURF-100 (A Mycophenolic Acid/Betamethasone Sodium Phosphate Combination), Works and What Side Effects There Are in Subjects With Dry Eye Disease
Not yet reported Surface Ophthalmics, Inc. 349 participants Est. completion 2022-03-25 40 sitesOther conditions: Dry Eye DiseaseView official trial listing → -
Withdrawn NCT NCT04748939
Shingrix in Patients With Rheumatic Diseases: a Double-blind Placebo-controlled RCT
Not yet reported Tuen Mun Hospital Est. completion 2026-09-29 1 siteOther conditions: Herpes ZosterView official trial listing → -
Completed NCT NCT04762615
Impact of Underlying Renal Disease and Immunosuppressive Regimen on Ovarian Reserve in Renal Patients
Wroclaw Medical University 153 participants Est. completion 2020-12-01 1 siteOther conditions: Anti-Mullerian Hormone Deficiency, Immunosuppression, Ovarian Reserve, X-rays; EffectsView official trial listing → -
Terminated NCT NCT04773392
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
Not yet reported University of Southern California 20 participants Est. completion 2024-02-23 1 siteOther conditions: Kidney Transplantation, Kidney Transplant RejectionView official trial listing → -
Completed NCT NCT04775563
COVID-19 Vaccine Hesitancy Among Rheumatic Diseases Patients
National Institute of Medical Sciences and Nutrition, Salvador Zubiran 891 participants Est. completion 2021-10-01 1 siteOther conditions: Covid19View official trial listing → -
Active, not recruiting NCT NCT04789070
Phase III Trial of Sirolimus in IBM
Not yet reported University of Kansas Medical Center 140 participants Est. completion 2027-12 10 sitesOther conditions: Inclusion Body MyositisView official trial listing → -
Active, not recruiting NCT NCT04798625
Vaccine Response to COVID-19 Vaccines in Patients Using Immunosuppressive Medication
Diakonhjemmet Hospital 2300 participants Est. completion 2027-02-15 2 sitesOther conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondyloarthritis, Crohn Disease, Ulcerative Colitis, Autoimmune Hepatitis, Liver Transplant; ComplicationsView official trial listing → -
Terminated NCT NCT04809623
Study of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
Not yet reported Gilead Sciences 3 participants Est. completion 2022-10-18 5 sitesOther conditions: Cutaneous Lupus ErythematosusView official trial listing → -
Completed NCT NCT04818892
Immunogenicity of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease
University of Wisconsin, Madison 222 participants Est. completion 2022-11-11 1 siteOther conditions: IBD, Covid19 VaccineView official trial listing → -
Completed NCT NCT04835441
ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus
Not yet reported Alpine Immune Sciences Inc, A Subsidiary of Vertex 76 participants Est. completion 2024-07-09 46 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT04848493
National Project on Vaccines, COVID-19 and Frail Patients
Azienda USL Reggio Emilia - IRCCS 747 participants Est. completion 2022-12-31 12 sitesOther conditions: COVID-19, Solid Tumor, Hematologic Diseases, Neurologic Disorder, Rheumatic DiseasesView official trial listing → -
Completed NCT NCT04870359
Pre-emptive Treatments in Lupus Nephritis Patients With Serological Reactivation
Not yet reported The University of Hong Kong 49 participants Est. completion 2022-03-31 2 sitesOther conditions: Lupus NephritisView official trial listing → -
Terminated NCT NCT04870411
Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics
Assistance Publique - Hôpitaux de Paris 78 participants Est. completion 2022-03-13 1 siteOther conditions: Autoimmune Diseases, Inflammatory DisorderView official trial listing → -
Active, not recruiting NCT NCT04877691
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus
Not yet reported AstraZeneca 367 participants Est. completion 2026-11-06 140 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT04878770
NMF-CsA-Dupi Trial
Not yet reported Erasmus Medical Center 318 participants Est. completion 2025-01-01 1 siteOther conditions: Dermatitis, AtopicView official trial listing → -
Status unknown NCT NCT04883164
Immunity After COVID-19 Vaccination
Plexision 300 participants Est. completion 2023-03-31 1 siteOther conditions: Immunity to COVID-19View official trial listing → -
Status unknown NCT NCT04886206
Injection of Lymphocytes From Haplo-identical Donor Following Chemotherapy in Patients With High-risk Acute Myeloblastic Leukemia Not Eligible for an Allogeneic Hematopoietic Stem Cell Transplantation
Not yet reported Nantes University Hospital 12 participants Est. completion 2024-11 1 siteOther conditions: Acute Myeloid Leukemia (AML)View official trial listing → -
Status unknown NCT NCT04892212
Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis
Not yet reported, Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2023-10-30Other conditions: Lupus Nephritis, Immunosuppression, Effect of DrugView official trial listing → -
Status unknown NCT NCT04895423
Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood
Not yet reported National Medical Research Center for Children's Health, Russian Federation 160 participants Est. completion 2023-07-25 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Withdrawn NCT NCT04898309
Efficacy and Safety of GNR-038 vs Berinert® in Patients With Hereditary Angioedema
Not yet reported, Not yet reported AO GENERIUM Est. completion 2023-05-31 5 sitesOther conditions: Hereditary AngioedemaView official trial listing → -
Withdrawn NCT NCT04903054
Selective CD28 Blockade in Renal Transplant Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2022-09-22 1 siteOther conditions: Kidney Transplantation, Renal Transplant RecipientsView official trial listing → -
Active, not recruiting NCT NCT04904588
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Not yet reported Center for International Blood and Marrow Transplant Research 300 participants Est. completion 2026-12 39 sitesOther conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, LymphomaView official trial listing → -
Status unknown NCT NCT04915482
TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 94 participants Est. completion 2025-02-28 1 siteOther conditions: Immune Thrombocytopenia (ITP), Autoantibodies, Evan Syndrome, Connective Tissue DiseasesView official trial listing → -
Status unknown NCT NCT04928586
Immunosuppressant Combined With Pirfenidone in CTD-ILD
Not yet reported Qilu Hospital of Shandong University 200 participants Est. completion 2025-06-01 1 siteOther conditions: Pirfenidone, Connective Tissue Diseases, Interstitial Lung DiseaseView official trial listing → -
Terminated NCT NCT04930055
Immune Responses in Oncology Patients to Novel Coronavirus Vaccines (IROC)
Indiana University 2206 participants Est. completion 2022-03-08 2 sitesOther conditions: CancerView official trial listing → -
Status unknown NCT NCT04942314
Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective Study
Jia Deng 600 participants Est. completion 2023-06-01Other conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT04945889
Sepsis in Geriatric Patients With Suspected Infection.
A.O.U. Città della Salute e della Scienza 580 participants Est. completion 2019-10-31 1 siteOther conditions: SepsisView official trial listing → -
Status unknown NCT NCT04946669
An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis
Not yet reported The First Affiliated Hospital with Nanjing Medical University 20 participants Est. completion 2022-07-31 1 siteOther conditions: Dermatomyositis, AbataceptView official trial listing → -
Completed NCT NCT04955366
Abatacept Conversion in Kidney Transplantation
Not yet reported Emory University 87 participants Est. completion 2026-06-10 1 siteOther conditions: Renal Transplant RecipientView official trial listing → -
Withdrawn NCT NCT04963673
Evaluation of Interaction Between Immunosuppressive Drugs and Protein-bound Uremic Toxins in Renal Transplant Patients
Centre Hospitalier Universitaire, Amiens Est. completion 2023-09-12 1 siteOther conditions: Kidney Transplant, Immunosuppression, Uremic; ToxemiaView official trial listing → -
Completed NCT NCT04976933
Post-HSCT Medication Adherence mHealth App
Micah Skeens 15 participants Est. completion 2023-01-31 1 siteOther conditions: Stem Cell TransplantationView official trial listing → -
Completed NCT NCT04978623
Role of High Frequency Ultrasound in Demyelinating Polyneuropathies
Centre Hospitalier Universitaire de Nice 48 participants Est. completion 2022-12-01 1 siteOther conditions: Chronic Inflammatory Demyelinating PolyradiculoneuropathyView official trial listing → -
Completed NCT NCT04989686
Microsampling Assays for Immunosuppressive Drugs in Children
Children's Hospital of Philadelphia 66 participants Est. completion 2025-05-01 1 siteOther conditions: ImmunosuppressionView official trial listing → -
Completed NCT NCT04995770
Text Messages for Liver Transplant Recipients
Not yet reported Children's Hospital Los Angeles 35 participants Est. completion 2020-12-26 1 siteOther conditions: Medication Adherence, Liver Transplant DisorderView official trial listing → -
Terminated NCT NCT05000216
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 258 participants Est. completion 2024-03-28 29 sitesOther conditions: Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris, Multiple Sclerosis (MS), Systemic Sclerosis (SSc), Pediatric SLE, Juvenile Idiopathic Arthritis (JIA), Juvenile Dermatomyositis (JDM), Pediatric-Onset Multiple Sclerosis (POMS)View official trial listing → -
Status unknown NCT NCT05001386
In Vitro Drug Sensitivity Testing of Fresh Human Samples
Not yet reported Hospices Civils de Lyon 800 participants Est. completion 2025-03 2 sitesOther conditions: Myeloproliferative Disorders, Lymphoproliferative DisordersView official trial listing → -
Completed NCT NCT05005637
The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA
Not yet reported Fakultas Kedokteran Universitas Indonesia 78 participants Est. completion 2024-11-20 1 siteOther conditions: Tuberculous UveitisView official trial listing → -
Completed NCT NCT05020145
COVID-19 Vaccination and Breakthrough Infections Among Persons With Immunocompromising Conditions in the United States
Pfizer 1277747 participants Est. completion 2021-12-17 1 siteOther conditions: Immunocompromised, Immunosuppressed, Covid-19, SARS-COV-2, SARS-COV-2 Infection, Breakthrough InfectionView official trial listing → -
Completed NCT NCT05030974
RECOVAC Repeated Vaccination Study
Not yet reported University Medical Center Groningen 336 participants Est. completion 2022-03-12 4 sitesOther conditions: Covid19, Kidney Diseases, Vaccine Response Impaired, SARS-CoV2 InfectionView official trial listing → -
Completed NCT NCT05038982
Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
Not yet reported Johns Hopkins University 20 participants Est. completion 2022-07-11 1 siteOther conditions: Prurigo Nodularis, Pruritus, Chronic Pruritus, Chronic Prurigo, Skin DiseasesView official trial listing → -
Status unknown NCT NCT05047406
Bacillus Clausii in Liver Transplantation
Not yet reported Ain Shams University 60 participants Est. completion 2023-08-30 1 siteOther conditions: Transplantation Infection, Liver Grafting, Hepatic TransplantationView official trial listing → -
Status unknown NCT NCT05051605
Immune Response to COVID-19 Vaccine in Recipients of Living Donor Liver Transplantation
Ain Shams University 50 participants Est. completion 2023-11-30 1 siteOther conditions: Liver TransplantView official trial listing → -
Completed NCT NCT05060354
COVID-19 Vaccine Response in Treated MS Patients
Brigham and Women's Hospital 159 participants Est. completion 2023-09-28 1 siteOther conditions: Multiple Sclerosis, HealthyView official trial listing → -
Completed NCT NCT05077254
COVID Protection After Transplant-Immunosuppression Reduction
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2025-02-21 15 sitesOther conditions: Kidney Transplant Recipients, Liver Transplant RecipientsView official trial listing → -
Terminated NCT NCT05078710
Telitacicept in Primary APS Patients
Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2025-06-01 1 siteOther conditions: Anti Phospholipid SyndromeView official trial listing → -
Completed NCT NCT05089370
Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma
Not yet reported, Not yet reported University of Colorado, Denver 8 participants Est. completion 2026-08-10 1 siteOther conditions: Malignant MelanomaView official trial listing → -
Completed NCT NCT05089565
Immune Response to SARS-CoV-2/COVID-19 Vaccination in Sarcoidosis
Northwestern University 101 participants Est. completion 2022-12-31 1 siteOther conditions: Sarcoidosis, SARS-CoV2 Infection, Vaccine Response ImpairedView official trial listing → -
Status unknown NCT NCT05110040
Multi-model Image of Immunosuppressive Agents in TAO
Not yet reported Sun Yat-sen University 12 participants Est. completion 2025-12-01 1 site Stand-aloneOther conditions: Thyroid Associated OphthalmopathyView official trial listing → -
Status unknown NCT NCT05112484
Therapeutic Monitoring of Drugs Used in the Treatment of Multiple Sclerosis
University Hospital Ostrava 600 participants Est. completion 2026-05 2 sitesOther conditions: Multiple SclerosisView official trial listing → -
Active, not recruiting NCT NCT05132166
A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease
Not yet reported University Health Network, Toronto 50 participants Est. completion 2026-04-26 1 siteOther conditions: Graft Vs Host DiseaseView official trial listing → -
Status unknown NCT NCT05138666
Non-invasive Tools to Diagnose Invasive Aspergillosis Infections in ICU Patients With COVID-19 and Other Conditions.
Not yet reported Centre Hospitalier Universitaire de Besancon 363 participants Est. completion 2024-03 1 siteOther conditions: Invasive Pulmonary AspergillosisView official trial listing → -
Status unknown NCT NCT05140616
Study of Chidamide for Steroid-resistant/Steroid-dependent Severe cGVHD
Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 20 participants Est. completion 2024-05-31 1 siteOther conditions: Safety and EfficacyView official trial listing → -
Status unknown NCT NCT05154370
China National Registry of Neuro-Inflammatory Diseases
Beijing Tiantan Hospital 10000 participants Est. completion 2026-11-01 1 siteOther conditions: Multiple Sclerosis, NMO Spectrum Disorder, Clinically Isolated Syndrome, CNS Demyelinating Autoimmune Diseases, Acute Disseminated Encephalomyelitis, Primay Angiitis of the Central Nervous System, Autoimmune Glial Fibrillary Acidic Protein AstrocytopathyView official trial listing → -
Status unknown NCT NCT05157750
Endoscopic Remission, Histologic Remission and Barrier Healing for Predicting Disease Behaviour in IBD
University of Erlangen-Nürnberg Medical School 180 participants Est. completion 2022-05-01 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT05195086
A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt
Nada Magdy Mansour 122 participants Est. completion 2021-06-05 1 siteOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT05195645
AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
Not yet reported Assistance Publique - Hôpitaux de Paris 21 participants Est. completion 2025-01-28 1 siteOther conditions: MyocarditisView official trial listing → -
No Longer Available NCT NCT05215288
Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant Patients
Direct Biologics, LLC 2 sitesOther conditions: Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ RejectionView official trial listing → -
Withdrawn NCT NCT05218408
CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type
Not yet reported, Not yet reported Celularity Incorporated Est. completion 2021-10-23Other conditions: Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma, Glioblastoma MultiformeView official trial listing → -
Terminated NCT NCT05220397
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients
Not yet reported Mark Stegall 468 participants Est. completion 2025-02-28 3 sitesOther conditions: Kidney Transplant RecipientView official trial listing → -
Completed NCT NCT05237323
Micophenolate Mofetil Versus Azathioprine in Myocarditis
Not yet reported I.M. Sechenov First Moscow State Medical University 50 participants Est. completion 2025-07-10 1 siteHeart failureSubstance use disorder Other conditions: Lymphocytic Myocarditis (Disorder), Dilated Cardiomyopathy, CardiomyopathiesView official trial listing → -
Completed NCT NCT05238467
Immunological Responses of COVID-19 Vaccination
University Hospitals Cleveland Medical Center 42 participants Est. completion 2023-02-13 1 siteOther conditions: Cancer; ChemotherapyView official trial listing → -
Completed NCT NCT05245344
Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study
Neuromed IRCCS 154 participants Est. completion 2023-10-31 3 sitesOther conditions: Relapsing-Remitting Multiple Sclerosis (RRMS), Neuromyelitis Optica, HealthyView official trial listing → -
Completed NCT NCT05247203
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus
Not yet reported RemeGen Co., Ltd. 92 participants Est. completion 2023-11-13 19 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT05248022
Efficacy and Safety of DEB-BACE Combined With PD-1 Inhibitors in Stage II/III NSCLC With Standard Treatment Failure
Not yet reported The Central Hospital of Lishui City 98 participants Est. completion 2024-12-31 Stand-aloneOther conditions: Carcinoma, Non-Small-Cell LungView official trial listing → -
Active, not recruiting NCT NCT05256537
Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil
Not yet reported Ronald Paquette 60 participants Est. completion 2027-01-07 1 siteOther conditions: Hematologic NeoplasmsView official trial listing → -
Completed NCT NCT05274308
Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples
Thermo Fisher Scientific Oy 46 participants Est. completion 2022-07-26 1 siteOther conditions: Transplantation Drugs StabilityView official trial listing → -
Status unknown NCT NCT05277285
STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care
Not yet reported Hellenic Institute for the Study of Sepsis 30 participants Est. completion 2023-12-31 1 siteOther conditions: COVID-19, Virus Diseases, Corona Virus InfectionView official trial listing → -
Status unknown NCT NCT05282875
Anti-HLA Immunization And Immunosuppressive Therapy Management In Kidney Transplant Patients Returning to Dialysis
Central Hospital, Nancy, France 430 participants Est. completion 2022-09-01 1 siteOther conditions: Kidney Transplantation, Immunosuppressive Agents, HLA Sensitization, DialysisView official trial listing → -
Status unknown NCT NCT05294822
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
Not yet reported Shanghai Changzheng Hospital 20 participants Est. completion 2023-12 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT05303402
A Phase IIb/III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.
Not yet reported, Not yet reported Hipra Scientific, S.L.U 240 participants Est. completion 2024-01-09 6 sitesOther conditions: SARS CoV 2 InfectionView official trial listing → -
Status unknown NCT NCT05308628
Pediatric Liver Transplantation-Liver Fibrosis Evaluation by Using Fibrosis Panel
Not yet reported RenJi Hospital 1200 participants Est. completion 2025-11-30 2 sitesOther conditions: Liver Fibrosis, Pediatric Disorder, Liver Transplant; ComplicationsView official trial listing → -
Withdrawn NCT NCT05323617
Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy
Not yet reported Amgen Est. completion 2025-02-25Other conditions: Severe Aplastic Anemia (SAA)View official trial listing → -
Active, not recruiting NCT NCT05342519
Daily Topical Rapamycin for Vitiligo
Not yet reported Medical University of South Carolina 20 participants Est. completion 2027-12-01 1 siteOther conditions: VitiligoView official trial listing → -
Active, not recruiting NCT NCT05345197
Emicizumab in Patients With Acquired Hemophilia A
Not yet reported University of Washington 51 participants Est. completion 2026-12 16 sitesOther conditions: Acquired Hemophilia AView official trial listing → -
Completed NCT NCT05354583
Treatment Outcome Between Mycobacterium Abscessus Infection in Chronic Lung Disease and Acquired Interferon-gamma Autoantibody Syndrome
King Chulalongkorn Memorial Hospital 36 participants Est. completion 2023-09-30 1 siteOther conditions: Mycobacterium Abscessus Infection, Adult-Onset Immunodeficiency With Acquired Anti-Interferon-Gamma Autoantibodies, Nontuberculous Mycobacterial Pulmonary InfectionView official trial listing → -
Status unknown NCT NCT05366062
ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab
Not yet reported Epitopoietic Research Corporation 28 participants Est. completion 2026-07-31 1 siteOther conditions: Glioma, MalignantView official trial listing → -
Completed NCT NCT05367986
Electro-acupuncture at Zusanli, Qihai, and Guanyuan Acupoints Regulate Immune Function in Patients With Sepsis
Not yet reported Guangdong Provincial Hospital of Traditional Chinese Medicine 78 participants Est. completion 2022-01-30 1 siteOther conditions: Sepsis, Immune DysfunctionView official trial listing → -
Completed NCT NCT05369975
Efficacy and Safety in Imlifidase Desensitized Kidney Tx Patients, Including Two Non-Comparative Reference Cohorts
Not yet reported Hansa Biopharma AB 113 participants Est. completion 2026-04-21 22 sitesOther conditions: Kidney Transplantation in Highly Sensitized PatientsView official trial listing → -
Completed NCT NCT05399641
Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis
Not yet reported Scynexis, Inc. 150 participants Est. completion 2023-08-02 25 sitesOther conditions: Vulvovaginal CandidiasisView official trial listing → -
Suspended NCT NCT05400122
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
Not yet reported David Wald 12 participants Est. completion 2027-06-01 1 siteOther conditions: Colorectal Cancer, Hematologic Malignancy, Rectum Cancer, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Myeloproliferative Syndrome, Plasma Cell Myeloma, Gastric Cancer, Esophageal Cancer, Esophagus Cancer, Gastric Cancer, Metastatic, Unresectable Esophageal Cancer, Metastatic Esophageal CancerView official trial listing → -
Not yet recruiting NCT NCT05415579
Demyelinating Diseases of the Central Nervous System Registry for Patients With Traditional Chinese Medicine (DATE-TCM)
Dongzhimen Hospital, Beijing 2000 participants Est. completion 2030-05-31Other conditions: Demyelinating Diseases of the Central Nervous System (DDC)View official trial listing → -
Status unknown NCT NCT05415995
A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases
Not yet reported Zhejiang Zylox Medical Device Co., Ltd. 202 participants Est. completion 2024-12 20 sites Stand-aloneOther conditions: Peripheral Artery DiseaseView official trial listing → -
Withdrawn NCT NCT05423496
KidneyCare Immuno-optimization in Renal Allografts (KIRA)
Not yet reported CareDx Est. completion 2023-02-23Other conditions: Kidney Transplant, Immunosuppression, AllograftView official trial listing → -
Completed NCT NCT05452187
Evaluation of the Safety and Effectiveness of Direct-acting Antiviral Drugs in the Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease: National Multicenter Study
Hospital Mutua de Terrassa 79 participants Est. completion 2021-12-20 1 siteOther conditions: Inflammatory Bowel Diseases, Hepatitis C Virus InfectionView official trial listing → -
Status unknown NCT NCT05459181
HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
Not yet reported CareDx 930 participants Est. completion 2026-09Other conditions: Heart Transplant, Immunosuppression, AllograftView official trial listing → -
Completed NCT NCT05464043
Hyperglycemia and (Pre)Diabetes in Pediatric Renal and Liver Transplantation.
Not yet reported Université Catholique de Louvain 250 participants Est. completion 2022-04-30 1 siteOther conditions: Diabetes Mellitus RiskView official trial listing → -
Completed NCT NCT05468320
Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura
Not yet reported Sanofi 51 participants Est. completion 2024-12-26 27 sitesOther conditions: Thrombotic Thrombocytopenic PurpuraView official trial listing → -
Status unknown NCT NCT05498740
Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia
Not yet reported Zhejiang Zylox Medical Device Co., Ltd. 200 participants Est. completion 2024-12 24 sites Stand-aloneOther conditions: Peripheral Arterial Disease (PAD)View official trial listing → -
Status unknown NCT NCT05505409
Efficacy and Safety of Pirfenidone in CTD-ILD
Not yet reported Qilu Hospital of Shandong University 120 participants Est. completion 2025-12-01 1 siteOther conditions: Pirfenidone, Connective Tissue Diseases, Interstitial Lung DiseaseView official trial listing → -
Active, not recruiting NCT NCT05537948
Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients
Not yet reported National Medical Research Center for Therapy and Preventive Medicine 59 participants Est. completion 2025-01-31 1 siteOther conditions: Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder, Immunosuppression, Hydroxymethylglutaryl-CoA Reductase Inhibitors, StatinsView official trial listing → -
Completed NCT NCT05542381
The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain
Not yet reported Virginia Polytechnic Institute and State University 64 participants Est. completion 2025-05-01 1 siteOther conditions: Age-Related Macular DegenerationView official trial listing → -
Terminated NCT NCT05570409
Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy
Not yet reported, Not yet reported LMU Klinikum 9 participants Est. completion 2025-04-14 14 sitesOther conditions: Inflammatory CardiomyopathyView official trial listing → -
Status unknown NCT NCT05590416
A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
Tianjin Medical University 15 participants Est. completion 2024-12-30 1 siteOther conditions: Vogt-Koyanagi-Harada Disease, AdalimumabView official trial listing → -
Status unknown NCT NCT05592717
A Study of YUTIQ® 0.18 mg Intravitreal Implant for the Management of Chronic Non-infectious Uveitis
Tianjin Medical University 15 participants Est. completion 2026-11-01 1 siteOther conditions: Uveitis, YUTIQView official trial listing → -
Terminated NCT NCT05600426
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)
Not yet reported Boston Children's Hospital 53 participants Est. completion 2026-08-06 52 sitesOther conditions: Severe Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT05605145
PCP in Immunocompromised Population in Southern China
First Affiliated Hospital of Guangxi Medical University 300 participants Est. completion 2023-06-30 1 siteOther conditions: Immunocompromised Patients, Pneumocystis Pneumonia, Diagnosis, Polymerase Chain ReactionView official trial listing → -
Withdrawn NCT NCT05607589
The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects
Not yet reported Daewoong Pharmaceutical Co. LTD. Est. completion 2024-03-08Other conditions: HealthyView official trial listing → -
Completed NCT NCT05607901
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
Not yet reported Tanta University 100 participants Est. completion 2023-08-20 1 siteOther conditions: Dermatologic DiseaseView official trial listing → -
Status unknown NCT NCT05621356
Monitoring Allergen Immunotherapy in Allergic Rhinitis
Rijnstate Hospital 25 participants Est. completion 2023-03-31 1 siteOther conditions: Immunotherapy, Rhinitis, Allergic, Treatment OutcomeView official trial listing → -
Active, not recruiting NCT NCT05626387
An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 144 participants Est. completion 2026-10-23 9 sitesOther conditions: Hypersensitivity PneumonitisView official trial listing → -
Withdrawn NCT NCT05627089
Rheumatoid Arthritis and Myositis Cohort
Attune Health Research, Inc. Est. completion 2035-01-01Other conditions: Rheumatoid Arthritis, MyositisView official trial listing → -
Active, not recruiting NCT NCT05637112
A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice.
AstraZeneca 551 participants Est. completion 2030-12-30 74 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT05679336
Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy
Not yet reported St. Petersburg State Pavlov Medical University 40 participants Est. completion 2024-08-31 1 siteOther conditions: Membranous Nephropathy - PLA2R InducedView official trial listing → -
Status unknown NCT NCT05696106
Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID
Assistance Publique - Hôpitaux de Paris 750000 participants Est. completion 2024-01-15 1 siteOther conditions: Inflammatory DiseaseView official trial listing → -
Completed NCT NCT05697809
Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema
Not yet reported Oxular Limited 3 participants Est. completion 2024-12-05 9 sitesOther conditions: Diabetic Macular EdemaView official trial listing → -
Completed NCT NCT05700565
Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype
Lucie Heinzerling 46 participants Est. completion 2025-10-01 1 siteOther conditions: Immune-related Adverse EventView official trial listing → -
Status unknown NCT NCT05707520
Long-term Benefit of MPA in Liver Transplantation
Third Affiliated Hospital, Sun Yat-Sen University 500 participants Est. completion 2023-09-30 1 siteOther conditions: Liver Transplant Rejection, Immunosuppressant Adverse ReactionView official trial listing → -
Status unknown NCT NCT05727709
Dynamic Changes of Torquetenovirus (TTV) Load in Chinese Renal Transplant Recipients
Tongji Hospital 220 participants Est. completion 2024-06-30 5 sitesOther conditions: Kidney Transplant Rejection, Kidney Transplant Infection, Virus, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT05744635
Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients
Chiesi Hungary Ltd. 110 participants Est. completion 2026-06-01 2 sitesOther conditions: Liver FailureView official trial listing → -
Terminated NCT NCT05747053
Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
George Washington University 105 participants Est. completion 2022-12-08 1 siteOther conditions: Kidney Injury, Kidney Failure, Kidney Failure, Chronic, Kidney Failure, Acute, Kidney Diseases, Kidney Transplant Rejection, Kidney Transplant Infection, Kidney Transplant; Complications, Kidney Disease, Chronic, Kidney IschemiaView official trial listing → -
Completed NCT NCT05765955
Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses
Not yet reported Poolbeg Pharma plc 36 participants Est. completion 2022-12-16 1 siteOther conditions: Influenza, HumanView official trial listing → -
Status unknown NCT NCT05772871
The Efficacy and Safety of Prednisone Combined With Huaiqihuang Granule for Primary Nephrotic Syndrome in Children
Not yet reported Jianhua Zhou 402 participants Est. completion 2025-10-30 26 sitesOther conditions: Nephrotic Syndrome in ChildrenView official trial listing → -
Active, not recruiting NCT NCT05782907
Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.
Not yet reported AbbVie 122 participants Est. completion 2031-10 89 sitesOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT05799755
Myositis Interstitial Lung Disease Nintedanib Trial
Not yet reported Rohit Aggarwal, MD 62 participants Est. completion 2025-12-31 10 sitesOther conditions: Myositis Associated Interstitial Lund Disease (MA-ILD)View official trial listing → -
Active, not recruiting NCT NCT05806749
Immunological Tolerance in Patients With Mismatched Kidney Transplants
Not yet reported University of California, Los Angeles 16 participants Est. completion 2028-08 1 siteChronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and RejectionView official trial listing → -
Completed NCT NCT05808192
De Novo Metabolic Syndrome in Liver Transplant Patients After Immunosuppression Withdrawal
University of Rome Tor Vergata 92 participants Est. completion 2022-05-01 1 siteOther conditions: Single Transplant, 5 Years of Follow-up After Transplant, in Which an Attempt Was Made to Suspend ISView official trial listing → -
Completed NCT NCT05816486
BIOtechnology Applied to Renal TRansplantation With IMmunobiogram
Biohope Scientific Solutions for Human Health, S.L. 443 participants Est. completion 2024-06-30 15 sitesOther conditions: Kidney Transplant Failure and RejectionView official trial listing → -
Status unknown NCT NCT05848427
The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19
Lebanese University 1000 participants Est. completion 2025-12-30 2 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT05852977
Study of Dengue in Patients With Autoimmune Diseases During the Epidemics of 2020 and 2021 in Reunion Island
Centre Hospitalier Universitaire de la Réunion 90 participants Est. completion 2026-06Other conditions: DengueView official trial listing → -
Completed NCT NCT05854472
Using Smartphone Application After Liver Transplantation
Not yet reported Saglik Bilimleri Universitesi 55 participants Est. completion 2024-02-26 1 siteOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT05863936
Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis
Not yet reported Nanjing University School of Medicine 15 participants Est. completion 2024-12-31 1 siteOther conditions: Lupus Nephritis, Remission, Safety IssuesView official trial listing → -
Status unknown NCT NCT05872815
Precision Drug Use of Immunosuppressants Guided by Population Pharmacokinetics/Pharmacodynamic Models in Kidney Transplant Patients
The Second Affiliated Hospital of Chongqing Medical University 120 participants Est. completion 2024-07-01 1 siteOther conditions: Kidney Transplantation, Immunosuppressive AgentsView official trial listing → -
Active, not recruiting NCT NCT05873205
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2027-06-29 7 sitesOther conditions: Blood Cancer, Refractory Immune CytopeniasView official trial listing → -
Completed NCT NCT05874349
Histopathologic and Lymphocyte Subpopulations Evaluation of the Upper Gastrointestinal Tract of Crohn's Disease
Hospital Mutua de Terrassa 200 participants Est. completion 2023-01-01 1 siteOther conditions: Crohn DiseaseView official trial listing → -
Active, not recruiting NCT NCT05879419
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
Not yet reported University of Sao Paulo General Hospital 2005 participants Est. completion 2032-06-30 1 siteOther conditions: Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis, Systemic Lupus Erythematosus, Sjogren's Syndrome, Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Vasculitis, Systemic, Juvenile Idiopathic Arthritis, Dermatomyositis, Juvenile, Behçet DiseaseView official trial listing → -
Withdrawn NCT NCT05881668
MSC-EV in Acute-on-Chronic Liver Failure After Liver Transplantation
Not yet reported Third Affiliated Hospital, Sun Yat-Sen University Est. completion 2025-04-30 1 siteOther conditions: Liver Failure, Acute on ChronicView official trial listing → -
Status unknown NCT NCT05891379
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Xuanwu Hospital, Beijing 50 participants Est. completion 2025-07-31 1 siteOther conditions: Neuromyelitis Optica Spectrum DisorderView official trial listing → -
Completed NCT NCT05894512
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
Istanbul University 44 participants Est. completion 2026-02-15 1 siteOther conditions: Membranous Nephropathy, Membranous Nephropathy - PLA2R Induced, Membranous Nephropathy - THSD7A InducedView official trial listing → -
Completed NCT NCT05924685
PREPARE-iVAC Trial
Not yet reported University Medical Center Groningen 110 participants Est. completion 2024-02-27 7 sitesOther conditions: COVID-19 Vaccines, Varicella Zoster Vaccine, Vaccine Response, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT05925140
LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients
Not yet reported Lebanese University 1000 participants Est. completion 2025-12-30 2 sitesOther conditions: COVID-19, Hospitalized COVID-19 PatientsView official trial listing → -
Active, not recruiting NCT NCT05925803
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Not yet reported AstraZeneca 314 participants Est. completion 2028-04-05 150 sitesOther conditions: Systemic Sclerosis, SclerodermaView official trial listing → -
Not yet recruiting NCT NCT05928754
Prospective CoHoRt Of Non-infectious Intermediate, pOsterior or panuveitiS
Not yet reported Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 2000 participants Est. completion 2028-08Other conditions: Non-infectious UveitisView official trial listing → -
Status unknown NCT NCT05928780
An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)
Not yet reported, Not yet reported Fudan University 125 participants Est. completion 2025-09-01Other conditions: TNBC - Triple-Negative Breast CancerView official trial listing → -
Status unknown NCT NCT05947864
Monitoring of Measles-specific Immune Status in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients
Not yet reported Hospices Civils de Lyon 60 participants Est. completion 2026-07 1 siteOther conditions: Transplantation, Hematopoietic Stem CellView official trial listing → -
Completed NCT NCT05975450
Subcutaneous Abatacept in Renal Transplant Recipients
Not yet reported Idelberto Badell 16 participants Est. completion 2025-02-14 2 sitesOther conditions: Kidney Transplant RecipientView official trial listing → -
Status unknown NCT NCT05975996
Cyclophosphamide Added to Standard Immunosuppressive Therapy With Herombopag as Front-line Therapy in Patients With Severe Aplastic Anemia
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 43 participants Est. completion 2025-12-31 1 siteOther conditions: Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT05995938
Mindfullnes-Based Cognitive Therapy Effect
Not yet reported SEMRA BÜLBÜLOĞLU 140 participants Est. completion 2023-01-30 1 siteOther conditions: Mindfullnes-Based Cognitive Therapy and Adherence to Immunosuppressive TherapyView official trial listing → -
Completed NCT NCT05999955
Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis
Not yet reported Huro Biotech Joint Stock Company 60 participants Est. completion 2023-05-25 1 siteOther conditions: Rhinosinusitis, RhinitisView official trial listing → -
Active, not recruiting NCT NCT06001385
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
Not yet reported Center for International Blood and Marrow Transplant Research 313 participants Est. completion 2026-12-30 32 sitesOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myeloproliferative Neoplasm, Lymphoma, Chronic Myelomonocytic Leukemia, Pro-Lymphocytic Leukemia, MyelofibrosisView official trial listing → -
Completed NCT NCT06004102
Medication Adherence in Kidney Transplant
Not yet reported Akdeniz University Hospital 100 participants Est. completion 2023-02-08 1 siteOther conditions: Medication AdherenceView official trial listing → -
Status unknown NCT NCT06009965
Efficacy of IST Combined With TPO-RA in the Treatment of AA and Establishment of a Recurrence Prediction System
Not yet reported Peking Union Medical College Hospital 210 participants Est. completion 2025-01-31 1 siteOther conditions: Aplastic Anemia, CSA, Drug TherapyView official trial listing → -
Withdrawn NCT NCT06015750
Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia
Not yet reported Alexion Pharmaceuticals, Inc. Est. completion 2030-03-13Other conditions: HypophosphatasiaView official trial listing → -
Status unknown NCT NCT06019234
Juvenile Systemic Sclerosis, a Retrospective Epidemiological Study on a French Cohort
University Hospital, Strasbourg, France 30 participants Est. completion 2024-10-03 1 siteOther conditions: Juvenile Systemic SclerosisView official trial listing → -
Completed NCT NCT06026787
Clinical Value of Adding Dapagliflozin in Patients With Nephrotic Syndrome
Not yet reported Ain Shams University 60 participants Est. completion 2023-08-01 1 siteOther conditions: Nephrotic Syndrome, Sodium-Glucose Transporter 2 InhibitorsView official trial listing → -
Completed NCT NCT06046534
Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
AstraZeneca 46 participants Est. completion 2024-06-10 15 sitesOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Not yet recruiting NCT NCT06084780
Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
Not yet reported Case Comprehensive Cancer Center 20 participants Est. completion 2027-12-31 1 siteOther conditions: Secondary Malignant Neoplasm of Retroperitoneum, Secondary Malignant Neoplasm of Peritoneum, Pseudomyxoma PeritoneiView official trial listing → -
Status unknown NCT NCT06105658
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With AML
Not yet reported Anhui Provincial Hospital 20 participants Est. completion 2026-02-01 1 siteOther conditions: Acute Myelocytic LeukemiaView official trial listing → -
Completed NCT NCT06106854
Medication Adherence in Kidney Transplant Patients: SystemCHANGE™ Results of the Turkish MAGIC Randomized Clinical Trial
Not yet reported Dokuz Eylul University 42 participants Est. completion 2022-09-15 1 siteOther conditions: Medication AdherenceView official trial listing → -
Status unknown NCT NCT06109064
Safety and Efficacy of Unrelated Umbilical Cord Blood Microtransplantation in Patients With Higher-risk MDS
Not yet reported Anhui Provincial Hospital 14 participants Est. completion 2026-02-01 1 siteOther conditions: Myelodysplastic SyndromesView official trial listing → -
Not yet recruiting NCT NCT06109961
Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study
Not yet reported, Not yet reported University of British Columbia 54 participants Est. completion 2028-03Other conditions: Inflammatory Bowel Disease (IBD), Crohn DiseaseView official trial listing → -
Status unknown NCT NCT06121804
Immunosuppressants to Postoperative Infection and Death
Chung Shan Medical University 20000 participants Est. completion 2024-12-20 1 siteOther conditions: Organ Transplantation, Immunosuppressive Agents, Cohort StudyView official trial listing → -
Status unknown NCT NCT06125457
Epidemiology of IgA Selective Deficiency - Clinical Manifestations and Risk of Transmission
University Hospital, Strasbourg, France 120 participants Est. completion 2023-12-31 1 siteOther conditions: COVID-19View official trial listing → -
Completed NCT NCT06138379
Video-supported Training in Line With the Health Belief Model
Not yet reported Inonu University 90 participants Est. completion 2024-08-16 1 siteOther conditions: EducationView official trial listing → -
Not yet recruiting NCT NCT06147375
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation
Not yet reported Wei Gao 47 participants Est. completion 2028-12 1 siteOther conditions: Immune Tolerance, Immunosuppression, Liver Transplant; ComplicationsView official trial listing → -
Not yet recruiting NCT NCT06150287
Effect of Probiotics on Immunosuppressive-drug-associated Diarrhea Among Renal Transplant Recipients
Not yet reported State University of New York - Upstate Medical University 70 participants Est. completion 2027-05Other conditions: Renal TransplantationView official trial listing → -
Status unknown NCT NCT06178146
Thymosin Alpha-1 for irAE Secondary to ICIs
Not yet reported Jun Wang 40 participants Est. completion 2025-04 1 siteOther conditions: IrAEView official trial listing → -
Status unknown NCT NCT06196996
Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus
Not yet reported Shanghai Changzheng Hospital 18 participants Est. completion 2026-09 1 siteOther conditions: Brittle Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT06219616
Prediction of BK Virus Reactivation in Kidney Transplant Recipient
Not yet reported King Chulalongkorn Memorial Hospital 80 participants Est. completion 2025-05-31 1 siteOther conditions: Kidney Transplant Infection, BK Virus Infection, BK Virus NephropathyView official trial listing → -
Withdrawn NCT NCT06224270
Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications
Not yet reported University of Wisconsin, Madison Est. completion 2027-09 6 sitesOther conditions: Inflammatory Bowel Diseases, IBDView official trial listing → -
Completed NCT NCT06231745
Paroxetine Safety and Efficacy in Rheumatoid Arthritis
Not yet reported Mostafa Bahaa 100 participants Est. completion 2025-07-20 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT06238336
Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours
Not yet reported, Not yet reported Shanxi Bethune Hospital 30 participants Est. completion 2025-12-20 1 siteOther conditions: Hematological MalignancyView official trial listing → -
Active, not recruiting NCT NCT06268769
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Not yet reported Edward Geissler 322 participants Est. completion 2028-11 13 sitesOther conditions: ImmunosuppressionView official trial listing → -
Not yet recruiting NCT NCT06271681
Evaluation of PCV21 Vaccination Among PPSV23-experienced, Immunocompromised Elderly Veterans
Not yet reported VA Sierra Nevada Health Care System 45 participants Est. completion 2027-06-01Other conditions: Pneumococcal Vaccines, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT06297408
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus
Not yet reported Shanghai Ming Ju Biotechnology Co., Ltd. 24 participants Est. completion 2026-05Other conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT06307808
Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination
University Hospital, Grenoble 66 participants Est. completion 2025-10-01 1 siteOther conditions: HBV, Kidney Transplantation, Liver TransplantationView official trial listing → -
Completed NCT NCT06310837
Effect of Immunosuppressants With Adalimumab Biosimilars vs Corticosteroids on Noninfectious Uveitis
Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 128 participants Est. completion 2026-07-03 1 site Stand-aloneOther conditions: UveitisView official trial listing → -
Active, not recruiting NCT NCT06332534
Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's Disease
Not yet reported AbbVie 111 participants Est. completion 2031-01 85 sitesOther conditions: Crohn's DiseaseView official trial listing → -
Status unknown NCT NCT06341686
Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection
Not yet reported Hospital do Rim e Hipertensão 100 participants Est. completion 2025-05Other conditions: CMV InfectionView official trial listing → -
Not yet recruiting NCT NCT06352515
T Lymphocyte Subsets in Ulcerative Colitis
Assiut University 80 participants Est. completion 2027-06-01Other conditions: Ulcerative ColitisView official trial listing → -
Not yet recruiting NCT NCT06356506
A Study on Factors of Biochemical Response in Autoimmune Hepatitis
Beijing Friendship Hospital 630 participants Est. completion 2034-05-01 1 siteOther conditions: Autoimmune HepatitisView official trial listing → -
Status unknown NCT NCT06364046
Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC
Not yet reported The Central Hospital of Lishui City 56 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Carcinoma, Small Cell Lung CancerView official trial listing → -
Completed NCT NCT06368349
Persistent Lymphopenia in Liver Transplantation and Its Molecular Insights for Hepatocellular Carcinoma
Chang Gung Memorial Hospital 190 participants Est. completion 2023-06-30 1 siteOther conditions: LymphopeniaView official trial listing → -
Completed NCT NCT06457035
Development and Validation of a Nomogram for Predicting Surgery in Newly-diagnosed Crohn's Disease: a Retrospective Cohort Study
First Affiliated Hospital, Sun Yat-Sen University 490 participants Est. completion 2023-12-01Other conditions: Newly-diagnosed Crohn's DiseaseView official trial listing → -
Completed NCT NCT06460987
Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 245 participants Est. completion 2024-03-31 1 siteOther conditions: Finerenone, IgA Nephropathy, Proteinuria, Safety IssuesView official trial listing → -
Withdrawn NCT NCT06461546
Imlifidase in Living Donor Renal Transplantation Highly Sensitized Recipients
Not yet reported Fundacion Clinic per a la Recerca Biomédica Est. completion 2027-05Other conditions: Kidney Transplant CandidatesView official trial listing → -
Status unknown NCT NCT06469424
An Active Surveillance, Post-Authorization Study to Characterize the Safety of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis in the Real-World Setting Using Data From the United Registries for Clinical Assessment and Research (UR-CARE) in the European Union (EU)
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 104 participants Est. completion 2026-03-31 5 sitesOther conditions: Ulcerative ColitisView official trial listing → -
Status unknown NCT NCT06479603
RCT of Nintedanib in Fibrotic Sarcoidosis
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 120 participants Est. completion 2026-01-31 1 siteOther conditions: Sarcoidosis, PulmonaryView official trial listing → -
Status unknown NCT NCT06504784
The Role of Gut Bacteria in the Immune Response to Vaccination in Patients With Ulcerative Colitis
Not yet reported Sahlgrenska University Hospital 150 participants Est. completion 2025-10 1 siteOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT06512766
a Retrospective Study on the Systemic Treatment of LPP and FFA
Erasmus Medical Center 315 participants Est. completion 2023-02-01 1 siteOther conditions: Cicatricial Alopecia, Lichen Planopilaris, Lichen Plano-Pilaris, Frontal Fibrosing Alopecia, Hair Diseases, Scarring Alopecia, Hair Loss/BaldnessView official trial listing → -
Status unknown NCT NCT06523049
Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy
Not yet reported Hao Zeng 67 participants Est. completion 2026-09 1 siteOther conditions: Renal Cell Carcinoma, Immunotherapy, Molecular Targeted TherapyView official trial listing → -
Status unknown NCT NCT06544343
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy
Not yet reported University Of Perugia 190 participants Est. completion 2026-03-18 1 siteOther conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Systemic Lupus Erythematosus, Systemic Sclerosis, Spondyloarthritis, Axial, Ankylosing SpondylitisView official trial listing → -
Status unknown NCT NCT06584773
Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
Not yet reported University of Sao Paulo General Hospital 80 participants Est. completion 2025-07 1 siteOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Enrolling by invitation NCT NCT06596148
Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression
Not yet reported University of California, San Francisco 130 participants Est. completion 2026-06-30 1 siteOther conditions: ImmunosuppresionView official trial listing → -
Status unknown NCT NCT06601361
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients at Assiut University Hospital
Assiut University 112 participants Est. completion 2025-12MASLDView official trial listing → -
Active, not recruiting NCT NCT06613880
Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 48 participants Est. completion 2027-09-30 1 siteOther conditions: Aplastic Anemia, TPO Receptor AgonistsView official trial listing → -
Enrolling by invitation NCT NCT06635863
Comparing Immune System Suppression to Medication for Unexplained Heart Function and Irregular Heartbeat
Not yet reported Roderick Tung 40 participants Est. completion 2027-10 1 siteOther conditions: Ventricular Arrythmia, Non-ischemic Cardiomyopathy, Arrhythmogenic Inflammatory CardiomyopathyView official trial listing → -
Completed NCT NCT06637683
Efficacy of LiveSpo COLON as a Supportive Treatment for Inflammatory Bowel Disease (IBD)
Not yet reported Anabio R&D 60 participants Est. completion 2020-06-20 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT06637865
A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers
Not yet reported Immutep S.A.S. 79 participants Est. completion 2026-08-27 1 siteOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT06650124
Induction of Remission in Autoimmune Hepatitis With Azathioprine vs. MMF
Not yet reported, Not yet reported Institute of Liver and Biliary Sciences, India 108 participants Est. completion 2025-12-31Other conditions: Autoimmune HepatitisView official trial listing → -
Active, not recruiting NCT NCT06673134
Prospective Cohort Establishment and Clinical Observation of Children With Crohn's Disease
Tongji Hospital 100 participants Est. completion 2028-07-24 1 siteOther conditions: Crohn DiseaseView official trial listing → -
Completed NCT NCT06689098
Magnetocardiography as a Diagnostic Screening Tool for Myocarditis and Other Types of Cardiomyopathy
German Heart Institute 330 participants Est. completion 2024-12-01 1 siteOther conditions: CardiomyopathiesView official trial listing → -
Suspended NCT NCT06694454
Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Not yet reported, Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2034-12-31 1 siteOther conditions: Non-small Cell Lung Cancer (NSCLC), Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Carcinoma, Non Small Cell Lung Cancer, Non Small Cell Lung CarcinomaView official trial listing → -
Terminated NCT NCT06695741
Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 14 participants Est. completion 2025-06-30 1 siteOther conditions: Severe Aplastic Anemia, Cyclophosphamide Reduced-dose, Immunosuppressive TherapyView official trial listing → -
Active, not recruiting NCT NCT06700343
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
Not yet reported Amgen 152 participants Est. completion 2027-10-04 109 sitesOther conditions: Relapsing-remitting Multiple Sclerosis (RRMS)View official trial listing → -
Not yet recruiting NCT NCT06723548
Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis
Not yet reported First Affiliated Hospital of Wenzhou Medical University 30 participants Est. completion 2026-12Other conditions: Myasthenia Gravis, Autoimmune DiseasesView official trial listing → -
Not yet recruiting NCT NCT06802822
Prevent Allosensitization in Patients Who Have Failed a First Renal Transplant (PART)
Not yet reported University of British Columbia 96 participants Est. completion 2027-12 1 siteOther conditions: Kidney Transplant, Kidney Transplant Failure, ImmunosuppresionView official trial listing → -
Not yet recruiting NCT NCT06821659
Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined With Immunosuppressants in the Treatment of Refractory Autoimmune Diseases
Not yet reported, Not yet reported Peking University Third Hospital 9 participants Est. completion 2028-12-31Other conditions: Systemic Lupus Erthematosus, Systemic Sclerosis (SSc), Inflammatory Myopathies, ANCA Associated Vasculitis (AAV), Sjogren SyndromeView official trial listing → -
Active, not recruiting NCT NCT06821971
Study of Risk Factors for Therapeutic Failure in Chronic Non-Infectious Uveitis After First-Line Immunosuppressive Therapy
Centre Hospitalier Universitaire, Amiens 200 participants Est. completion 2025-08 1 siteOther conditions: UveitisView official trial listing → -
Not yet recruiting NCT NCT06825572
MSC-EVs in Acute/ Acute-on-Chronic Liver Failure After Liver Transplantation
Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 30 participants Est. completion 2026-09-30 1 siteOther conditions: Liver Failure, Mesenchymal Stem Cell, Extracellular VesiclesView official trial listing → -
Not yet recruiting NCT NCT06846424
SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer
Not yet reported Shanghai Gynecologic Oncology Group 24 participants Est. completion 2030-06-01 1 siteOther conditions: Ovarian Cancer, Fallopian Tube Carcinoma, Peritoneal CarcinomaView official trial listing → -
Not yet recruiting NCT NCT06851845
Clinical Outcomes of C3 Glomerulopathy and IC-MPGN in Russia: Hybrid Retrospective - Prospective Study
Novartis Pharmaceuticals 100 participants Est. completion 2028-02-01Other conditions: Kidney DiseasesView official trial listing → -
Completed NCT NCT06879106
Effect of Cognitive Therapy on Immunosuppressive Treatment Compliance and Motivation
Not yet reported Bitlis Eren University 140 participants Est. completion 2025-08-30 1 siteOther conditions: Liver Transplant; Complications, Immunosuppression, Compliance, TreatmentView official trial listing → -
Not yet recruiting NCT NCT06886646
Allogeneic Umbilical Cord Mesenchymal Stromal Cells for the Treatment of Chronic Antibody-Mediated Rejection in Kidney Transplantation
Not yet reported Assistance Publique - Hôpitaux de Paris 22 participants Est. completion 2029-10-15 1 siteOther conditions: Chronic Antibody-mediated Rejection (cABMR)View official trial listing → -
Completed NCT NCT06914089
Thin Versus Thicker Strut Thickness Stents in Primary Percutaneous Intervention
Not yet reported Assiut University 146 participants Est. completion 2023-09-30 1 siteOther conditions: Primary Percutaneous Coronary InterventionView official trial listing → -
Active, not recruiting NCT NCT06924476
Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort Study
Yipeng Liu 282 participants Est. completion 2025-09-30 1 siteOther conditions: Primary Membranous NephropathyView official trial listing → -
Not yet recruiting NCT NCT06925698
Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease
Not yet reported Marmara University 110 participants Est. completion 2028-04-01 2 sitesOther conditions: Behcet Disease, Behcet Disease and Vascular Involvement, Deep Venous Thromboses, Post Thrombotic SyndromeView official trial listing → -
Not yet recruiting NCT NCT06942156
Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
Not yet reported Chong Kun Dang Pharmaceutical 140 participants Est. completion 2030-12 1 siteOther conditions: Heart TransplantView official trial listing → -
Not yet recruiting NCT NCT06971172
Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients.
Not yet reported Cairo University 22 participants Est. completion 2025-09-01Other conditions: Pemphigus VulgarisView official trial listing → -
Not yet recruiting NCT NCT06981845
Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis
Not yet reported China National Center for Cardiovascular Diseases 52 participants Est. completion 2028-06-01Cardiovascular disease Other conditions: In-stent Restenosis LesionView official trial listing → -
Not yet recruiting NCT NCT06993337
Effect of Topical Bromelain Versus Topical Corticosteroids in the Management of Recurrent Aphthous Stomatitis
Not yet reported Cairo University 63 participants Est. completion 2026-06-15Other conditions: Recurrent Aphthous StomatitisView official trial listing → -
Withdrawn NCT NCT07001254
UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia
Not yet reported Anjali Sharathkumar Est. completion 2031-12-31 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Not yet recruiting NCT NCT07001397
Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAA
Not yet reported Peking Union Medical College Hospital 70 participants Est. completion 2027-03-23Other conditions: Aplastic AnemiasView official trial listing → -
Completed NCT NCT07005466
Bronchoalveolar Lavage Combined With High-throughput Sequencing Technology
Nanfang Hospital, Southern Medical University 500 participants Est. completion 2024-12-30 1 siteOther conditions: PneumoniaView official trial listing → -
Active, not recruiting NCT NCT07015983
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)
Not yet reported Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 89 participants Est. completion 2032-06-15 97 sitesOther conditions: Lupus Erythematosus, Systemic, Lupus NephritisView official trial listing → -
Completed NCT NCT07032337
Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder
Samsung Medical Center 2985 participants Est. completion 2022-12-31Other conditions: Neuromyelitis Optica Spectrum Disorder (NMOSD)View official trial listing → -
Completed NCT NCT07035561
Rituximab Therapy in Patients With Treatment Refractory Hypersenstivity Pneumonitis
Not yet reported Shereen Medhat Mohammed Elsayed Nassar 30 participants Est. completion 2025-01-31 1 siteOther conditions: Hypersenstivity Pneumonitis, ILDView official trial listing → -
Not yet recruiting NCT NCT07052981
Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis
Not yet reported Guixia Ding 124 participants Est. completion 2027-06-30Other conditions: IgA Nephropathy (IgAN), IgAVNView official trial listing → -
Active, not recruiting NCT NCT07071597
The Selection of Initial Treatment Regimens for Adolescent Nephrotic Syndrome.
Nanjing Children's Hospital 400 participants Est. completion 2026-12 1 siteOther conditions: Nephrotic Syndrome, Adolescent, BiopsyView official trial listing → -
Active, not recruiting NCT NCT07080125
A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis
Boehringer Ingelheim 2000 participants Est. completion 2033-12-31 1 siteOther conditions: Interstitial Lung Diseases, Systemic Sclerosis Associated Interstitial Lung DiseaseView official trial listing → -
Completed NCT NCT07080346
Upadacitinib for Refractory Behcet's Syndrome
Not yet reported Liu Tian 27 participants Est. completion 2025-07-08 1 siteOther conditions: Behcet SyndromeView official trial listing → -
Completed NCT NCT07089420
ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects
American Laboratory Products Company 121 participants Est. completion 2026-04-15 1 siteOther conditions: IBD (Inflammatory Bowel Disease), IBS - Irritable Bowel Syndrome, Crohn Disease (CD), UC - Ulcerative ColitisView official trial listing → -
Active, not recruiting NCT NCT07092865
A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant
Not yet reported GlaxoSmithKline 168 participants Est. completion 2027-07-16 38 sitesOther conditions: Respiratory Syncytial Virus InfectionsView official trial listing → -
Active, not recruiting NCT NCT07098897
To Evaluate the Effect and Safety of Telitacicept and Standard Treatment for 6months in IgA Nephropathy
Not yet reported The Affiliated Hospital of Xuzhou Medical University 150 participants Est. completion 2025-09-30 1 siteOther conditions: IgA Nephropathy (IgAN)View official trial listing → -
Enrolling by invitation NCT NCT07102849
Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study
National Heart, Lung, and Blood Institute (NHLBI) 1400 participants Est. completion 2030-07-11 1 siteOther conditions: Bone Marrow Failure Disorders, VEXAS Syndrome, Hemoglobinurea, Paroxysmal, Myelodysplastic Syndromes, Bone Marrow DiseasesView official trial listing → -
Enrolling by invitation NCT NCT07113743
Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2029-09-01 1 siteOther conditions: Chronic Granulomatous Disease (CGD)View official trial listing → -
Completed NCT NCT07114016
Efficacy of Topical Glucosamine Versus Corticosteroid in Oral Lichen Planus
Not yet reported Future University in Egypt 36 participants Est. completion 2025-07-31 1 siteOther conditions: Oral Lichen PlanusView official trial listing → -
Not yet recruiting NCT NCT07172945
Research and Follow-up of the Determinants of the Progression and Complications of Inflammatory Bowel Diseases Treated or Not With Immunosuppressants.
Not yet reported Assistance Publique - Hôpitaux de Paris 4500 participants Est. completion 2040-11Other conditions: Crohn, Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease)View official trial listing → -
Not yet recruiting NCT NCT07194057
"A Privacy-protecting Environment for Child Transplants Health Related and Genomic Data Integration in the European Reference Network"
Instituto de Investigación Hospital Universitario La Paz 200 participants Est. completion 2028-01 4 sitesOther conditions: Transplant Complication, Kidney Transplant, Liver TransplantView official trial listing → -
Not yet recruiting NCT NCT07203664
Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.
Not yet reported Hospital Universitario La Paz 30 participants Est. completion 2026-12-31 1 siteOther conditions: Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant RecipientsView official trial listing → -
Active, not recruiting NCT NCT07219121
Sparsentan in Posttransplant Immunoglobulin A Nephropathy or Focal Segmental Glomerulosclerosis
Not yet reported Travere Therapeutics, Inc. 20 participants Est. completion 2027-05 8 sitesOther conditions: Proteinuria, Immunoglobulin A (IgA) Nephropathy, Focal Segmental Glomerulosclerosis, Kidney TransplantView official trial listing → -
Completed NCT NCT07235813
IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy
Not yet reported Kasr El Aini Hospital 16 participants Est. completion 2025-10-01 1 siteOther conditions: Mycosis FungoidesView official trial listing → -
Completed NCT NCT07239128
Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus
Not yet reported University of Seville 160 participants Est. completion 2025-06-01 2 sitesOther conditions: Dry Eye Disease (DED)View official trial listing → -
Not yet recruiting NCT NCT07248644
Immunosuppressant Discontinuation in Elderly Patients With Ulcerative Colitis And Long-term Remission
Not yet reported Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa 304 participants Est. completion 2027-09Other conditions: Ulcerative Colitis (UC)View official trial listing → -
Active, not recruiting NCT NCT07262437
Targeting Immunosuppressive Treatment for Non-infectious Uveitis Using Aqueous Humor Cytokine Profiles
Not yet reported University of Milan 220 participants Est. completion 2026-07-01 3 sitesOther conditions: Uveitis Posterior Non-Infectious, Inflammation Eye, Uveitis, Uveitis, AnteriorView official trial listing → -
Not yet recruiting NCT NCT07297550
Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia
Not yet reported, Not yet reported Institute of Hematology & Blood Diseases Hospital, China 42 participants Est. completion 2027-07-01Other conditions: Severe Aplastic Anemia, Refractory Aplastic Anemia, Newly Diagnosed Aplastic AnemiaView official trial listing → -
Enrolling by invitation NCT NCT07309588
Hyaluronic Acid in the Treatment of Hyposalivation
Not yet reported, Not yet reported Poznan University of Medical Sciences 100 participants Est. completion 2026-01-19 1 siteOther conditions: Xerostomia Due to Hyposecretion of Salivary GlandView official trial listing → -
Not yet recruiting NCT NCT07319793
Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT
Not yet reported Peking University People's Hospital 200 participants Est. completion 2028-06-30Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS)View official trial listing → -
Not yet recruiting NCT NCT07325357
Effect of Pirfenidone on TA Fibrosis
Not yet reported Shanghai Zhongshan Hospital 92 participants Est. completion 2030-12-31Other conditions: Takayasu ArteritisView official trial listing → -
Not yet recruiting NCT NCT07329959
CAR-DC for End-Stage IPF
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 8 participants Est. completion 2029-02-28Other conditions: Idiopathic Pulmonary Fibrosis(IPF)View official trial listing → -
Not yet recruiting NCT NCT07338422
HID-HSCT Versus IST as First-line Treatment for SAA
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 116 participants Est. completion 2030-09-14Other conditions: Aplastic AnaemiaView official trial listing → -
Completed NCT NCT07343401
Sarcoidosis Immunotsuppressive Therapy and Lymphoma Development
Alexandria University 40 participants Est. completion 2026-01-01 1 siteOther conditions: Sarcoidosis LungView official trial listing → -
Enrolling by invitation NCT NCT07343661
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
Not yet reported Azienda Ospedaliero Universitaria di Cagliari 90 participants Est. completion 2028-09-30 1 siteOther conditions: EGPA - Eosinophilic Granulomatosis With Polyangiitis, Severe Asthma, Eosinophilic AsthmaView official trial listing → -
Not yet recruiting NCT NCT07345000
A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia
Not yet reported Qilu Pharmaceutical Co., Ltd. 210 participants Est. completion 2030-08Other conditions: Treatment-naïve Severe Aplastic AnemiaView official trial listing → -
Not yet recruiting NCT NCT07354503
Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis
The Children's Hospital of Zhejiang University School of Medicine 300 participants Est. completion 2028-06-30Other conditions: IgAVN, IgA VasculitisView official trial listing → -
Not yet recruiting NCT NCT07364123
Kidney Transplant Immunosuppressive Therapy Adherence Trial (KITE)
Not yet reported University of Gaziantep 60 participants Est. completion 2026-08-15 1 siteOther conditions: Kidney Transplantation, Medication Non-Adherence, Immunosuppressive Therapy, Renal Transplant RecipientsView official trial listing → -
Not yet recruiting NCT NCT07380659
Safety and Efficacy of FAP iCDC in Acute Myocardial Infarction With Cardiogenic Shock
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 18 participants Est. completion 2027-02-28 1 siteCardiovascular disease Other conditions: Cardiogenic ShockView official trial listing → -
Not yet recruiting NCT NCT07382375
AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection
Not yet reported Nanjing Medical University 300 participants Est. completion 2027-12-31 8 sitesOther conditions: Aortic Aneurysm and DissectionView official trial listing → -
Completed NCT NCT07415083
A Study of the Safety and Effectiveness of Eltrombopag in Combination With Immunosuppressive Therapy (IST) in Korean Pediatric Patients With Treatment Naïve Severe Aplastic Anemia
Novartis Pharmaceuticals 13 participants Est. completion 2025-02-25 1 siteOther conditions: Aplastic AnemiaView official trial listing → -
Completed NCT NCT07430449
The Effect of Education Given According to Roy's Adaptation Model
Not yet reported Trakya University 78 participants Est. completion 2025-06-15 1 siteChronic kidney disease Other conditions: Immunosuppressive TherapyView official trial listing → -
Not yet recruiting NCT NCT07431775
Saphnelo Use in Females of Child-bearing Potential
AstraZeneca 26000000 participants Est. completion 2032-03-31Other conditions: Systemic Lupus ErythematosusView official trial listing → -
Not yet recruiting NCT NCT07447388
Development, Pilot Testing and Evaluation of the Effectiveness of Immunosuppressive Medication Adherence Care Bundle in Patients Undergoing Solid Organ Transplantation
Not yet reported Hacettepe University 100 participants Est. completion 2027-04-01Other conditions: Transplant PatientsView official trial listing → -
Not yet recruiting NCT NCT07448363
Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
Caja Costarricense de Seguro Social 50 participants Est. completion 2031-05 1 siteOther conditions: Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema), Atopic Dermatitis Patients, Atopic Dermatitis / Eczema, Atopic Dermatitis, UnspecifiedView official trial listing → -
Not yet recruiting NCT NCT07471165
A Prospective, Single-Arm, Phase II Study: PD-L1 Monoclonal Antibody + Chemoradiotherapy as Bridge Therapy to Liver Transplantation for Locally Advanced Perihilar Cholangiocarcinoma (ACHIEVE-LT)
Not yet reported The First Affiliated Hospital with Nanjing Medical University 25 participants Est. completion 2029-07-01 2 sitesOther conditions: Locally Advanced Perihilar CholangiocarcinomaView official trial listing → -
Completed NCT NCT07473752
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects
Not yet reported Tonix Pharmaceuticals, Inc. 26 participants Est. completion 2024-02-22 1 siteOther conditions: Phase 1 First-in-human Study Involving Healthy SubjectsView official trial listing → -
Active, not recruiting NCT NCT07486206
Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial
Not yet reported Hospital de Granollers 152 participants Est. completion 2027-09-30 1 siteOther conditions: Interstitial Lung Disease (ILD), Fibrotic Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis (IPF), Progressive Pulmonary Fibrosis, Interstitial Lung Disease Due to Connective Tissue Disease (Disorder)View official trial listing → -
Not yet recruiting NCT NCT07505576
Anti-alpha-actinin Antibodies and Lupus Nephritis Activity
Assiut University 96 participants Est. completion 2027-10-01Other conditions: Lupus NephritisView official trial listing → -
Active, not recruiting NCT NCT07519005
Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure
Not yet reported Xijing Hospital 1 participants Est. completion 2026-12-31 1 siteOther conditions: Hepatic FailureView official trial listing → -
Not yet recruiting NCT NCT07543640
EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL.
Not yet reported Eman Raafat Said 56 participants Est. completion 2026-08Other conditions: Flexural Psoriasis (Also Known as Inverse or Intertriginous Psoriasis) and Genital PsoriasisView official trial listing → -
Active, not recruiting NCT NCT07555106
Dapagliflozin in Living-Donor Kidney Transplant Recipients
Not yet reported University of Guadalajara 54 participants Est. completion 2026-09-30 1 siteOther conditions: Kidney Transplant, Kidney Transplant FailureView official trial listing → -
Enrolling by invitation NCT NCT07564609
the REMONO-CD and the REMONO-UC Studies
University Hospital, Clermont-Ferrand 420 participants Est. completion 2026-10 18 sitesOther conditions: Crohn Disease (CD), Ulcerative Colitis (UC)View official trial listing → -
Not yet recruiting NCT NCT07570433
HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial
Not yet reported Oriol Manuel 100 participants Est. completion 2028-03 4 sitesOther conditions: CMV InfectionView official trial listing → -
Not yet recruiting NCT NCT07572695
Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2028-12Other conditions: Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/RefractoryView official trial listing → -
Active, not recruiting NCT NCT07597733
Telitacicept for Refractory Chronic Inflammatory Demyelinating Polyneuropathy
Not yet reported Sichuan Academy of Medical Sciences 76 participants Est. completion 2027-08-31 1 site Stand-aloneOther conditions: Refractory Chronic Inflammatory Demyelinating PolyneuropathyView official trial listing → -
Not yet recruiting NCT NCT07638709
Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases
Xiangya Hospital of Central South University 150 participants Est. completion 2030-06-01 1 siteOther conditions: Non Small Cell Lung, Brain MetastasasesView official trial listing → -
Not yet recruiting NCT NCT07642297
TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)
Fondazione Policlinico Universitario Campus Bio-Medico 20 participants Est. completion 2028-09-01 1 siteOther conditions: Systemic Sclerosis (SSc), Diffuse Cutaneous Systemic Sclerosis, Skin FibrosisView official trial listing → -
Not yet recruiting NCT NCT07643038
Treatment Strategy for Patients With RA-ILD
Not yet reported Chinese SLE Treatment And Research Group 204 participants Est. completion 2029-07-31 22 sitesOther conditions: Rheumatoid Arthritis Associated Interstitial Lung DiseaseView official trial listing → -
Not yet recruiting NCT NCT07643103
Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative B-ALL: A Prospective Umbrella Trial
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 32 participants Est. completion 2030-05-31Other conditions: Ph- Acute Lymphoblastic Leukemia (Ph-ALL)View official trial listing → -
Completed NCT NCT07662265
Tocilizumab in Refractory ASS-ILD
Hu Yinan 111 participants Est. completion 2025-10-31 1 siteOther conditions: Antisynthetase Syndrome, TocilizumabView official trial listing → -
Not yet recruiting NCT NCT07682350
SGLT2i Effect on PTDM Development and Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients: A Randomized, Doubleblind, Placebo Controlled, National Multicenter Trial
Not yet reported Odense University Hospital 184 participants Est. completion 2029-10-01 3 sitesOther conditions: Kidney Transplant Recipient, Sodium Glucose Co-Transporter 2 Inhibitors, Non-Diabetic Patients, Randomized Controlled Trial (RCT), Placebo Control Design, Post Transplant Diabetes MellitusView official trial listing → -
Not yet recruiting NCT NCT07715565
Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
Not yet reported West China Hospital 66 participants Est. completion 2029-12 1 siteOther conditions: Renal Cell Carcinoma (Kidney Cancer), Immunotherapy, Molecular Targeted TherapyView official trial listing → -
Not yet recruiting NCT NCT07717060
Extracellular Vesicle Dynamics Predicting Vascular Complications and Treatment Response in Systemic Sclerosis
Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60 participants Est. completion 2028-09-01Other conditions: Systemic Sclerosis, Pulmonary Arterial Hypertension, Digital Ulcers, Vascular ComplicationsView official trial listing → -
Not yet recruiting NCT NCT07718633
Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)
Not yet reported Natera, Inc. 750 participants Est. completion 2031-07Other conditions: Kidney Transplant, ImmunosuppresionView official trial listing → -
Completed NCT NCT07728604
Effect of Digital Follow-up Supported Patient Education on Immunosuppressive Medication Adherence and Quality of Life After Liver Transplantation
Not yet reported Cansu Yıldız 48 participants Est. completion 2026-06-20 1 siteOther conditions: Liver Transplantation, Medication AdherenceView official trial listing → -
Not yet recruiting NCT NCT07731672
Incidence of Tuberculosis in Patients With Autoimmune Rheumatic Diseases
Not yet reported University of Sao Paulo General Hospital 1660 participants Est. completion 2031-07-30 1 siteOther conditions: Autoimmune Rheumatic Diseases, PreventionView official trial listing → -
Enrolling by invitation NCT NCT07735650
Immunosuppressant Withdrawal Based on Parenchymal Chimerism in the Liver Transplantation
Not yet reported Chang Gung Memorial Hospital 60 participants Est. completion 2027-07-31 1 siteOther conditions: Liver Transplantation, Liver Transplantation in Long-termView official trial listing → -
Not yet recruiting NCT NCT07736612
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer
Not yet reported, Not yet reported Zhejiang University 80 participants Est. completion 2029-12-30 1 siteOther conditions: Pancreatic Cancer, RAS Mutations or AmplificationsView official trial listing → -
Not yet recruiting NCT NCT07737249
Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease
Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2027-08-31 1 siteOther conditions: Interstitial Lung DiseasesView official trial listing → -
Not yet recruiting NCT NCT07743047
Harnessing the Immunosuppressive Leukemic Microenvironment to Engineer T Cells With Enhanced Anti-tumor Functionality
IRCCS San Raffaele 65 participants Est. completion 2030-12-31Other conditions: Acute Myeloid LeukemiaView official trial listing → -
Not yet recruiting NCT NCT07762703
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy
Not yet reported, Not yet reported BreakBio Corp 10 participants Est. completion 2030-09 1 siteOther conditions: Triple-Negative Breast Cancer (TNBC)View official trial listing → -
Not yet recruiting NCT NCT07762716
Combination Immunotherapy Treatment for Glioblastoma Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy
Not yet reported, Not yet reported BreakBio Corp 10 participants Est. completion 2030-09 1 siteOther conditions: Glioblastoma (GBM)View official trial listing → -
Not yet recruiting NCT NCT07765914
Zuberitamab in the First Episode of Paediatric Nephrotic Syndrome
Not yet reported Children's Hospital of Fudan University 120 participants Est. completion 2028-12-31 9 sitesOther conditions: Nephrotic SyndromeView official trial listing → -
Active, not recruiting NCT NCT07773623
An Interventional Study of Upadacitinib Extended-Release Tablets in Patients With Refractory Uveitis
Not yet reported Tianjin Medical University 30 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: UveitisView official trial listing → -
Not yet recruiting NCT NCT07785128
Efficacy and Safety of Mycophenolate Mofetil in Refractory IgA Nephropathy
Not yet reported Shaheed Suhrawardy Medical College and Hospital 104 participants Est. completion 2027-08-31 3 sitesOther conditions: IgA NephropathyView official trial listing → -
Not yet recruiting NCT NCT07786922
A Study of Avatrombopag in Adults With Aplastic Anemia Who Did Not Respond to, Cannot Receive, or Had Return of Disease After Standard Treatment
Not yet reported, Not yet reported Swedish Orphan Biovitrum 26 participants Est. completion 2029-12-31Other conditions: Aplastic AnemiaView official trial listing → -
Enrolling by invitation NCT NCT07813416
The mHTX APP Program
Not yet reported University of Aarhus 200 participants Est. completion 2027-12-01 1 siteOther conditions: Rehabilitation, Follow upView official trial listing → -
Active, not recruiting NCT NCT07825207
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
Fondazione Italiana Sindromi Mielodisplastiche-ETS 100 participants Est. completion 2027-07-31 26 sitesOther conditions: Myelodysplastic Neoplasm, Myelodysplastic SyndromeView official trial listing → -
Not yet recruiting NCT NCT07833163
Corticotropin for Behçet's Disease: A Multicenter Randomized Controlled TrialAcronym.
Not yet reported Peking University People's Hospital 60 participants Est. completion 2029-09 1 siteOther conditions: Behçet's Syndrome, Behçet's Syndrome (BS)View official trial listing → -
Not yet recruiting NCT NCT07836790
A Randomized, Double-Blind, Placebo-Controlled Trial of Fufei Huazhuo Tongluo Formula Combined With Standardized Medicine in Patients With Anti-Synthetase Syndrome-Associated Interstitial Lung Disease
Not yet reported First People's Hospital of Hangzhou 54 participants Est. completion 2028-12-31 1 siteOther conditions: Anti-Synthetase Syndrome, Interstitial Lung Disease (ILD)View official trial listing → -
Not yet recruiting NCT NCT07844200
The Primary Objective of the Trial is to Evaluate the Effect of the Addition of Belantamab Mafodotin to Standard of Care Therapy on the Titres of Serum Anti-dsDNA Antibodies in Patients With Previously Treated SLE.
Not yet reported Medical Association for the Study of Cancer Biology and Treatment 12 participants Est. completion 2031-12Other conditions: SLE - Systemic Lupus ErythematosusView official trial listing → -
Not yet recruiting NCT NCT07846943
Epstein-Barr Virus Antibodies in Egyptian Patients With Multiple Sclerosis
Assiut University 140 participants Est. completion 2027-11Other conditions: Multiple Sclerosis, Epstein-Barr Virus Infections, Epstein-Barr Virus (EBV) InfectionView official trial listing → -
Completed NCT NCT07850362
Clinical Study of UC-MSC Combined With Immunosuppressive Agents in the Treatment of Pediatric HAAA
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 20 participants Est. completion 2025-10-31 1 site Stand-aloneOther conditions: Hepatitis-associated Aplastic Anemia, Severe Aplastic Anemia(SAA), Umbilical Cord Blood, Mesenchymal Stem Cells, PediatricView official trial listing → -
Completed NCT NCT07851142
The Effect of the 5th Sign Intervention on Medication Adherence in Kidney Transplant Recipients
Not yet reported Dokuz Eylul University 100 participants Est. completion 2025-12-31 1 siteOther conditions: Kidney Transplant, Drug-Related Side Effects and Adverse Reactions (MeSH Term), Medication Adherence, Mobile ApplicationsView official trial listing → -
Not yet recruiting NCT NCT07858201
Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of Immunosuppression
Not yet reported University Hospital, Montpellier 190 participants Est. completion 2028-10-01Other conditions: Human Papillomavirus Infection, Anal HPV Infection, Human Papillomavirus 16 InfectionView official trial listing → -
Not yet recruiting NCT NCT07859839
Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD
Not yet reported Post Graduate Institute of Medical Education and Research, Chandigarh 177 participants Est. completion 2027-07-31 1 siteOther conditions: Interstitial Lung DiseaseView official trial listing → -
Completed NCT NCT07884084
Effect of Probiotics on Immunosuppressant Therapy in Kidney Transplant Recipients
Not yet reported Federico II University 40 participants Est. completion 2025-10-03 1 siteOther conditions: Kidney Transplantation, Kidney Transplantation RecipientsView official trial listing → -
Not yet recruiting NCT NCT07893691
Microbiota Changes Related to Outcomes in Kidney Transplantation
Hospices Civils de Lyon 30 participants Est. completion 2029-01-15 1 siteOther conditions: End-stage Renal Disease (ESRD), Kidney TransplantationView official trial listing → -
Not yet recruiting NCT NCT07897968
GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors
Not yet reported Universität Münster 30 participants Est. completion 2032-12-31 1 siteObstructive sleep apnea Other conditions: Neuroblastoma (NBL), Ewing SarcomaView official trial listing → -
Not yet recruiting NCT NCT07901764
MYTP01 for Immune-Mediated Diseases
Not yet reported Zhejiang Provincial People's Hospital 160 participants Est. completion 2028-12 1 siteOther conditions: IgA Nephropathy, Kidney Transplant Recipients, Lupus Nephritis, Primary Membranous Nephropathy, ANCA-associated Vasculitis, Systemic Lupus Erythematosus, Rheumatoid Arthritis (RA), Sjogren's Syndrome, Hashimoto ThyroiditisView official trial listing → -
Completed NCT NCT07903649
A Randomized, Controlled Clinical Study on the Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Combined With Standard Immunosuppressants in the Treatment of Children With Severe Aplastic Anemia
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 64 participants Est. completion 2026-04-20 1 siteOther conditions: Sever Aplastic Aneia, Children, Umbilical Cord Mesenchymal Stem CellsView official trial listing → -
Completed NCT NCT07910526
Umbilical Cord Mesenchymal Stem Cell Secretome in Patients With Sjogren's Syndrome
Not yet reported, Not yet reported Universitas Sebelas Maret Hospital 29 participants Est. completion 2026-10-20 2 sitesOther conditions: Sjogren's SyndromeView official trial listing → -
Not yet recruiting NCT NCT07927400
An Exploratory Study of the Efficacy and Safety of SBRT Following Induction Therapy With Neoadjuvant Immunotherapy Combined With Chemotherapy in Muscle-Invasive Bladder Cancer
Not yet reported Tianjin Medical University Cancer Institute and Hospital 36 participants Est. completion 2030-12-01Other conditions: Muscle-invasive Bladder CancerView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
